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ABSTRACT 
A major quest in modem neurobiology is to understand how the brain controls behavior. To this end, 
the convergence of two traditionally separate fields, systems neuroscience and molecular neuroscience, is 
required. The delineation of brain regions responsible for different behaviors, and in particular, their 
underlying neural circuits should be accompanied by the appreciation of the molecules that compose such 
circuits. 
I have taken two approaches toward unraveling the molecular signatures of specific neural structures. 
First, I conducted microarray-based RNA expression analyses to search, in a large scale and with no a 
priori constraints, for differentially expressed gene products in several brain regions, including the 
amygdala, cerebellum, hippocampus, olfactory bulb and periaqueductal gray. Interestingly, only 0.3% of 
the genes characterized to date showed restricted expression in distinct brain areas. Further characterization 
by in situ hybridization was performed for genes enriched in the amygdala, a structure that modulates 
emotional behavior. Remarkably, this revealed that most region-specific genes possessed expression 
domains whose limits respected subnuclear boundaries defined by classical cytoarchitectonic criteria. 
These analyses were not only informative about the molecular composition of distinct brain areas, but also 
provided tools to genetically dissect the role of different brain nuclei in specific behaviors. 
Second, I have used a genetic strategy to label all cellular derivatives of neural crest precursor cells 
expressing a particular gene, Ngn2. Such lineage tracing study uncovered a segregated cellular 
subpopulation in the developing peripheral nervous system, which was strongly biased for the generation of 
sensory rather than autonomic neurons. Despite this fate bias, Ngn2-derived cells in the dorsal root 
ganglion were equally likely to give rise to neurons or glia. This suggests that some neural crest cells 
become restricted to sensory or autonomic sub lineages before becoming committed to neuronal or glial 
fates. In general, visualization of the behavior of neural progenitors during the formation of the nervous 
system may further our understanding of the generation of specific neuronal subtypes and, eventually, 
neuronal connections that shape the functioning brain. 
The combination of strategies here described will enable the characterization of brain regions at the 
molecular level on a broad, systems-based approach. 
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INTRODUCTION 
The adult brain contains around 100 billion neurons that make 100,000 billion 
synaptic contacts (Kandel et aI., 2000). Our brain's exquisite pattern of connections and 
the way different brain regions transduce signals underlie the control of voluntary and 
involuntary body actions as well as feelings or emotions. Understanding brain function at 
the molecular level poses one of the most fascinating challenges in modem science. 
How the brain controls behavior is being studied from several flanks at once, 
among others, by molecular biologists and system neuroscientists. The former examine in 
detail genes and signals that modulate neural function, usually concentrating on 
simplified model systems amenable to experimental manipulation. System 
neuroscientists, on the other hand, analyze the intricacies of the nervous system by 
looking at the entire brain (or large regions of it) as a whole, often treating the brain as a 
black box disregarding neuronal diversity. Much progress has been made recently in both 
domains, reviewed in (Albright et aI., 2000); we are now entering an exciting era in 
which both fields can be integrated to provide a more comprehensive view of the brain. 
The mammalian brain is subdivided into cytoarchitectonic ally and physiologically 
distinct regions. Functional magnetic resonance imaging (fMRI) and lesion studies have 
suggested that this anatomical parcellation reflects a modular functional organization 
(Kandel et aI., 2000). A major goal then is to elucidate the functional roles of such brain 
modules, and of the neuronal subtypes that comprise them, in mediating specific 
behaviors. An important first step in applying the tools of molecular biology to this goal 
is to identify molecular markers for these subregions. This point is well illustrated by 
recent work (Abel et aI., 1997; Rotenberg et aI., 1996; Tsien et aI., 1996 (a); Tsien et aI., 
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1996 (b» that combined mouse genetics and behavioral paradigms. There, insight about 
the action of particular molecules in defined neuronal circuits was only possible thanks to 
the ability to manipulate genes in specific neuronal subpopulations, namely in the 
hippocampus. To date, very few genes have been reported to be specifically expressed in 
different brain regions, however, subtractive hybridization experiments have suggested 
that such brain subregion-restricted genes do exist (Gautvik et aI., 1996). Examples of 
these genes include orexin-A and -B, neuropeptides produced exclusively by a well-
defined group of neurons in the lateral hypothalamus (Chemelli et aI., 1999), or the alpha 
6 subunit of the GABA (A) receptor, expressed only in cerebellar granule cells (Pirker et 
aI.,2000). 
In particular, no region-specific gene had been reported in the amygdala, a 
structure of appeal because it mediates fear responses of psychiatric interest. The 
amygdala is extensively studied in rodents and primates since it plays a crucial role in the 
control of sexual, aggressive and fear behaviors, usually referred to as 'emotional' 
behaviors (Davis, 1992; Gallagher and Chiba, 1996; LeDoux, 1995). Because many 
human mental disorders, including anxiety, phobia, post-traumatic stress syndrome and 
panic attack, involve malfunctions in the brain's ability to control fear, studies of the 
neural basis of this emotion may help us understand and eventually treat these 
disturbances (LeDoux, 1994). 
The amygdala is composed of over a dozen subnuclei with specific functions 
(Davis, 1992; Pitkanen et aI., 1997). A simplified organizational view of the amygdala is 
that it receives sensory information through its main input structure, the lateral nucleus, 
and directs behavior through its main output system, the central nucleus. This subnucleus 
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projects to autonomic centers in the brain stem and hypothalamus, and is responsible for 
the stereotypical generation of fear responses. In addition, the amygdala receives 
projections from multiple other brain regions, like the hippocampus (that mainly projects 
to the basolateral nucleus), frontal cortex (that mostly connects with the basomedial 
nucleus) and hypothalamus (that heavily connects with the medial nucleus (Pitkanen et 
aI., 1997; Swanson and Petrovich, 1998).) Thus, this forebrain structure is capable of 
integrating multiple incoming information and of modulating the animal's behavior 
according to external stimuli and internal state. 
To find amygdala-specific transcripts in the mouse relative to other brain regions, 
I set out to search for genes differentially expressed in this region. At the same time, the 
screen could determine whether differences in brain areas reflect absolute differences in 
gene expression or rather combinatorial expression of transcripts. In other words, is the 
molecular uniqueness of each brain structure determined by the expression of a few 
region-specific genes, or are most genes expressed throughout the brain, instead, but at 
different levels or in distinct combinations in each region? Recently developed 
micro array technology (reviewed in Supplement, 1999) was well suited to answer these 
questions. Briefly, DNA microarrays exploit the preferential binding of complementary 
single-stranded nucleic acid sequences. The sample (in this case, each brain region) is 
hybridized to an ordered array of "probes," or immobilized DNA molecules of known 
sequence arranged in a defined matrix. Specific hybridization to each probe on the array 
can be read and translated into abundance levels of each gene in the sample. Unlike 
conventional nucleic acid hybridization methods, DNA micro arrays can quantitatively 
monitor expression of thousands of genes simultaneously, which has revolutionized 
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biological experiments lately. However, neural science has initially lagged behind other 
fields of biology in the exploitation of micro array technology (Serafini, 1999), perhaps 
due to the enormous complexity of the subject of study. 
I have therefore employed micro array technology coupled with in situ 
hybridization to identify and characterize amygdala-enriched gene products compared to 
genes expressed in four other brain regions, including the cerebellum, hippocampus, 
olfactory bulb, and periaqueductal gray. This work and others (Lee et aI., 1999; Mimics 
et aI., 2000; Rampon et aI., 2000; Sandberg et aI., 2000) were among the first ones to 
apply micro array technology to the study of the brain (reviewed in Cao and Dulac, 2001). 
In addition, I have later polished the molecular characterization of the amygdala by 
identifying genes differentially enriched within its various subnuclei. This was 
accomplished by comparing gene expression profiles from finely dissected pieces of 
tissue obtained by laser-capture microdissection (LCM), followed by amplification of 
RNA contents. Briefly, LCM allows the extraction of specific cell populations from a 
thin tissue section (Emmert-Buck et aI., 1996). The strategy consists on the transfer of 
cells to a laser-activated specially designed transfer film. Thus, with the aid of a 
microscope, a low-power laser is aimed at the region of interest and specific cells can be 
collected on the film, while surrounding material is left intact. 
The coupling of LCM-tissue extraction, RNA amplification, microarray analysis 
and in situ hybridization inspection of identified enriched genes proved a powerful 
combination of techniques to characterize brain regions at an unusually high level of 
detail. Remarkably, we observed that the majority of amygdala-enriched genes had 
expression domains, whose limits coincided, at least in part, with subregion boundaries 
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demarcated by classical histological techniques, such as Nissl staining. This was the case 
regardless of the homogeneity of the starting material, since we obtained subregion-
confined genes when the entire amygdala tissue was extracted in a rather crude manner 
by hand dissection, as well as when specific amygdala subnuclei were carefully dissected 
by laser capture. By extension, this suggests that classically defined brain nuclei may be 
also delineated by domains of gene expression. The results obtained here set the grounds 
for establishing a "molecular brain atlas", in which each structure is also depicted by its 
molecular repertoire. 
In addition, I have taken a seemingly opposite strategy to study the outstanding 
cellular diversity observed in the nervous system. I have used the expression of a single 
gene, Neurogenin-2 (Ngn2), to label all cellular derivatives of particular neural progenitor 
cells marked by the expression of such gene in the peripheral nervous system. Since 
neural progenitor cells build the nervous system, their characterization may also shed 
light on brain composition and presumably synaptic connectivity. 
Ngn2 is a proneural bHLH transcription factor expressed early in the ontogeny of 
some neural crest cells, as well as in a variety of eNS neural precursors, e.g. in cortex. It 
is necessary for the development of some sensory neurons (Ma et al., 1999) but 
dispensable for the generation of autonomic neurons and glia (Fode et al., 1998). The 
genetic requirement of Ngn2 for sensory but not autonomic neurogenesis raised the 
possibility that intrinsically restricted sensory precursor cells existed in neural crest cells, 
which give rise to the neurons and glia of the peripheral nervous system. Previous 
lineage-tracing studies in vivo (Fraser and Bronner-Fraser, 1991) have indicated the 
presence of neural crest precursors with restricted fates. However, it was not possible to 
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distinguish whether the manifestation of restricted fates reflected true cellular 
commitment or rather stochastic variations in the behavior of a more homogeneous 
progenitor population. Later in vitro studies (Henion and Weston, 1997) favored the idea 
that the neural crest is a heterogeneous cellular population containing progenitor cells that 
generate neurons or glia. Nevertheless, the neuronal subtype(s) generated by restricted 
progenitors was not examined. 
I have used a genetic strategy to label specific Ngn2-expressing progenitor cells 
and their derivatives during nervous system formation in transgenic mice. To do this, a 
temporally inducible Cre/loxP recombination system (Danielian et aI., 1998; Sauer, 1993) 
was employed. This permits the visualization of the fates adopted by derivatives of 
progenitor cells expressing Ngn2 during a well-defined time window. This strategy, 
although not necessarily equivalent since this is not a clonal cell marking approach, poses 
many advantages over classical lineage-tracing experiments performed by injection of a 
vital dye (reviewed in Bronner-Fraser et aI., 1991) or a replication-incompetent retrovirus 
(Frank and Sanes, 1991). First, extensive experimental manipulation is not required as in 
the case of lineage-dye injection or viral infection. Second, the integrity and survival of 
labeled cells are not challenged by expression of the reporter transgene. In addition, 
higher number or labeled cells can be typically obtained. Analyses of transgenic mice 
designed to observe the fate of Ngn2+ expressing cells suggested that these cells are 
strongly biased towards the generation of sensory rather than autonomic derivatives when 
compared to the behavior of the bulk neural crest cell population. Moreover, they showed 
that despite this neuronal subtype bias, Ngnf-progenitors generated neurons and glia 
with equal probabilities. 
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This finding runs counter to classical views of neural cell lineage segregation, 
since it has been usually proposed that neuronal and glial diversification occurs prior to 
neuronal subtype specification (Anderson, 2001; Gage, 2000; Temple and Qian, 1996). 
Progenitor cells are responsible for generating the various neurons and glia in 
appropriate locations, ratios and times for the right development of the nervous system. 
Understanding the logic of their development thus provides another perspective towards 
uncovering the secrets of nervous system formation and function. 
Overview of the Thesis 
Described in Chapter 1 is the overall strategy employed to search for genes 
differentially expressed in the brain. I describe the preparation of the samples, an 
overview of DNA micro array technology, the custom algorithms developed to analyze 
the data and the posterior validation by in situ hybridization techniques. I also present 
here the unexpected finding that most amygdala-enriched genes identified respect intra-
amygdaloid expression boundaries corresponding to cytoarchitectonic ally-defined 
subnuclei. This prompted the further study of gene expression within these specific areas. 
Therefore, I later refined the search to find genes differentially expressed within 
amygdala subnuclei. Chapter 2 explains the use of a similar screen to the one described in 
the first chapter but starting with finely dissected material from distinct amygdala 
subnuclei. To this end, I applied a relatively novel technique based on Laser Capture 
Microdissection (LCM) to obtain the samples that were then submitted to microarray 
hybridization. More amygdala-enriched genes with restricted subnuclear distribution are 
presented in this chapter, together with a methodological discussion that addresses the 
benefits of LCM use and the lessons learnt from these screens. 
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There has been an explosion in the number of papers using DNA micro array 
technology recently. A large number of manuscripts have also appeared these last years 
describing new methods for the quantitative analysis of these data. I briefly describe 
some of these other methods in Appendix 1 and compare the results of some of them 
(SOM and Bullfrog) to those obtained with my algorithm in the analysis of my datasets. 
Diversification in peripheral neural cells is the focus of Chapter 3. Results 
obtained with genetic lineage tracing experiments indicate that neuron-subtype 
specification precedes neuron-glial fate determination. A brief description of the genetic 
strategy employed is also presented in this chapter. 
I present some conclusions and observations in the Concluding Remarks section. I 
discuss the major advancements obtained by the use of these novel techniques and, in 
particular, their relevance to study the brain. A number of potentially interesting future 
directions for further investigation has stemmed from this research and I discuss some of 
them here as well. 
9 
1 AMYGDALA-ENRICHED GENES IDENTIFIED BY 
MICROARRAY TECHNOLOGY ARE RESTRICTED TO 
SPECIFIC AMYGDALOID SUBNUCLEI 
1. 1 Introduction 
Functional imaging and lesion studies have uncovered a modular functional 
organization of the brain (Kandel et aI., 2000). It is also well established that the brain is 
subdivided into cytoarchitectonically and physiologically distinct regions. However, little 
is known about the regional differences in gene expression that may regulate brain 
function. The speculation of the existence of differentially expressed genes which may 
confer such specificity embarked me on the search of genes differentially expressed in 
the adult mouse brain. To maximize this search, I have employed commercially available 
microarrays that simultaneously monitor expression of thousands of genes and then 
concentrated on the study of amygdala-specific genes to illustrate the validity of the 
screen. 
Microarray technology represents a potentially powerful new approach to 
identifying genes specifically expressed in different cell or tissue types (Brown and 
Botstein, 1999; Lipshutz et aI., 1999). The application of microarray technology to the 
brain, however, poses problems of interpretation not encountered in more homogeneous 
cell populations, because of its complex anatomical organization and extreme cellular 
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heterogeneity. This anatomical complexity necessitates that Ill1croarray analysis be 
integrated with systematic in situ hybridization studies in order to resolve the cellular 
distribution of identified transcripts. 
Here I report the application of such an integrated analysis to the identification of 
genes expressed in the amygdala, a brain region implicated in emotional behaviors 
(Davis, 1992; LeDoux, 1995). In situ hybridization has revealed that the majority of 
genes identified as amygdala-specific on micro arrays exhibit intra-amygdaloid expression 
boundaries corresponding to cytoarchitectonically defined subnuclei. These results 
support the idea that brain subdivisions detectable by classical neuroanatomical methods 
reflect underlying differences in gene expression, and demonstrate that systematic 
identification of molecular markers for such subregions is a feasible near-term goal. 
Parts of this chapter have been already reported (Zirlinger et aI., 2001). 
We thank Raymond Mongeau for dissecting the PAG, Alan Smith and Jingwei 
Xiao (StanfordlHHMI) for performing micro array hybridizations, Geoffrey Meissner, 
Cindy Hsu and Sean Pintchovski for help with in situ hybridization, Gabriel Miller for 
help with Figure 2 and Gabriele Mosconi for managerial assistance. We also 
acknowledge Mark Zylka and Barbara Wold for helpful discussions. 
1.2 Methods 
1.2.1 Experimental design 
A schematic diagram of the strategy used to identify region-enriched 
genes is shown: 
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Briefly, five brain regIOns were chosen for analysis: amygdala, cerebellum, 
hippocampus, olfactory bulb, and periaqueductal gray (P AG). Biotinylated cRNA probes 
were prepared for each region and hybridized to Affymetrix microarrays. A custom made 
program was written to analyze the data which allowed to set different criteria to define 
what constituted "differentially enriched" genes. In situ hybridization was performed on 
selected enriched genes and based on these results, refinements in the criteria to search 
for enriched genes were introduced. 
1.2.2 Probe preparation 
Brains from CD-I, 3 week-old male mice were dissected and kept cold under 
RNAse-free conditions over the course of the preparation. For isolation of the amydala 
12 
and PAG, 34 mice were used. Thick sections (500-600 j.tm) were sliced with a vibratome 
and the structures were dissected from these sections under a dissecting scope, following 
delineations from the mouse brain atlas (Franklin and Watson, 1997). Dissected areas 
span approximately from -1.06 to -2.18 mm and from -2.92 to -4.24 mm with respect to 
Bregma, for amygdala and PAG, respectively. Hippocampi, olfactory bulbs, and 
cerebella were dissected in their entirety from 17 brains. Briefly, total RNA was 
extracted using Trizol (Gibco), and polyA+ RNA was purified by poly-dT affinity 
chromatography (Oligotex direct mRNA kit, Qiagen). At least 5 j.tg ofpolyA+ RNA was 
extracted from each brain region. First-strand cDNA was synthesized with a T7-polydT 
primer (Genset Corp.) using the Superscript Choice System (Gibco). Following second-
strand synthesis, approximately 20 j.tg of biotinylated cRNA hybridization probe was 
generated from each sample using the MEGA Script T7 kit (Ambion). Because the 
purpose of the microarray analysis was to identify candidate genes for in situ 
hybridization analysis, rather than to provide accurate measurements of individual 
transcript abundance, a single set of micro arrays was hybridized with each probe. 
1.2.3 Overview of Affymetrix microarray technology 
Oligonucleotide solid-phase arrays (Fodor et aI., 1991; Lockhart et aI., 1996) (also 
known as GeneChips), comprising 34,325 murine genes and ESTs, were purchased from 
Affymetrix (One set consisted of five subarrays= Mu lIkA, lIkB, 19kA, 19kB and 19kC 
chips). Each gene or EST is represented on the GeneChips by approximately 20 
independent (non-overlapping) "probe cell" sequences, each 25 nucleotides in length. 
Each perfect match probe cell is located above a control probe cell containing a single-
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base mismatch. Biotinylated cRNA from each sample (brain region) is then hybridized to 
the chips. A fluorescent-tagged streptavidin is allowed to bind to the arrays and the 
fluorescent signal, which is proportional to RNA abundance, is read with a scanning 
-
confocal microscope. A score termed the "average difference" (L1) is assigned to each 
gene, calculated as the average signal from the 20 perfect-match probe cells minus the 
corresponding mismatch probe cells. Average difference values are thus indicators of 
RNA abundance and were used for data analysis (see below). The perfect match and 
mismatch probe cells pairing strategy, together with the multiple representation of a gene, 
facilitate data analysis by subtracting nonspecific hybridization and background signals. 
The reason for using these arrays was that their reliability and reproducibility in 
other cell types had been previously shown (Wodicka et aI., 1997). However, only known 
genes or ESTs are represented on the arrays, which precluded the analysis of previously 
uncharacterized genes. 
1.2.4 Data analysis 
Prior to analysis, the data were normalized to correct for small differences in the 
amounts of each cRNA probe applied to the microarrays. Normalization factors were 
calculated (Affymetrix software) by comparing the mean fluorescent intensity of each 
array with respect to the corresponding amygdala array. Briefly, the output of each array 
was multiplied by a factor (the normalization factor) to make its average intensity 
equivalent to the average intensity of the baseline (amygdala) array. The average 
intensity of an array is calculated by averaging all the average difference values of every 
probe set on the array, excluding the highest 2% and lowest 2% of the values. On 
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average, the mean ~ value for each amygdala array was 1160. Normalized average 
difference values were exported and analyzed with custom software (available at 
http://www.its.caltech.edu/~mariela/gene _ screen.html), written III Matlab (The 
MathWorks, Natick, MA), and with GENECLUSTER, which implements self organizing 
maps (SOMs) (Tamayo et aI., 1999). 
Two criteria were applied to identify genes enriched in each of the five brain 
-
regions: (1) the average difference (~) value for the gene in that region; and (2) the ratio 
-
(fold-difference) of its ~ value in the reference region to that in each of the other four 
regions. A given gene g;, with an average difference value in the amygdala of ~ ~myg , was 
considered to be enriched in the amygdala relative to the other areas examined if it 
satisfied the following constraints for these two criteria: 
i) ~ amyg > minimum 
g, 
ii) ~ ;~yg / ~;:her > threshold or ~ amyg / ~ other < 0 g, g, for all four other regions 
(cerebellum, hippocampus, olfactory bulb, and PAG). 
To identify genes that were enriched in one region with respect to any three of the 
other regions, constraint ii) had to be met for any three (but not four) of the remaining 
four samples. The minimum ~ values and threshold ratios were iteratively adjusted and 
optimized based on the results of preliminary in situ hybridization experiments (see 
below). 
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1.2.5 In situ hybridization 
Three to four week-old male and female CD-l mice were used. Clones were 
purchased from Research Genetics when available, or templates for probes were 
synthesized by PCR using specific primers and cDNA from mouse brain. For some 
genes, sense probes were also synthesized to control for non-specific hybridization. 
Digoxigenin-Iabeled RNA probes were made and hybridization was performed 
essentially as previously described (Henrique et aI., 1995), with some modifications. 
Briefly, fresh frozen, 20 11m thick coronal sections were cut with a cryostat. Sections 
were dried and fixed in 4% paraformaldehyde, washed in PBS and subjected to 
acetylation using 0.25% acetic anhydride in 1M Triethanolamine-HCI pH 8.0. Slides 
were prehybridized for 1-3 hr, and hybridized overnight at 70°C, using a probe 
concentration of 0.5 - 1 Jlg/mI. Sections were washed twice in 0.2X SSC at 70°C for 30 
min, incubated with anti-digoxigenin alkaline phosphatase-conjugated Fab fragments 
(Roche) at a 1 :2000 dilution in 0.1 M maleic acid buffer, pH 7.5, with 0.2% Tween-20, 
20% sheep serum and 2% blocking reagent (Roche). Staining was developed for 4-16 hr 
with NBT and BCIP (Roche) in alkaline phosphatase buffer to yield a purple product. 
Slides were fixed in 4% formaldehyde and mounted with glycerol. Adjacent sections 
were Nissl-stained for comparison. Images were collected with a Zeiss Axioskop, or an 
Olympus IMT2 microscope attached to a CCD camera and Neurolucida software 
(Microbrightfield, Colchester, VT), using 35 mm film or electronically acquired 
composite images, respectively. To aid in the visualization of brain regions, Nissl 
staining was done on adjacent sections. 
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1.3 Results 
To evaluate the distribution of mRNA species within a given brain region, we 
plotted a histogram of the average difference values for all genes from each region (Fig. 
lA). Only the plot for one subset of chips (1lkA) is shown here, but all other chips had 
similar distributions. The histogram describes a unimodal distribution, wherein the bulk 
of the mRNA species is of relatively low abundance. Only a minority of the mRNA 
species were highly expressed. These results are in agreement with previous estimates of 
mRNA abundance and complexity in other tissues (Lewin, 2000; Zhang et aI., 1997). 
F or an initial comparison of gene expression levels between the different brain 
regions, I first plotted all possible pairwise comparisons of the average difference values 
for all genes represented on the llkA array (Fig. lB). Although the hippocampus 
appeared to have more off-diagonal points of greater abundance relative to the other four 
regions, the bulk of the transcripts lay close to a line of slope= 1. The lack of obvious 
clusters of genes underscored the need for algorithms to systematically identify 
differentially expressed genes. 
To facilitate the parallel analysis of relative gene expression levels between all 
five brain regions, we developed a custom algorithm (see Data Analysis section). I then 
systematically varied different parameters in this algorithm to maximize the search for 
region-enriched genes. For example, I searched for genes whose average difference 
values were at least 3.5, 5, or 6 times higher in any given reference region compared to 
the remaining four. Based on in situ hybridization experiments with genes identified in 
early iterations of this search, it was concluded that a threshold ratio of 3.5 was optimal. 
Using higher threshold ratios (e.g., 5- or 6-fold) failed to identify many genes found by 
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the lower-stringency search, whose differential expression could be validated by in situ 
hybridization (for example, probe 4, Fig. 2D). Conversely, lowering the threshold below 
3.5 was more likely to identify genes whose expression would not be region-specific. To 
filter out genes satisfying the ratio criteria, but whose absolute expression levels were 
likely to be too low to be detectable by our in situ hybridization procedure, we 
empirically arrived at a minimum average difference value. For genes enriched in the 
amygdala sample, this lower limit corresponded to one-tenth of the mean average 
difference value for all genes on a given array. On the 11kA array, for example, this 
-
minimum Ll value was 110.4, a figure approximately five-fold above the noise level for 
this array (22.5). 
To compare the performance of our search algorithm to that of an independent 
method, we carried out a clustering analysis using the Genecluster program (Tamayo et 
aI., 1999), that implements self-organizing maps (SOMs). All genes identified by our 
method were also included in SOM-derived clusters corresponding to single region-
enriched genes. However, the total number of genes in each of these SOM clusters was 
about 6 to 10 times larger than the number of genes identified using our algorithm, even 
with the use of stringent filters for SOMs. Logically, these additional genes were rejected 
by our algorithm because they either fell below Ll min, or because their -fold difference 
relative to the other four regions was too low. Most of these additional genes, however, 
were not considered good candidates for in situ hybridization because they either were 
not expressed well above background levels, or had a low fold-difference relative to the 
other regions. 
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1.3.1 Analytical characterization of differentially expressed genes 
We found that only 455 of the 34,325 genes and ESTs analyzed (1.3%) fulfilled 
our selection criteria for enrichment in anyone of the five brain regions, relative to the 
other four (Table 1). Of these, 33 genes were enriched in the amygdala. On average, 
0.3% of the sampled genes were highly enriched in anyone of the five brain regions 
(Table 1). We also computed the number of genes that were "present" (i.e. had significant 
expression above background levels) in all five regions, as well as those that had no 
detectable expression. 9,604 genes (28% of the genes on the array) were expressed in all 
areas examined, whereas 15,303 (45%) were present in none. Thus, of the 19,022 genes 
with detectable expression in one or more regions, half were present in all regions. 
Among the present genes, only 2.4 % were differentially expressed in one region 
(455/19,022). A complete table with all 455 genes or ESTs and their corresponding 
-
~ values IS shown III Table 3, which can also be found III 
http://www.its.caltech.edul~mariela/gene_screen.htmI. 
To investigate whether certain classes of genes were preferentially represented 
among these sequences, we classified all annotated differentially expressed genes based 
on their structure or function. Of the 455 sequences, 117 (26%) were annotated genes. In 
four cases, annotation was accomplished by using 5' RACE to clone the coding region. 
The genes were classified among 21 different functional categories, following the Gene 
Ontology (GO) Consortium guidelines (Ashbumer et aI., 2000). The categories that were 
the most highly represented (contained >7% of the 117 genes) comprised signaling 
molecules (26%, n=30), DNA binding molecules (17%, n=20), enzymes (15 %, n=18), 
and structural proteins (9%, n=IO). Some examples of these are shown in Table 2. See 
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Table 4 for a full list of the functional categories and the percentage of genes in each 
class for each of the five brain regions analyzed. 
Several of these genes had previously been reported to be enriched in their given 
areas. These included vasopressin (Caffe and Vanleeuwen, 1983; Price et aI., 1987) and 
arp-l (Dasilva et aI., 1995) in the amygdala, P400 (Nakanishi et aI., 1991) and NeuroD 
(Lee et aI., 1995; Schwab et aI., 1998) in the cerebellum, and tyrosine hydroxylase in the 
olfactory bulb (Hokfelt et aI., 1984). Of 13 genes identified as cerebellum-enriched in a 
recent Genechip study (Sandberg et aI., 2000), we independently identified 6. Of the 
-
remaining 7 genes, 2 were rejected by our algorithm because they had l1 values < 0, and 
5 were rejected because they were also expressed at substantial levels in the olfactory 
bulb, a structure not analyzed in the earlier study. However, as that study included other 
brain regions, such as the cortex, not examined in our experiments, the two data sets are 
complementary. 
1.3.2 Validation of GeneChip results by in situ hybridization 
It was essential to validate the results of the microarray analysis by an 
independent method. We employed in situ hybridization rather than biochemical assays 
such as RNase protection, because the complex anatomical organization of the brain 
necessitates a method with high spatial resolution. Thirty-five genes were analyzed by in 
situ hybridization. Of these, about 60% were expressed in a manner consistent with the 
results of the microarray analysis. Twenty percent did not show any signal, 13% 
hybridized everywhere and 7% were inconsistent with the microarray results (i.e., 
hybridized more strongly to regions that were predicted to have lower abundance). Since 
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it was impractical to optimize probe design and hybridization parameters for each gene, it 
is possible that the actual false negative and false positive rate is lower than we observed. 
To determine the extent to which our algorithm conditions could be further 
relaxed, we performed in situ hybridization experiments for four "best candidate" genes 
identified by Genecluster that marginally failed to meet our selection criteria. Three of 
these did not show any signal, but one was indeed expressed in the amygdala (probe 41, 
Fig. 2C). However, this gene was identified by Genecluster only with the use of a very 
lax filter that included many other genes that fell well below our selection criteria. 
Strikingly, although our selection criteria required only a 3.5-fold difference in 
the level of expression in one region compared to the others, in many cases this 
seemingly modest quantitative difference on the arrays translated into an apparent 
qualitative difference when examined by in situ hybridization. Thus, the expression of 
many amygdala-enriched genes was simply not detected by in situ hybridization in the 
other regions examined in the Microarray analysis. This may reflect the fact that many of 
the genes had fairly low average difference values in the amygdala, so that a 3.5-fold 
lower level of expression in one of the other regions might be below the detection limit of 
the non-isotopic in situ method. As might be expected, most of the amygdala-enriched 
genes proved to be expressed in at least one other brain area not tested in the Microarray 
experiment, such as the cortex (Fig. 3C). 
The absolute ~ values obtained from the Microarrays do not distinguish whether 
a given gene is expressed at high levels in a small subpopulation of cells, or at lower 
levels in a larger popUlation. Among the genes that we examined, one-fourth (25%) 
showed strong expression in relatively small, scattered cell populations, while the 
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majority (75%) were expressed more broadly. Because the pieces of tissue we dissected 
for RNA isolation were relatively large and heterogeneous, it is likely that our analysis 
was biased against genes expressed at lower levels in small subpopulations of cells. 
1.3.3 Amygdala-enriched genes respect subnuclear boundaries 
The amygdala is a complex structure that can be anatomically subdivided into at 
least 13 distinct regions (Pitkanen et aI., 1997), such as the lateral, basolateral, medial, 
and central nuclei (Fig. 2A). This structural organization raises two questions: 1) Do the 
boundaries of amygdaloid nuclei reflect boundaries of gene expression domains?; 2) Do 
gene expression patterns reveal features of amygdaloid organization not visible by 
classical neuroanatomical techniques? To address these questions, we examined in detail 
the in situ hybridization pattern of 12 genes predicted by the microarray analysis to be 
enriched in the amygdala. 
Surprisingly, the majority (75%) of these genes exhibited restricted, contiguous 
domains of expression, whose boundaries at least partly coincided with those of 
amygdaloid subnuclei (Fig. 2A). (The remaining genes were expressed in scattered 
populations of cells). Within this larger group of genes, about 50% completely respected 
nuclear boundaries (Fig. 2B, C; Fig. 3A, C, E). The other half respected nuclear 
boundaries along part of their length, but in places extended beyond these boundaries into 
a well-defined territory not coincident with any described amygdaloid subdivisions (e.g., 
Fig. 3D, dotted vs. dashed lines). 
All of the amygdala-enriched genes we examined could be parsed into three 
groups, according to the distinct ontogenetic origins of the subnuclei in which they are 
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expressed. One group of genes (5 genes; 42%) was expressed in the lateral, basolateral, 
and cortical nuclei (Fig. 2A, blue), which are cortical-like structures embryologically 
derived from the pallium. Probes 29 (activin receptor type II; Fig. 2B) and 75 
(unconventional type myosin; Fig. 3A) are characteristic of this group. The second group 
(5 genes; 42%) was formed by genes expressed in the central and medial nuclei (Fig. 2A, 
yellow), which have sub-pallial (striatal or pallidal) origin. Probe 41 (laminin B3, Fig. 
2C) is characteristic of this group. The third group (16%) consisted of two genes (the 
transcription factor arp-l (Fig. 2D) and Ccte chaperonin epsilon subunit (Fig. 3F) with 
widespread expression throughout the amygdala, including pallial and subpallial nuclei. 
Thus, the majority (84%) of the genes were expressed in either of two subsets of 
amygdaloid subnuclei related by a common developmental origin. 
Genes in the first and second groups also shared some other features of their 
expression. For example, several of the genes in the first group (e.g., probes 75 and 50, 
Figs. 3A and 3C) were also expressed to varying extents in the neocortex, consistent with 
the pallial origin of the amygdaloid regions in which this group is expressed. Conversely, 
a number ofthe genes in the second group (e.g., probe 28 and probe 41, Figs. 3D and 2C) 
also labeled the hypothalamus, a pattern also noticed by Sutcliffe and colleagues when 
characterizing expression patterns of hypothalamic genes (Gautvik et aI., 1996). 
Interestingly, all genes in the first group were expressed in contiguous cell populations. 
This observation may reflect the fact that the lateral and basolateral complexes are 
relatively homogeneous with respect to both cell type and neurotransmitter content 
(McDonald, 1992; Price et aI., 1987). By contrast, 80% of the genes in the second 
(striatal) group, such as the neuropeptide vasopressin, were expressed in scattered 
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subpopulations of cells. This observation is consistent with the fact that amygdaloid 
neuropeptides are generally expressed in scattered cell populations (Roberts et aI., 1982), 
and also that the centromedial aspect of the amygdala is the most neuropeptide-rich 
region in the brain outside the hypothalamus (Roberts, 1992). Other genes in this 
subgroup included the Lim homeodomain transcription factors Lhx-6 (Fig. 3B) and Lhx-
7. It is possible that these factors are involved in the regulation of amygdaloid 
neuropeptide gene expression. 
1.4 Discussion 
The modular functional organization of the mammalian brain is likely to reflect, 
at least in part, its anatomical parcellation into distinct substructures. We have used 
microarray analysis in conjunction with in situ hybridization to identify molecular 
markers of this anatomical regionalization. Using commercially available microarrays, 
we identified in each of five selected brain regions, on average, 91 genes that were highly 
enriched. This estimate is very close to that arrived at in a previous study employing 
subtractive hybridization (Gautvik et aI., 1996), which estimated the number of 
transcripts highly enriched in the hypothalamus to be on the order of one hundred. Our 
figure constitutes 0.3% of the approximately 34,000 genes interrogated, and 0.5% of all 
genes expressed in at least one of the five areas (91119,022). Similar values were 
recently reported by Sandberg et aI., who analyzed the expression of about 13,000 genes 
and ESTs in a different subset of brain regions than we examined (Sandberg et aI., 2000). 
These values may, however, be an underestimate because genes expressed at low levels 
in small subsets of cells may have been systematically excluded by both analyses. 
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Nevertheless, the gross molecular homogeneity of the brain was apparent. It is of course 
also likely that many other unknown region-specific genes exist, which were not 
interrogated by the Affymetrix GeneChips. Other microarray methods that do not rely on 
previous knowledge of sequences may prove useful in identifying these. 
Among the identified differentially expressed genes with known function, 67% 
fell into 4 of 21 functional categories, comprising signaling molecules, transcription 
factors, enzymes or structural proteins. However, the majority (72%) of the differentially 
expressed genes were unannotated ESTs, making it difficult to draw firm conclusions 
about categorical representation. 
1.4.1 Analytic considerations 
For simply identifying region-specific or highly enriched genes, our custom 
algorithm proved more efficient than SOMs cluster analysis (Tamayo et ai., 1999). That 
is because our program permits the explicit specification of multiple criteria for 
"enriched" genes. In contrast, Genecluster identifies collections of genes that share 
similar features. Therefore, no constraint about the ratio of expression in one brain region 
relative to all the others can be independently set. However, SOM analysis is designed for 
gene-profiling studies, where the comparison of expression patterns among a large 
collection of samples is sought (Tamayo et ai., 1999). This is fundamentally different 
from positively selecting highly enriched genes that fulfill specific ratio criteria. 
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1.4.2 Validation of microarray data 
A recent study (Sandberg et aI., 2000) also employed Affymetrix GeneChips to 
characterize region-specific gene expression in the brain, but did not validate the 
microarray results by in situ hybridization. Our results suggest that in situ hybridization is 
essential to confirm GeneChip data. Of the 35 genes we tested, 80% yielded detectable 
in situ hybridization signals. Of these, about 25% exhibited patterns apparently 
inconsistent with the Microarray data. Thus, 60% of the 35 genes examined were 
validated by in situ hybridization. Of the 14 cases of inconsistency, most (65%) reflected 
probes that hybridized everywhere. These cases may simply represent sUboptimal probe 
design rather than any inherent inaccuracy of the GeneChip method. The remaining 
cases, however, constituted probes that gave strong in situ signals in regions predicted to 
be weak or negative by the microarrays. It is possible that replicate microarray 
experiments with independently prepared samples and chips would have lowered the 
number of false-positives. However, considering that at least 17 mice were used to 
prepare cRNA probes from each brain region, it is unlikely that the discrepancies we 
observed are due to inconsistent tissue dissection, or to biological differences between the 
animals used to prepare microarray probes and those used for in situ hybridization. 
Even for those genes whose in situ pattern was consistent with the predictions of 
the microarray data, in situ hybridization was also essential to identify sites of expression 
not included among the original five samples. This is important, as it is technically 
impossible to analyze every brain region or nucleus in a given microarray experiment. 
Our in situ analysis also revealed how extrapolating mRNA abundance levels based on 
Ll values from the Microarrays is not necessarily informative, since this value reflects 
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both the abundance of a given transcript within expressing cells, as well as the proportion 
of cells expressing the transcript in a given brain region. We have found examples of 
-
genes with low ~ values that were expressed at very high levels in a few cells, and 
conversely, genes expressed broadly at more modest levels, that yielded high ~ values. 
1.4.3 Towards a molecular anatomy of the amygdala 
The amygdala, a brain region implicated in emotional learning (Davis, 1992; 
LeDoux, 1995), lies at the interface between the cortex and sub-cortical structures such as 
the striatum and hypothalamus, and therefore is well-positioned to integrate 
computational and neuromodulatory functions. Accordingly, the amygdala is structurally 
and ontogenetically heterogeneous, consisting of over a dozen subnuclei (Pitkanen et aI., 
1997; Price et aI., 1987; Puelles et aI., 1999). The central and medial nuclei are subpallial 
(striatal or pallidal) derivatives, whereas the cortical-like subnuclei (nucleus of the lateral 
olfactory tract, lateral, basolateral, cortical, and claustral amygdala) are pallial (cortical) 
derivatives. This division is based on the expression of homeobox transcription factors 
whose expression domains delineate pallio-subpallial boundaries in the embryonic 
telencephalon (Puelles et aI., 1999). Such a general division fits well with the proposal of 
Swanson and Petrovich (Swanson and Petrovich, 1998), who have divided the amygdala 
into cortical- and striatal-like structures based on anatomical features and 
neurotransmitter expression. The majority of the amygdala-enriched genes we examined 
obeyed this basic dichotomous subdivision. 
We made no special effort to microdissect distinct subnuclei in preparing the 
microarray hybridization probe; rather, a relatively crude dissection of the entire 
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amygdala was used. Thus, it is striking that 75% of the amygdala-enriched genes that we 
examined by in situ hybridization (n=12) exhibited expression boundaries at least partly 
coinciding with those of one or more subnuclei (Fig. 4v). A priori, this need not have 
been the case. At least four other kinds of expression patterns could have been obtained 
(Fig. 4): (i) uniform expression throughout the amygdala; (ii) contiguous subdomains 
bearing no relationship to classically defined subnuclei; (iii) scattered expression in cells 
contained within specific subnuclei; and (iv) scattered expression not respecting 
subnuclear boundaries. It is striking that no genes fell into either of the first two 
categories. These data suggest not only that the boundaries of amygdaloid subnuclei 
reflect gene expression boundaries, but moreover that the majority of amygdala-enriched 
genes may respect such boundaries. The genes we have identified should, therefore, 
provide useful markers for amygdaloid subnuclei, some of which can be difficult to 
visualize by Nissl staining on thin histological sections. 
Our data also indicate, however, that not all gene expression boundaries 
correspond precisely to boundaries of amygdaloid subnuclei. For example, we observed 
three genes that had a similar, well-defined expression domain that included the medial 
amygdala, but which extended into a limited subregion of the adjacent basomedial 
amygdala (Fig. 3D, dotted line). This suggests that the medial and basomedial 
amygdaloid cells expressing these genes share previously unrecognized molecular 
similarities, and may form a novel subdivision not detected by classical anatomical 
methods. Thus, gene expression domains do not simply validate classically defined 
anatomical units, but may also reveal organizational features not easily visualized by 
existing staining techniques. 
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At present, the rate-limiting step in the analysis of micro array data derived from 
the brain is its validation by in situ hybridization. When efficient, large-scale, high-
throughput automated in situ hybridization procedures for adult brain sections become 
available, it should be possible to exploit Microarray data to generate a "molecular brain 
atlas," in which each structure is also delineated by its molecular repertoire. The results 
presented here demonstrate that such a long-term goal is, in principle, feasible. The 
genes identified by such an exercise, moreover, are not simply markers, but also will 
provide tools to genetically dissect the roles of such brain substructures in specific 
behaviors. 
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Table 1-1: Genes that are at least 3.5- or 5-fold enriched in each of the five areas. 
Amv Cb Hpc OB PAG Total Ave: 
3.5-fold relative to 33 159 89 (0.3) 101 73 455 91 (0.3) 
all 4 other areas (0.1) (0.5) (0.3) (0.2) (1.3) 
5-fold relative to 21 86 57 68 44 276 55 
all 4 other areas (0.1) (0.3) (0.2) (0.2) (0.1) (0.8) (0.16) 
5-fold relative to 65 164 105 127 95 556 111 
any 3 other areas (0.2) (0.5) (0.3) (0.4) (0.3) (1.6) (0.3) 
Genes that are at least 3.5 or 5-fold enriched in each of the five areas are shown. 
Percent of total genes interrogated (34,325) are in parentheses. Enriched genes with 
respect to all 4 other regions or to any other 3 regions are indicated. (Amy= amygdala, 
Cb= cerebellum, Hpc= hippocampus, OB= olfactory bulb and PAG= periaqueductal 
gray). 
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Table 1-2: Examples of genes enriched at least 3.5-fold in each region. 
Functional Amy Cb Hpc OB PAG 
category 
Signaling vasopressm cerebellum ND B219/0B angiotensinogen 
(M88354) P400 protein receptor precursor 
(XI5373) (ET61693) (Msa.7127.0) 
DNA- arp-l Neuro-D Friend of Dlx-l Gata-2 
binding (X76653) (U28068) GATA-l (U51000) (ABOOO096) 
(FOG) 
(AF006492) 
structural unconvention pro-alpha-2 dynactin pro-collagen ND 
al type (I) (Msa.12975. type V 
myosm collagen 0) alpha-2 
(TC37197) (Msa.2220.0) (Msa.544.0) 
(*) 
enzyme or ND parvalbumin neuropsin tyrosine angiotensin-
ligand (X67141) (D30785) hydroxylase converting 
binding (M69200) enzyme 
(Msa.24687. 
0) 
EST TC35462 TC33451 TC36417 TC20543 TC36249 
[activin 
receptor type 
II (*) 1 
Some examples of genes enriched at least 3.5-fold in each region. Gene names 
and (Affymetrix probe set names) are presented. (*): Gene identity was determined by 5' 
RACE. ND= not detected among the 117 genes that were annotated. Abbreviations are as 
in Table 1. 
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Table 1-3: List of enriched genes. 
Affymetrix probe sets l enriched at least 3.5-fold in each brain region relative to 
all others. Average difference values (avg diff) in the 5 brain regions are presented 
(Amy= amygdala; Cb= cerebellum; Hpc= hippocampus; OB= olfactory bulb; PAG= 
periaqueductal gray.) Bold numbers indicate the region where the gene is enriched. 
enri.ched Probe Set avg diff avg diff avg diff avg diff avg diff 
In Amy Cb Hpc 08 PAG 
Amy D49658 at 114.0 -19.1 -87.7 27.0 -17.6 
Amy M88354 s at 4161.0 -1406.4 -790.7 -845.3 -748.9 
Amy u26460 s at 362.0 -559.3 43.9 -543.6 -106.7 
Amy ET62460 i at 2943.0 641.7 633.3 266.2 713.4 
Amy Msa.27328.0 177.0 17.5 2.6 -75.6 23.1 
Amy Msa.38650.0 1026.0 -418.6 -421.7 -276.1 -411.6 
Amy Msa.38727.0 351.0 -70.2 -147.2 -36.2 15.7 
Amy U96386 s at 2485.0 -166.7 25.0 -1.1 48.9 
Amy x76653 s at 551.0 94.0 23.6 150.1 -13.8 
Amy TC15611 at 815.0 220.8 175.0 117.4 208.0 
Amy TC16820 at 169.0 -85.6 -226.6 -88.6 -109.1 
Amy TC17395 at 917.0 -7.4 83.1 149.7 61.2 
Amy TC17396 at 86.0 -1.1 -0.8 8.4 15.3 
Amy TC19868 at 81.0 20.1 -90.3 -28.7 4.1 
Amy TC26406 r at 746.0 104.4 172.6 107.4 83.9 
Amy TC27128 at 579.0 -136.6 -110.2 -150.6 -444.8 
Amy TC29518 s at 3801.0 499.9 479.3 1044.8 854.9 
Amy TC29994 at 3039.0 -203.6 751.1 729.6 796.2 
Amy TC30095 _g_ at 1369.0 101.8 121.2 323.4 362.9 
Amy TC30886 at 1605.0 63.1 0.0 245.2 282.2 
Amy TC31535 at 840.0 -1458.3 -1199.2 -23.3 -1.0 
Amy TC35282 at 2359.0 -6.9 578.1 129.6 498.8 
Amy TC35411 at 1784.0 -8.3 29.1 246.5 -224.2 
Amy TC35462 at 2249.0 -409.9 -534.5 173.8 -16.8 
Amy TC35509 at 3393.0 191.2 221.4 151.7 965.3 
Amy TC36086 at 370.0 -370.0 -455.8 -2251.9 -1167.9 
I A description of Affymetrix Probe sets (i.e. gene name and Genbank Accession) is shown in Table 3 
online at http://www.its.caltech.edul-marielalgene_screen.html 
TIGR cluster probe sets are named based on their cluster identifiers. For e.g. probe set TCIIIII_at 
represents TIGR cluster TC 11111. 
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Amy TC36144 at 3240.0 663.0 856.3 719.0 777.0 
Amy TC37197 at 2824.0 -3642.4 -2970.8 -1725.6 -467.7 
Amy TC3 7997 _g_ at 1421.0 -925.7 -980.1 -769.6 -131.9 
Amy TC38200 at 1250.0 -495.2 148.5 52.1 227.8 
Amy TC38589_g_at 1059.0 -90.8 167.5 196.0 254.2 
Amy TC39813_g_at 406.0 -731.8 78.6 -518.3 -52.8 
Amy TC41875 at 530.0 -405.8 -598.5 -903.9 -243.4 
Cb AA009039 at 366.0 6939.3 1341.6 895.3 811.1 
Cb aa035912 at 398.0 5983.2 955.1 448.6 843.2 
Cb aa035912_g_ 957.0 3802.4 1031.9 679.5 704.4 
Cb aa111276 s -161.0 383.4 -215.2 -85.9 -124.3 
Cb AA177965 at 78.0 290.7 -57.6 7.0 42.5 
Cb aa185911 s -3.0 137.7 -60.3 -16.0 -65.3 
Cb aa199418 s -88.0 270.6 -90.4 -123.9 -58.0 
Cb aa217487 s 61.0 1046.0 23.3 121.9 183.4 
Cb aa266033 s 184.0 827.0 95.9 201.8 124.3 
Cb AA266172 at 421.0 2165.5 359.0 406.7 236.2 
Cb aa266791 s 674.0 2376.8 483.7 235.8 374.0 
Cb aa289572 s 36.0 1092.8 43.9 173.9 108.8 
Cb aa472865 s 656.0 3264.1 520.7 738.4 594.6 
Cb aa473309 f at 781.0 4446.8 361.8 864.3 771.7 
Cb aa529056_g_ 592.0 3764.1 681.1 962.2 1062.8 
Cb aa562600 s -51.0 235.2 -146.6 -22.0 -532.4 
Cb AA589492 R 15.0 182.6 4.1 31.0 4.1 
Cb AA617336 R 394.0 1435.1 371.4 393.7 364.6 
Cb aa624821 at 84.0 500.0 91.8 137.9 52.8 
Cb AA688923 at -1351.0 694.1 -1282.7 -667.5 -573.9 
Cb AA688944 at -343.0 308.8 -375.5 -254.8 -377.1 
Cb AB000777 _g_ -516.0 1242.0 -900.3 -326.7 -401.9 
Cb afO 16697 _g_ at 1390.0 7592.3 1097.7 1412.9 1635.7 
Cb AF031816 at 85.0 1483.8 372.7 212.8 178.2 
Cb c76668 RC a 66.0 255.3 17.8 51.0 54.9 
Cb C77771 RC a -13.0 369.1 -34.3 100.9 -75.6 
Cb c78385 RC a 13.0 492.4 30.1 103.9 110.8 
Cb c78995 RC a -524.0 592.8 57.6 -327.7 98.4 
Cb C80068 RC a -166.0 301.2 15.1 15.0 -122.2 
Cb D19038 RC a -641.0 231.4 20.6 -493.6 -753.1 
Cb d31898 s at 1637.0 5973.6 945.6 762.4 909.5 
Cb D83262 at 337.0 1786.9 171.3 132.9 439.2 
Cb D84391 f at 1099.0 5649.5 1330.6 1447.8 1251.3 
Cb L02241 s at 128.0 596.6 -16.4 118.9 119.1 
Cb Ll0426 s at 172.0 1585.2 216.5 281.8 69.4 
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Cb L12147 s at 22.0 677.9 -79.5 -7.0 74.6 
Cb 112705 s at 351.0 4090.1 376.9 254.8 557.3 
Cb 128177 s at -253.0 222.8 -102.8 39.0 28.0 
Cb 135029 s at 164.0 2566.1 420.7 376.7 78.7 
Cb m21531 s at 2944.0 11351.0 1312.8 450.6 1562.1 
Cb M21532 s at 182.0 15783.0 -78.1 224.8 167.8 
Cb M90388 s at 21.0 425.5 48.0 41.0 -5.2 
Cb r74641 s at 34.0 4633.2 -39.7 -50.0 1228.6 
Cb U19860 s at 683.0 2557.5 485.1 607.5 336.7 
Cb U28068 s at -17.0 7939.3 243.9 95.9 6.2 
Cb u58112 s at -38.0 165.4 4.1 -26.0 -91.2 
Cb Msa.11910.0 115.0 1064.0 -56.5 88.7 183.7 
Cb Msa.1375.0_g 170.0 1168.0 287.7 0.0 89.5 
Cb Msa.1461.0 a 121.0 1630.5 113.0 27.4 117.2 
Cb Msa.18074.0 1477.0 9112.4 2493.7 2162.6 1799.6 -
Cb Msa.2220.0 f -3.0 906.1 -49.9 247.6 79.4 
Cb Msa.24313.0 -265.0 3480.3 660.9 589.4 180.0 
Cb Msa.2440.0 i -35.0 757.0 13.1 47.1 139.4 
Cb Msa.24555.0 -32.0 213.1 -240.4 -86.5 53.5 
Cb Msa.24665.0 -237.0 129.1 -15.8 -391.1 -226.1 
Cb Msa.2619.0 s 1731.0 32818.0 2417.5 739.5 3855.7 
Cb Msa.28697.0 -163.0 263.2 -177.4 25.2 -186.4 
Cb Msa.326.0 _g_ -69.0 784.5 -160.3 179.7 -27.7 
Cb Msa.3299.0 s -118.0 1998.9 462.5 -4.4 80.3 
Cb Msa.419.0 s -185.0 3761.0 392.8 169.8 -110.7 
Cb Msa.43183.0 1345.0 6317.6 1646.2 1474.6 1541.2 
Cb Msa.549.0 s -64.0 206.8 14.5 15.3 49.8 
Cb Msa.728.0 at 117.0 557.7 -73.6 46.0 103.4 
Cb S74567_g_at -114.0 1125.4 -107.7 290.3 -157.8 
Cb w41032 s at 1667.0 8552.2 1913.0 1438.4 1845.7 
Cb w82359 _g_at 146.0 1663.1 2.6 155.6 -29.5 
Cb X15373-2 s a 2128.0 23082.0 1824.9 403.2 530.7 
Cb x16490 s at -23.0 210.6 -25.0 18.6 -19.4 
Cb X51986 s at 467.0 24775.0 290.4 212.5 316.5 
Cb x60304 at 1432.0 6756.3 1384.8 573.0 703.2 
Cb X61397 s at 220.0 19185.0 -76.2 -21.9 438.4 
Cb X61448 s at 951.0 19231.0 921.0 3040.1 2143.8 
Cb x63963 s at 297.0 2423.8 147.2 650.8 250.1 
Cb X65128 s at 333.0 2119.2 415.2 525.9 452.2 
Cb x67141 at 778.0 23721.0 1616.0 186.2 1942.6 
Cb x67141_g_at -308.0 5493.0 751.5 340.7 81.2 
Cb X78197 s at 255.0 3271.0 101.2 292.5 498.4 
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Cb y00305_s_at 293.0 13892.0 3417.3 479.9 833.4 
Cb Y11666 s at 84.0 1259.5 270.7 230.1 198.4 
Cb TC14307 s at -582.0 2632.7 262.1 -117.4 346.7 
Cb TC15800 at 604.0 6981.1 1719.3 565.3 1242.1 
Cb TC16082 at 657.0 3443.0 909.7 956.9 628.2 
Cb TC16546 at 25.0 287.4 29.0 -63.5 -26.5 
Cb TC16732 at 406.0 2157.3 496.0 446.7 447.7 
Cb TC17153 at -71.0 101.4 9.7 -142.5 -210.1 
Cb TCI7287 at -13.0 154.2 36.3 -14.4 -126.5 
Cb TC17839 at -251.0 502.9 -165.3 -64.7 -147.9 
Cb TC18167 at 69.0 1856.2 26.6 82.6 158.1 
Cb TC18873 at -411.0 121.5 -120.2 -231.1 -426.3 
Cb TC21031 at 1142.0 5816.9 1608.8 1013.1 197.8 
Cb TC21707 at -134.0 1194.9 260.5 220.4 193.8 
Cb TC22115 at -55.0 1208.6 0.8 4.8 -79.5 
Cb TC23559 at 364.0 2801.7 471.0 449.1 372.2 
Cb TC23741 at 65.0 738.5 -91.1 22.8 -43.8 
Cb TC23801 at -2.0 946.6 -21.8 167.7 231.5 
Cb TC23 80 l_g_ at 397.0 5743.0 350.0 804.8 734.2 
Cb TC24676 at 43.0 170.1 -146.8 46.7 -123.4 
Cb TC24816 s at -124.0 586.3 -102.4 -75.4 -67.3 
Cb TC24926 at 600.0 9482.8 411.3 1422.7 1007.5 
Cb TC25240 at -109.0 165.9 -59.7 -8.4 -139.7 
Cb TC25270 at -56.0 316.9 -92.7 -104.2 -131.6 
Cb TC26229 at -397.0 12669.0 -409.5 -344.4 1797.9 
Cb TC27828 at -333.0 331.1 -207.5 -49.0 -224.5 
Cb TC28671 at 607.0 2365.3 602.4 324.5 396.5 
Cb TC29334 f at 771.0 17642.0 578.5 1557.3 949.3 
Cb TC29445 at 191.0 2912.8 102.8 625.7 483.6 
Cb TC30591 at -70.0 636.4 121.2 85.2 146.9 
Cb TC30958 at 2536.0 13267.0 1719.0 2902.2 3014.7 
Cb TC31108 at 529.0 3969.2 1122.1 1128.9 628.3 
Cb TC31518 at 16.0 727.9 99.2 137.8 66.1 
Cb TC31783 at 359.0 3756.6 363.6 85.2 451.1 
Cb TC31991 at -11.0 753.6 82.6 42.0 91.3 
Cb TC32216 s at 953.0 6455.6 1685.9 1092.7 439.5 
Cb TC32340 at -428.0 5895.2 3.7 1306.3 -613.6 
Cb TC32450 at -6.0 345.3 11.0 96.9 68.2 
Cb TC32531 at -331.0 1284.4 -91.8 181.0 -606.3 
Cb TC32703 at -488.0 394.2 -745.6 -638.6 -380.8 
Cb TC32804 s at 86.0 698.3 183.7 145.9 -1.0 
Cb TC32850 _g_ at -1061.0 167.5 -1309.4 -87.6 -119.6 
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Cb TC33451 at 41.0 1222.6 -49.6 192.6 -89.2 
Cb TC33667 at 2199.0 10253.0 1465.5 1950.8 1440.2 
Cb TC33746 at 397.0 13043.0 216.7 309.4 371.3 
Cb TC33767 at 314.0 1556.2 405.9 316.4 -115.4 
Cb TC34215 at 96.0 425.1 -51.4 57.2 16.8 
Cb TC34607 s at -64.0 882.5 156.1 155.3 -74.5 
Cb TC34901 at -318.0 512.7 -391.2 123.8 -395.5 
Cb TC35087 at -140.0 209.1 -206.8 -110.6 13.2 
Cb TC35235 at 456.0 6859.7 311.6 1237.3 -1283.1 
Cb TC36041 at 106.0 945.0 101.9 37.9 1.2 
Cb TC36118_g_at 558.0 4400.3 817.0 376.1 489.2 
Cb TC36594 at 57.0 540.6 61.2 129.6 10.8 
Cb TC36605 at 1220.0 5238.0 1057.3 1431.7 1385.0 
Cb TC36788 at 333.0 2004.1 230.1 -254.4 299.8 
Cb TC37170 at 587.0 3101.8 125.2 858.1 855.0 
Cb TC37531 at 651.0 5691.9 1233.5 1106.2 496.4 
Cb TC37804 at -243.0 239.3 67.0 -369.8 -16.8 
Cb TC37834 s at 81.0 917.5 170.4 110.6 161.9 
Cb TC38320 at 27.0 542.0 -53.9 118.5 -57.6 
Cb TC38584 at 1408.0 7781.3 977.2 829.6 1506.1 
Cb TC39605 at 879.0 5017.9 1280.1 538.9 1317.8 
Cb TC39631 at 65.0 343.9 88.8 -143.8 54.0 
Cb TC40036 at 25.0 2115.6 -55.3 -159.6 525.2 
Cb TC40154 at 187.0 2291.6 33.5 33.2 -10.8 
Cb TC40249 at 63.0 1423.7 355.3 47.4 55.2 
Cb TC40339 at 1068.0 7166.5 639.3 1466.5 1465.3 
Cb TC40661 at 431.0 2790.9 -468.9 -1261.0 729.1 
Cb TC40833 at 187.0 1492.4 -214.1 -55.3 -488.0 
Cb TC40877 f at 446.0 2086.7 477.7 414.0 406.5 
Cb TC41060 at 422.0 9912.0 234.5 1158.3 509.6 
Cb TC41163 at 856.0 4624.5 888.3 711.1 705.1 
Cb TC41216 at -382.0 2122.4 196.6 -523.1 202.7 
Cb TC41320 at 478.0 1742.8 339.3 -45.8 491.6 
Cb TC41324 at 139.0 734.5 -116.5 -516.7 100.7 
Cb TC41351 at -24.0 195.3 14.6 -1.6 16.8 
Cb TC41712 at 16.0 240.7 58.3 -1199.4 -74.3 
Cb TC41829 at -154.0 206.3 -211.2 -112.2 -182.3 
Cb TC42055 at 878.0 5313.7 1338.3 1267.4 1509.7 
Cb TC42156 at -82.0 1983.5 23.3 -2293.0 -721.9 
Cb TC42157 at 34.0 580.5 -128.2 -6223.1 -1393.4 
Hpc aaOO0469_g_ 1561.0 1819.4 6809.3 1161.1 1414.0 
Hpc AA023445 at -109.0 -209.4 601.6 44.0 -120.2 
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Hpc aa217006 s -220.0 -615.7 374.1 -484.6 -153.3 
Hpc aa288448 at 247.0 -263.9 922.3 -179.9 -176.1 
Hpc aa408337 RC 202.0 182.6 1011.3 145.9 104.6 
Hpc aa408837 RC -1.0 -48.8 223.4 -12.0 -12.4 
Hpc aa422456 s 42.0 38.2 231.6 32.0 48.7 
Hpc aa590472 at 261.0 315.5 1770.5 125.9 148.1 
Hpc aa683731 s 1561.0 570.8 6205.0 318.7 314.9 
Hpc AF006492 at 152.0 312.6 1214.1 111.9 138.8 
Hpc AF006492 _g_ 77.0 155.8 1771.9 66.9 -20.7 
Hpc AF026072 at -129.0 -241.9 238.4 -42.0 -355.3 
Hpc AFFX-Gapdh -155.0 -295.4 215.2 -198.8 -132.6 
Hpc D30785 s at 63.0 -99.4 678.3 60.0 -97.4 
Hpc T25564 RC a -139.0 128.1 634.5 140.9 -204.1 
Hpc u29086 s at 175.0 22.9 822.2 -42.0 -1.0 
Hpc U65986 s at -75.0 -21.0 270.0 28.0 -68.4 
Hpc AFFX-Gapdh 1.0 522.6 1989.2 -12.1 -90.4 
Hpc AFFX-Gapdh -885.0 -337.1 555.8 -590.5 -616.5 
Hpc ET61808 i at -82.0 -174.2 160.3 -39.4 -169.8 
Hpc ET62782 at -74.0 -84.0 474.3 -434.9 -119.1 
Hpc Msa.12575.0 -52.0 -270.7 747.6 -209.3 52.6 
Hpc Msa.12975.0 -222.0 -853.5 306.1 17.5 -481.7 
Hpc Msa.18389.0 83.0 -294.5 1211.4 -353.9 -306.4 
Hpc Msa.19442.0 -276.0 -457.4 486.1 -31.8 -226.1 
Hpc Msa.21961.0 -236.0 -15.0 120.9 5.5 -71.1 
Hpc Msa.41663.0 -166.0 -124.1 287.7 60.3 -96.0 
Hpc Msa.6704.0 s -210.0 -166.7 367.9 -188.4 -106.1 
Hpc Msa.6742.0 f 156.0 401.0 2426.7 463.4 16.6 
Hpc X61800 s at -323.0 76.4 913.1 -37.2 -407.9 
Hpc Z50192 s at -232.0 -190.5 174.7 32.9 -532.5 
Hpc AFFX-Gapdh -164.0 54.9 784.7 -212.0 -305.9 
Hpc TC14336 at -51.0 -74.0 385.5 -103.0 -1.0 
Hpc TC14608 at -114.0 493.4 2320.9 33.5 142.8 
Hpc TC14829 s at 1784.0 366.6 7511.9 2125.7 1831.5 
Hpc TC15061 at 85.0 -49.7 2616.1 497.0 -28.6 
Hpc TCI5245_g_at 222.0 380.3 1420.1 182.0 183.6 
Hpc TCI6424_g_at 436.0 171.2 3059.6 168.9 162.1 
Hpc TC16425 s at 427.0 26.4 2428.2 52.7 -18.4 
Hpc TCI7256 at -173.0 -157.4 141.1 -209.6 -28.6 
Hpc TC17444 i at -196.0 -249.3 240.3 -180.8 -194.8 
Hpc TC17850 at -209.0 -40.1 162.9 -354.5 -345.7 
Hpc TC 17980 _g_ at 151.0 -278.9 1328.2 -142.5 -25.5 
Hpc TCI8982_g_at 155.0 -2.1 2387.8 180.8 -182.5 
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Hpc TC19176 at -138.0 183.8 656.4 74.2 79.5 
Hpc TC19193 at -99.0 -66.6 363.7 -81.4 3.1 
Hpc TCI9710_g_at 247.0 225.0 1446.7 293.4 183.6 
Hpc TC19871 at -120.0 -324.3 312.1 -310.2 27.5 
Hpc TC20006 at -286.0 -805.0 367.7 -293.4 -512.9 
Hpc TC20089 s at -198.0 37.0 236.3 -161.7 -305.9 
Hpc TC20098 f at 611.0 435.3 3242.7 614.4 758.7 
Hpc TC20098 i at 74.0 182.8 1252.4 148.5 283.5 
Hpc TC20339 at -236.0 -175.4 465.3 0.0 -244.7 
Hpc TC20454 at 58.0 27.5 271.8 -13.2 40.8 
Hpc TC20506 at 27.0 47.5 181.5 35.9 12.2 
Hpc TC20678 at -283.0 109.9 433.9 116.2 -144.8 
Hpc TC20709 at -32.0 84.5 366.9 55.1 98.9 
Hpc TC20738 at 333.0 232.4 2180.6 344.9 550.7 
Hpc TC21082 at -79.0 -8.5 202.4 -15.6 -32.6 
Hpc TC21313 at -696.0 356.0 1677.4 -239.5 -707.7 
Hpc TC22106 at -79.0 5.3 537.1 92.2 138.7 
Hpc TC22286 at -50.0 -197.6 146.8 -37.1 -124.4 
Hpc TC22963 at 524.0 339.1 1858.8 101.8 361.0 
Hpc TC23320 f at -360.0 -396.2 690.3 -419.2 -225.4 
Hpc TC23337 at -112.0 -195.5 178.2 -86.2 -237.6 
Hpc TC23506 at 42.0 153.2 754.0 79.0 31.6 
Hpc TC23617 f at -154.0 18.0 261.3 -401.2 1.0 
Hpc TC23836 at -28.0 45.4 294.4 69.5 -73.4 
Hpc TC24276 at -71.0 61.3 214.5 2.4 -40.8 
Hpc TC24724 s at 239.0 -668.7 1239.5 80.2 -309.0 
Hpc TC24742 at 1208.0 557.8 6299.8 658.7 455.8 
Hpc TC24876 at -19.0 -5.3 116.9 -27.5 -76.5 
Hpc TC25056 at -110.0 3.2 249.2 -14.4 -124.4 
Hpc TC25500 at 215.0 412.0 1824.1 304.2 235.6 
Hpc TC25822 at 105.0 100.5 569.3 -45.5 27.3 
Hpc TC26202 s at 260.0 -347.8 1368.2 1.2 231.8 
Hpc TC27162 at 318.0 559.1 2227.7 -19.8 353.5 
Hpc TC28297 at 28.0 59.3 214.9 26.9 34.6 
Hpc TC32654 at 47.0 41.2 181.8 -28.0 30.4 
Hpc TC33633 at -44.0 -20.6 121.2 -54.9 5.2 
Hpc AFFX-Gapdh -955.0 332.9 1208.7 -322.4 -885.0 
Hpc TC35302 at -138.0 -359.0 1052.9 -662.1 61.2 
Hpc TC36417 i at -2.0 -4.1 3326.1 -50.6 45.6 
Hpc TC36790 s at 92.0 386.5 2520.8 165.9 333.4 
Hpc TC37471 at -583.0 -1008.3 231.6 -510.4 -1409.0 
Hpc TC37672 f at -150.0 -1557.1 831.5 -94.8 -769.8 
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Hpc TC40680 _g_ at -96.0 -242.1 273.8 53.7 -244.6 
Hpc TC41370 s at 129.0 -121.1 969.9 170.7 -160.7 
Hpc TC41807 at 58.0 -143.1 525.7 -107.5 -103.1 
OB aa002925 s 244.0 -14.3 293.3 1126.1 97.4 
OB aa015322 s -33.0 -83.2 61.7 527.6 137.8 
OB aa028446 s 151.0 436.0 196.0 1944.4 -139.8 
OB aa174489 at 18.0 721.9 300.1 3508.2 128.5 
OB AA691224 at 46.0 -28.7 -9.6 204.8 -64.2 
OB C79906 RC a 236.0 323.2 249.4 1525.8 122.2 
OB C79906 _ RC_g 447.0 637.7 483.7 3669.0 276.6 
OB C80836 RC a -27.0 -28.7 -8.2 139.9 -539.7 
OB k01700-2 s a -21.0 -47.8 -64.4 302.8 34.2 
OB M32745 s at -75.0 26.8 -108.3 212.8 57.0 
OB M69200 s at 621.0 370.0 513.9 6243.9 1503.1 
OB m70642 s at 175.0 202.7 130.2 1928.4 74.6 
OB u03283 s at -6.0 88.9 28.8 392.7 5.2 
OB u37465 s at 493.0 236.2 405.6 1816.5 455.8 
OB u51000 s at 458.0 -312.6 270.0 8852.8 -230.0 
OB u57343 s at 242.0 59.3 -80.9 1575.7 53.9 
OB u67840 s at 364.0 70.8 112.4 1573.7 31.1 
OB u68058 s at 38.0 74.6 276.8 2172.2 -179.2 
OB u87456 s at -6.0 -63.1 -63.0 466.6 -13.5 
OB U88566 s at -175.0 -8.6 -34.3 158.9 -184.4 
OB ET61677 at -476.0 -114.1 -211.5 783.3 -145.8 
OB ET61693 at -25.0 -16.3 -19.7 185.2 -21.2 
OB Msa.lI014.0 59.0 67.7 -106.4 270.6 34.1 
OB Msa.2414.0 a 8.0 -50.1 -86.7 168.7 27.7 
OB Msa.25279.0 -102.0 62.7 61.8 478.8 55.4 
OB Msa.27849.0 -185.0 -676.8 14.5 267.3 -162.4 
OB Msa.3708.0 s -16.0 -1599.1 -1781.6 679.2 172.6 
OB Msa.3810.0 s 1076.0 26.3 166.9 5069.1 522.3 
OB Msa.4422.0 s 93.0 307.1 -48.6 9235.4 196.6 
OB Msa.444.0 at 137.0 -115.3 -461.2 809.6 -1.8 
OB Msa.4623.0 s -282.0 -734.4 -869.8 383.4 -658.0 
OB Msa.544.0 s 9.0 60.2 2.6 508.3 6.5 
OB U96700 s at 21.0 -134.1 -84.1 208.2 -74.8 
OB w84196 s at 172.0 185.5 -57.8 1229.2 77.5 
OB TC14785 f at -282.0 188.1 -150.0 670.6 63.2 
OB TCI5770_g_at -305.0 -365.5 -854.0 142.5 -377.3 
OB TCI5936_g_at -24.0 -45.4 -39.5 228.7 48.9 
OB TC16343 at -110.0 -70.8 -58.9 104.2 -135.6 
OB TC17513 at -22.0 10.6 -72.6 221.6 -48.9 
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OB TC18381 at 39.0 7.4 -28.2 263.5 -36.7 
OB TC18855 f at -87.0 -91.9 -141.9 796.4 -59.1 
OB TC18964 f at -11.0 -47.5 -155.6 319.8 53.0 
OB TC19736 at -515.0 -913.8 -791.9 617.9 -801.5 
OB TC20174 at -883.0 -1170.6 -1375.8 3470.5 -238.6 
OB TC20214 at 26.0 -24.3 -155.6 130.5 22.4 
OB TC20543 s at 36.0 15.8 0.8 843.1 79.5 
OB TC20573 at -22.0 -61.3 -63.7 238.3 -50.0 
OB TC20950 at -737.0 -1186.4 -441.1 2535.2 -1368.5 
OB TC21085 at -41.0 -8.5 -67.7 196.4 -106.1 
OB TC22268 at 202.0 -19.0 127.4 835.9 -142.8 
OB TC22661 at 5.0 -12.7 -57.3 206.0 4.1 
OB TC25512 s at -258.0 -94.0 -212.1 556.9 -240.7 
OB TC26138 at -86.0 -228.0 -253.4 216.0 -26.2 
OB TC26564 at -3.0 -520.5 -380.2 172.8 36.7 
OB TC26753_g_at -162.0 -1043.5 -1493.1 213.6 -289.5 
OB TC26829 i at 26.0 -10.3 -95.5 308.2 -45.1 
OB TC27099 s at 2104.0 1681.2 2042.2 8152.1 1646.8 
OB TC27790 at 82.0 -179.1 -141.4 471.6 82.9 
OB TC28487 at -124.0 -137.9 -62.4 374.7 -115.4 
OB TC28608 at 639.0 95.3 444.4 2785.5 547.6 
OB TC29521 at -515.0 -779.4 -202.0 855.7 -628.3 
OB TC29675 at 262.0 195.8 -194.7 990.0 219.2 
OB TC30868 f at 29.0 -105.6 -113.9 230.0 -93.4 
OB TC31261 at 658.0 240.9 319.6 3278.1 514.0 
OB TC31261_g_at 112.0 136.6 51.4 1097.4 143.7 
OB TC31401 at 110.0 -103.1 62.4 1159.2 -19.9 
OB TC31604 at 62.0 146.9 -468.3 680.6 -25.2 
OB TC31996 at -213.0 64.4 -323.2 410.9 25.2 
OB TC32133 at -52.0 18.0 -49.6 232.3 -8.4 
OB TC32211_g_at -699.0 -182.9 -1050.5 239.3 -174.1 
OB TC32255 _g_ at 13.0 46.4 14.7 358.4 39.9 
OB TC32944 at -296.0 -297.6 -183.7 166.9 14.7 
OB TC33215 at 37.0 37.4 95.5 342.1 89.2 
OB TC33295 at -8.0 -235.8 -657.5 605.9 -67.1 
OB TC33678 s at -71.0 -333.7 -576.7 166.9 -332.5 
OB TC33964 at 335.0 897.9 247.9 3487.1 291.6 
OB TC34316 at -308.0 -186.8 -213.0 693.5 -16.8 
OB TC34405 _g_ at -328.0 -27.1 -598.7 248.7 -270.6 
OB TC34509 at 17.0 346.6 -145.1 1901.7 -38.8 
OB TC34509 _g_at 357.0 927.6 139.6 3314.3 578.0 
OB TC34531 f at -34.0 12.9 -117.5 240.5 -2.1 
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OB TC34963 at -327.0 -206.3 -107.8 2008.5 140.3 
OB TC35065 at 616.0 396.2 410.7 2920.3 581.6 
OB· TC35158 at -334.0 -89.4 -502.4 591.0 -1432.9 
OB TC36785 at 663.0 218.7 640.8 6534.4 816.6 
OB TC36785 _g_ at 2295.0 590.1 1306.3 18514.0 2767.6 
OB TC37090 at -716.0 -326.0 -1000.5 184.9 -418.5 
OB TC37997 at 78.0 -308.1 -65.5 293.9 -136.7 
OB TC38418 at -31.0 45.4 -65.5 186.5 32.4 
OB TC38669 at -31.0 -2.8 -29.1 335.0 2.4 
OB TC39131_g_at 66.0 82.5 -301.5 1174.1 -394.5 
OB TC40403 at 155.0 -269.6 139.8 971.9 239.8 
OB TC40734 at -349.0 328.8 148.5 1717.7 -230.2 
OB TC40769 at 58.0 148.6 109.2 628.9 125.9 
OB TC40908 at 29.0 266.9 -45.1 1088.8 -27.6 
OB TC41850 at -979.0 -1630.0 -1885.9 1226.3 -1594.8 
OB TC41873 at 90.0 152.7 294.2 1651.4 170.3 
OB TC41873 _g_ at 378.0 349.4 447.1 5369.7 341.8 
OB TC41923 s at -783.0 -1072.9 -2273.3 1733.5 -780.6 
OB TC41945 at 544.0 551.6 588.3 2691.2 659.5 
OB TC42120 at 327.0 255.9 -64.1 3207.9 612.8 
PAG AA245183 at -200.0 46.8 -126.1 -218.8 556.3 
PAG aa386903 at -385.0 -362.4 -135.7 -117.9 119.1 
PAG aa734486_g_ -378.0 -306.9 -420.7 -331.7 397.8 
PAG AB000096 _g_ -53.0 67.9 91.8 -88.9 368.8 
PAG afD13604 s at 130.0 293.5 156.2 152.9 4232.6 
PAG c79089 RC s 435.0 1972.4 250.8 263.8 10187.0 
PAG d00754 s at 56.0 -187.4 217.9 -52.0 909.5 
PAG D00812 s at 206.0 243.8 264.5 176.9 929.2 
PAG DI1091 s at 412.0 449.4 422.1 437.7 1641.9 
PAG D16580 s at 9.0 308.8 -182.3 290.8 1203.7 
PAG D18061 RC a -6.0 -34.4 -8.2 21.0 239.3 
PAG d89571 at -355.0 44.0 -1208.7 -280.8 562.5 
PAG 107037 s at 114.0 -238.1 -134.3 -346.7 801.8 
PAG M31690 f at 189.0 -52.6 4.1 221.8 1272.1 
PAG ET62843 f at 63.0 -72.7 -758.1 -158.9 371.0 
PAG Msa.15757.0 -196.0 -55.1 93.3 -116.1 349.8 
PAG Msa.I7804.0 -110.0 82.7 -80.1 29.6 3271.6 
PAG Msa.2021.0 a -254.0 -350.9 294.3 -280.5 1229.3 
PAG Msa.23858.0 -133.0 61.4 2.6 -96.4 263.9 
PAG Msa.2451.0 s -42.0 448.7 -512.4 -123.8 1599.3 
PAG Msa.24687.0 -155.0 -446.2 -286.4 -410.8 650.6 
PAG Msa.26324.0 -64.0 86.5 -459.9 -204.9 594.3 
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PAG Msa.33045.0 -7.0 -66.4 -1.3 -87.6 669.1 
PAG Msa.6114.0 s 426.0 184.2 168.2 282.7 1629.8 
PAG Msa.6768.0 s -4.0 -125.3 0.0 96.4 641.4 
PAG Msa.7127.0 s 2065.0 452.4 -1744.8 -87.6 12361.0 
PAG Msa.8112.0 s 198.0 -66.4 -138.0 77.8 859.2 
PAG Msa.8622.0 s 487.0 22.6 -337.7 61.4 3094.4 
PAG W08454 s at 39.0 107.8 -467.7 -99.7 419.9 
PAG W67100 s at 0.0 84.0 105.1 11.0 464.2 
PAG TC14206 at 230.0 280.0 129.0 495.8 1966.1 
PAG TC16865 at 621.0 498.7 77.4 355.7 2775.8 
PAG TC17400 at -497.0 -328.6 -688.7 -518.5 257.0 
PAG TCI8118~g~at -144.0 -220.8 -190.3 -148.5 227.4 
PAG TC 19890 ~g~ at -45.0 -210.2 -1.6 15.6 179.5 
PAG TC19903 at 25.0 -63.4 3.2 -170.1 398.7 
PAG TC21111~g~at -56.0 -160.6 -715.3 -288.6 360.0 
PAG TC22581 s at -15.0 137.3 21.0 -22.8 633.3 
PAG TC23551~g~at 5.0 1.1 15.3 18.0 93.8 
PAG TC24421 at -29.0 -10.6 -2.4 13.2 97.9 
PAG TC24428 s at 5.0 -120.4 27.4 21.6 147.9 
PAG TC26053 at 271.0 -150.7 -1089.0 269.7 2427.3 
PAG TC26201 s at 1046.0 149.4 989.9 527.7 4742.3 
PAG TC27169~g~at 101.0 -435.4 36.7 71.2 403.8 
PAG TC29206 at 139.0 -168.8 -156.1 -220.6 692.3 
PAG TC29314 at -41.0 12.9 -473.8 -235.8 413.3 
PAG TC30851 at 3527.0 3255.5 1173.5 1571.3 13556.0 
PAG TC32701~g~at 260.0 838.7 828.3 -188.0 5092.6 
PAG TC33864~g~at 1061.0 405.8 820.9 767.0 3784.6 
PAG TC34956 at 166.0 145.8 630.6 505.7 6532.8 
PAG TC34957 at 547.0 433.3 225.7 872.3 4735.3 
PAG TC35074 at 49.0 -74.3 -16.0 85.3 356.1 
PAG TC35078 s at 424.0 319.1 355.3 499.4 1823.9 
PAG TC35230 at 57.0 70.2 71.4 -74.3 274.6 
PAG TC35254 at -163.0 11.0 -93.2 -131.2 309.4 
PAG TC35286 at -134.0 -101.8 -196.6 60.1 464.1 
PAG TC35359 at 74.0 181.6 69.9 39.5 845.4 
PAG TC35493 at -120.0 -166.4 46.6 -42.7 729.1 
PAG TC35564 at -1180.0 -354.9 -1668.9 -1517.0 967.7 
PAG TC35765 at 305.0 184.3 -94.7 104.3 1480.9 
PAG TC36245 at -134.0 -167.8 -69.9 -28.4 239.8 
PAG TC36249 at 122.0 -5.5 43.7 28.4 678.7 
PAG TC36868 s at -371.0 -66.0 -253.4 37.9 292.6 
PAG TC36897 s at 51.0 46.8 -179.1 -617.9 191.9 
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PAG TC37333 at -139.0 2.8 5.8 -167.5 178.7 
PAG TC37746 s at -250.0 12.4 53.9 -132.7 278.2 
PAG TC37944 at -370.0 -162.3 -538.8 -169.1 232.6 
PAG TC38491 at 18.0 59.1 -174.8 -28.4 256.6 
PAG TC39975 at 165.0 -371.4 -257.8 33.2 1008.5 
PAG TC40689 at -133.0 286.1 -135.4 -12.6 2362.3 
PAG TC40745 at 48.0 -386.5 -565.0 -926.0 376.5 
PAG TC40881 at 304.0 -231.1 -371.4 -349.2 1268.7 
PAG TC41736 at -154.0 -99.0 -297.1 -2024.3 1855.0 
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Table 1-4: Categories of genes. 
Of the 455 total genes and ESTs differentially enriched, 117 genes were annotated 
and classified based on molecular function. Guidelines from the Gene Ontology (GO) 
Consortium were followed for classification. (A): the number of genes enriched at least 
3.5-fold and the number of annotated genes among those in each region is presented. The 
percentage of annotated genes relative to enriched genes is also shown. (B): number of 
total genes identified and percentage in each region are shown for each category. 
Highlighted categories are the most represented. Abbreviations are as in table 3. 
(A) 
Amy Cb Hpc OB PAG total 
enriched genes 33 159 89 101 73 455 
# annotated genes 8 47 17 24 21 117 
%annotated genes / enriched 24 30 19 24 29 26 
(B) 
molecular function total # % %in %in %in %in %in genes genes Amy Cb Hpc OB PAG 
motor protein 1 1 13 0 0 0 0 
ribonuclear 2 2 0 4 0 0 0 
nuclear 1 1 0 2 0 0 0 
signaling 30 26 25 30 0 29 33 
transporter 3 3 0 4 0 0 5 
ligand binding or carrier 8 7 0 9 6 8 5 
DNA binding 20 17 50 17 12 17 10 
structural 10 9 0 6 18 17 0 
enzyme 18 15 0 15 18 8 29 
enzyme inhibitor 4 3 0 4 0 4 5 
membrane protein 6 5 13 4 0 4 10 
ubiquitin 2 2 0 0 6 4 0 
immunity, defense protein 1 1 0 0 6 0 0 
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zinc finger protein 2 2 0 0 12 0 0 
cell adhesion 1 1 0 0 6 0 0 
chaperone 1 1 0 0 6 0 0 
translation 5 4 0 2 6 8 5 
cell cycle regulator 1 1 0 2 0 0 0 
transcription factor 
1 1 0 0 6 0 0 
binding 
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1.4.4 Figure legends 
Figure 1-1: Distribution of normalized average difference values in each sample. 
(A) Distribution of nonnalized average difference (6 ) values in each sample. 
Only the llka array is plotted here, but all other chips had similar distributions. For 
clarity, only values below 7000 are shown. The dotted line indicates the mean value 
(1104). Bin size is 200. (B) Plots of average difference values for all possible two-way 
comparisons. The first row has the amygdala (A) on the x-axis. The second row are plots 
with the cerebellum on the x-axis, the third and fourth rows have the hippocampus and 
olfactory bulb, respectively, on the x-axis. The y-axes are the cerebellum (C), 
hippocampus (H), olfactory bulb (0) and PAG (P), from the first to fourth columns, 
respectively. For clarity, average difference values were divided by 1000 and only values 
below 30,000 are shown. The dashed line indicates a slope=1. 
Figure 1-2: In situ hybridization of amygdala-enriched genes. 
(A) Nissl staining of a coronal section (left side of the brain). To the right, a 
schematic representation of various amygdala subnuclei is shown. Cortical-like nuclei 
(lateral, basolateral and cortical) are shown in blue. Striatal-like subdivisions (central and 
medial) are in yellow, and the basomedial region is in orange (BMP= basomedial, 
posterior. BMA= basomedial, anterior). (B-D) Low magnification pictures of the left 
hemibrain. Amygdala-details are shown in the magnified area (boxes). To the right, 
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computer-aided schematics of staining in the amygdaloid region. Note that the nuclear 
boundaries vary slightly depending on the axial level. Color boundaries of subnuclei 
follow the diagram from A. (B) Probe 29 (activin receptor type II, TIGR identifier 
TC35462). Intense labeling in the lateral, basomedial and cortical amygdala is apparent 
(black arrows). Note that the medial nucleus is devoid of staining (white arrow). No 
signal was detected in the cerebellum or PAG. Very few cells were stained in the 
olfactory bulb (not shown). A sense probe (not shown) labeled the hippocampus and 
piriform cortex (arrowheads) in the same way as the antisense probe, so the signal in 
these regions may be mainly due to non-specific hybridization. (C) Probe 41 (laminin 63, 
Genbank accession U43298). Signal is visible in the medial amygdala (black arrow) and 
ventromedial hypothalamus (white arrow). No staining was detected in cerebellum, 
hippocampus, olfactory bulb, and PAG (not shown). (0) Probe 4 (arp-l, Genbank 
accession X76653). Strong signal is detected in the lateral and basolateral complexes 
(black arrow). Note also weaker signal in the medial amygdala (white arrow). The 
reticular thalamic nucleus also showed clear hybridization (arrowhead). No staining was 
detected in the other four regions examined on microarrays (not shown). 
Figure 1-3: Expression of amygdala-enriched genes in different amygdaloid subnuclei. 
(A) Probe 75 (unconventional type myosin, TIGR identifier TC37197). Note the 
sharp discontinuity in expression levels between the lateral (arrow), and basolateral 
(arrowhead) nuclei. Staining was also observed in cortical layers 2/3 (white arrow). No 
staining was detected in the cerebellum, olfactory bulb or PAG (not shown). (B) Probe 
45-6 (Lhx6, Genbank accession AB031 040). Lhx 6 hybridized to many scattered cells in 
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the forebrain, and was particularly concentrated in the dorsal aspect of the medial 
amygdala (arrow); the cerebellum was unlabeled (not shown). Lhx 6 was not represented 
on the microarray, but was analyzed due to its coexpression with Lhx7 (Grigoriou et aI., 
1998; Zhao et aI., 1999), which was also enriched in the amygdala (not shown). (C) 
Probe 50 (neuronal pentraxin receptor, TIGR identifier TC18750). The expression 
domain matches the boundaries of the lateral and basolateral amygdala (arrow). Staining 
was also observed throughout cortex (arrowhead) and in hippocampus (not shown). No 
signal was detected in the cerebellum or PAG. The olfactory bulb had weak staining (not 
shown). (D) Probe 28 (plasma glutathione peroxidase, TIGR identifier TC31122). 
Intense labeling is apparent in the medial amygdala (arrow), hypothalamus and PAG (not 
shown). Note also signal in a contiguous subregion of the basomedial amygdala (dotted 
line). Two other genes also showed expression in this same region (not shown). (E). 
Probe 68 (CSF-induced cysteine protease, TIGR identifier TC 30215). Hybridization in 
the basomedial amygdala (arrow) was detectable. Staining was also observed in the 
hippocampus, but was absent in the remaining regions of study (not shown). (F) Probe 
20 (Ccte chaperonin epsilon subunit, TIGR identifier TC30886). Signal was detected in 
the medial amygdala (arrow) and in the lateral, basolateral and basomedial complexes 
(not shown). No staining was detected in the other 4 regions of study (not shown). 
Figure 1-4: Possible gene expression patterns in the amygdala. 
Possible gene expression patterns in the amygdala and the percentage of 
amygdala-enriched genes examined that exhibited such patterns. (i) Contiguous, pan-
amygdaloid expression. (ii) Contiguous expression in subdomains whose boundaries bear 
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no relationship to those of classically defined amygdaloid subnuclei. (iii) Expression in 
scattered cells contained within specific subnuclei. (iv) Expression in scattered cells not 
respecting subnuclear boundaries. (v) Contiguous expression in subdomains whose 
boundaries match, at least in part, those of amygdaloid subnuclei. The majority of genes 
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2 LASER-CAPTURE MICRODISSECTION COMBINED 
WITH MICROARRAY TECHNOLOGY PERMIT THE 
IDENTIFICATION OF GENES DIFFERENTIALLY 
EXPRESSED WITHIN DISTINCT AMYGDALA 
SUBNUCLEI 
2. 1 Introduction 
The previous chapter described the successful characterization of amygdala-
enriched gene products using microarray technology followed by in situ hybridization. 
We found that only 91 genes were differentially enriched in each brain region. 
Considering that 19,022 genes were present in the brain regions examined based on 
microarray readings, only 0.5% of the expressed genes were thus differentially expressed 
in each region (91119,022). It is noteworthy that very similar figures were obtained by an 
independent study (Sandberg et aI., 2000). This relatively high homogeneity among brain 
regions was somewhat unexpected for two reasons. First, neurons are very 
heterogeneous, with potentially hundreds of different neuronal cell types in the cerebral 
cortex alone (Serafini, 1999). Second, early studies done prior to the advent of large-scale 
microarray technology had suggested that a large fraction of the genome was expressed 
in the brain (Milner and Sutcliffe, 1983). Thus why have we found relatively few 
differentially enriched transcripts? Two main reasons come to mind. On the one hand, the 
use of high-density oligonucleotide arrays by definition limits the screen to genes and 
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ESTs of previously known sequence. Therefore, if indeed highly specific brain transcripts 
exist, they may not have been cloned yet and thus represented on the arrays. On the other 
hand, highly specific, non-abundant transcripts may be lost due to a "dilution problem." 
Because of the cellular diversity in the brain, important expression differences occurring 
in a subpopulation of cells that make up a small fraction of the total population may 
simply be diluted out and undetected. We decided that even though the cost of the 
commercial arrays was high, their convenience and proved reliability merited their use. 
Thus, to try to solve the dilution problem we decided to start with more homogeneous 
tissue, obtained by laser-capture microdissection and search for genes differentially 
expressed within amygdala subnuclei. Laser capture microdissection (LCM) has been 
developed to extract pure cell populations from specific regions of tissue sections, under 
direct microscopic visualization (Simone et aI., 1998). A transfer film is applied on the 
surface of the tissue section placed on a standard glass slide, and is activated by a low-
power laser beam. When activated, the film focally adheres to the cells of interest and 
thus permits their collection, while surrounding tissue that has not been submitted to the 
laser shot is left intact. In principle, the low energy laser used does not alter cellular 
contents, which can then be reliably collected for nucleic acid or protein extraction 
(Emmert-Buck et aI., 1996). 
The use of finer dissections introduced a different problem, though: RNA had to 
be amplified prior to probe synthesis given the low number of cells isolated by LCM. I 
relied on linear, T7 RNA polymerase-based amplification methods, which had been used 
in the past (reviewed in Kacharmina et aI., 1999), and also in combination with LCM-
extracted dorsal root ganglion RNA (Luo et aI., 1999). Consequently, I compared gene 
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expression profiles among the central, lateral, and medial amygdala subnuclei and 
contrasted those with the profiles obtained in the previous screen, where a rather crude 
hand dissection of the whole amygdala was performed. The results presented in this 
chapter show that such a combination of technologies, namely LCM-extraction of RNA 
from distinct brain subnuclei, followed by linear RNA amplification and microarray 
analysis provides a useful tool to further characterize the molecular constituents of small 
neuronal subpopulations. 
2.2 Brief overview of anatomy and function of different 
amygdala subnuclei 
As mentioned in Chapter 1, the amygdala is thought to control emotional 
behaviors, such as fear, anxiety, and emotionalleaming (reviewed in Rogan and LeDoux, 
1996). A variety of lesion studies done in rodents or monkeys indicate that the amygdala 
is necessary for the evaluation of fearful stimuli. For example, rats with damage to the 
amygdala will approach a natural predator, such as an anesthetized cat (Blanchard and 
Blanchard, 1972). What is now called the Kluver-Bucy syndrome was recognized a long 
time ago in monkeys with lesions in the amygdala (Kluver and Bucy, 1939). These 
monkeys were generally placid and performed tasks normally perceived as threatening. In 
addition, human patients with damage in the amygdala fail to recognize fearful visual or 
auditory stimuli (Adolphs et aI., 1994; Scott et aI., 1997), and also show general 
hypo emotionality. Moreover, electrical stimulation of the amygdala in rodents can elicit 
typical autonomic manifestations of fear and cessation of ongoing activities (freezing), a 
stereotypical response often measured in behavioral paradigms (reviewed in Clark, 1995). 
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Since it is viewed that some psychiatric conditions such as generalized anxiety or 
post-traumatic stress disorders are maladaptations of normal fear responses (Rosen and 
Schulkin, 1998), the role of the amygdala in fear conditioning has attracted special 
attention (reviewed in Flint, 1997; LeDoux, 1995). Briefly, this associative learning 
phenomenon consists of the generation of fear by a harmless stimulus. It is achieved by 
the repetitive co-presentation of a neutral stimulus (such as a tone) and an aversive 
stimulus (e.g. electric shock). After a number of trials, animals (including humans) learn 
to associate both stimuli and show aversive responses to the single presentation of the 
previously neutral stimulus. 
Anatomically, the amygdala is a complex forebrain structure composed of over a 
dozen subnuclei (Pitkanen et ai., 1997), such as the central, lateral, basomedial, and 
medial subnuclei. 
Ontogenetically, the amygdala has mixed embryological origins (Puelles et ai., 
1999), as evidenced by different homoeobox gene expression domains in the developing 
prospective amygdala and by different neurotransmitter expression in the adult (Esclapez 
et ai., 1993). Accordingly, its various subnuclei have different functions. The lateral 
nucleus is the site of sensory input convergence (Maren and Fanselow, 1996; Pitkanen et 
aI., 1997). It presumably integrates different inputs before relaying information to other 
subnuclei. Just as the lateral nucleus is the main input system of the amygdala, the central 
nucleus is the output. In general, there is a unidirectional informational flow, from lateral 
structures (such as the lateral and basolateral nuclei), to more medial ones (including the 
medial, basomedial, and central nuclei) (Pitkanen et aI., 1997; Swanson and Petrovich, 
1998). Interestingly, there are heavy internuclear projections from the lateral nucleus to 
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the basolateral, bas orne dial and medial nuclei, whereas there are fewer reciprocal 
connections from these subnuclei to the lateral one. Most subnuclei in tum heavily 
project to the central nucleus, which has sparse axonal projections to any other 
amygdaloid nucleus (Pitkanen et aI., 1997). The central nucleus projects to hypothalamic 
and brainstem regions involved in the reactions to fear (Davis, 1992), that produce 
perspiration, increased blood pressure, and bradycardia. The posterior cortical and medial 
amygdaloid nuclei are interesting because they receive input from the accessory olfactory 
bulb (Swanson and Petrovich, 1998). The medial nucleus heavily projects to the medial 
hypothalamus, in regions known to mediate specific feeding, reproductive and defensive 
behaviors (Canteras et aI., 1994). In tum, the medial subnucleus receives input from 
ventromedial hypothalamic neurons. Thus, this subnucleus integrates pheromonal 
information and may indirectly regulate fundamental innate behaviors. In addition, the 
medial amygdala is sexually dimorphic, as the volume is about 20% larger in male than 
in female rats. Sex differences in synaptic organization in this nucleus have also been 
reported (Roberts, 1992). The accessory olfactory bulb, which directly projects to the 
medial nucleus, is also larger in males, thus sex differences in medial amygdala volume 
may be partly due to unequal synaptic input to this region. Moreover, the posterior medial 
amygdala harbor many estrogen and androgen receptor-containing neurons, thus its 
function is probably modulated by gonadal steroids (Roberts, 1992). 
Because their roles are better defined than other amygdala nuclei and their 
anatomical demarcations are more clearly visualized with Nissl staining, I decided to 
conduct RNA-expression studies from the lateral, central and medial subnuclei. 
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2.3 Methods 
2.3.1 Experimental design 
We compared gene expression among three amygdala subnuclei: central, lateral 
and medial. The overall strategy was similar to the one described previously, except that 
the tissue was dissected by laser-capture (LCM): 
LCM-RNA extrocton from central, lateral and medial 
amygdala submdei 
T7 -RNA ~Iymerase-batd amplificaton (2 rounds) 
+ 
cRNA biotinylaton .. 
Hybrdizaton to Affymetrix Microarrays (---36,000 genes and ESTS) 
+ . Data Analysl s .. 
In situ rl}'brdizatbn 
Briefly, subnuclei were dissected by LCM, RNA was amplified prior to probe 
synthesis, and biotinylated cRNA probe was hybridized to Affymetrix U74v2 
microarrays, comprising about 36,000 mouse genes and EST clusters 
(http://www.affymetrix.com/products/murineU7 4_ content.html). The Murine 
U74v2 sets are composed of three subarrays (U74v2A, U74v2B, U74v2C). Three 
biotinylated probe replicates were synthesized for each subnucleus, by independent 
cDNA synthesis from a single RNA LCM-extraction. 
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2.3.2 Sample preparation 
The following protocol involving RNA amplification prior to probe synthesis was 
adapted from (Luo et aI., 1999; Mahadevappa and Warrington, 1999; Ohyama et aI., 
2000). Please refer to the Affymetrix manual for a detailed protocol for standard probe 
synthesis. 
Histology: Brains from two C57/Bl6 mice sacrificed by cervical dislocation were 
used. 15-um thick sections were sliced with a cryostat and stored at -80°C immediately 
in a dry container. The day of the microdissection, sections were first fixed in 100% 
Ethanol for 3min and then hydrated through a series of 95%, 75%, and 50% ethanol 
solutions for 20 sec each. They were rinsed in water for 20 sec and stained with Nissl 
(0.5% Cresyl violet + 0.1 M Sodium acetate buffer, made with Molecular Biology Grade 
Biowhittaker water) for 40 sec. Consequently, slides were briefly rinsed in water, and 
then dehydrated in the graded ethanol solutions series above mentioned. Finally, sections 
were immersed in 2 washes ofxylenes, for 20 sec and 1 minute, respectively. Slides were 
allowed to air-dry for 5-10 min, and then were placed in a dry container with Drierite 
desiccant. 
Laser-capture Microdissection (LeM): An Arcturus LCM instrument was used 
for dissection. A large beam (of approximate 80 mW in Power and a duration of 8.5ms) 
was directed towards the subnuclei of interest and cellular contents were collected on 
large caps (Arcturus Cap Sure TF-lOO). Typically, around 2000 pulses were shot for each 
piece of tissue targeted with such laser beam. 
RNA extraction: Solutions from the Qiagen Rneasy total RNA isolation kit were 
used (cat. 74104). About 6-8 "pieces of subnuclei" from 15 ~m thick sections were 
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collected on the same cap. 40 , .. tl of RL T buffer were added to each cap inverted on an 
eppendorf tube. Contents were spun down at 4000 rpm for 30 sec. in a microcentrifuge. 
The tubes were left at -80°C until the microdissection was finished. Finally, all cellular 
contents from the same subnucleus were pooled in a final volume of 500 III of RLT 
buffer. About 30 "pieces of microdissected subnuclei" were used for each probe 
preparation for microarray hybridization. 
RNA purification and DNase treatment: Instructions from the Qiagen Rneasy 
total RNA isolation kit were followed. A DNase treatment step was included prior to 
elution from the columns (Qiagen cat 79254). RNA was eluted in 50lll water and then 
concentrated using Microcon-lOO columns (Fisher cat. 424l3) into 10111 (Spun at 3000 
rpm for 12 min in the microcentrifuge). 
First cDNA synthesis and quality control: llli of 20llM T7-(dT)24 pnmer 
(Genset Corp.) was mixed with 10 III RNA and heated 10 min at 70°C and 5 min at 42°C. 
Then the following reagents from the Superscript Choice System kit (Gibco 
18090-019) were added: llli RNAse inhibitor, 4 III transcription 5X buffer, 2 III DTT, 1 
III of 10 mM dNTP, III Superscript II RT. The reaction was incubated for 1 hr at 42°C. 
PCR controls were done with specific housekeeping gene primers such as actin, GAPdH, 
hprt and alpha-tubulin with 0.5 III of cDNA, using 40 cycles. Only samples that gave 
good PCR products were used for subsequent syntheses. 
Second strand synthesis: The following was mixed with the first strand cDNA 
product: 96 III RNase-free water, 30 III of 5X second strand buffer, 3 III of 10mM dNTP, 
4 III DNA polymerase I, 1 III RNAse H, 1 III DNA ligase, and incubated at 16°C for 2 hr. 
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2 )11 of T4 DNA polymerase were added for 10 min at 16°C. The reaction was 
stopped with 10 )11 of O.SM RNAse-free EDTA. DNA was then extracted with ISO )11 
Phenol: Chloroform: Isoamylacetate (2S:24:1) using PLG light columns (Fisher). The 
DNA was washed 3 times with a final volume of SOO )11 and concentrated using the same 
Microcon-lOO columns (Spun at 3000 rpm for 12 min in the microcentrifuge). 
T7-polymerase RNA amplification (first round): 12 )11 of ds cDNA were used 
for RNA amplification. They were mixed with the following from the Ampliscribe T7 
transcription kit (Epicentre Technologies AS2607): 2 )11 of lOX transcription buffer, O.S 
)11 each of 100 mM ofNTP, 2 )11 DTT, 2 )11 T7 polymerase. Incubation was carried out at 
37°C for 14 hr. 180 )11 of water was added and RNA was extracted with Phenol: 
Chloroform: Isoamylacetate (2S:24:1). RNA was washed 3 times and concentrated with 
Microcon-100 columns as described above and collected in 9 )11 of water. 
Second cDNA synthesis: for first strand, in a PCR tube 9 )11 RNA and 2)11 
random hexamers (SO ng/)1l) were mixed, heated 10 min at 70°C and then cooled at 4°C 
for S min in a PCR machine. The following reagents were added: 1 )11 RNAse-inhibitor, 4 
)11 SX transcription buffer, 2)11 DTT, 1 )11 (10 mM) dNTP, 1)11 Superscript II RT and 
incubation was carried out at 37°C for 1 hr. 
For second strand synthesis, 1 )11 RNAse H was first added for 20 min and then 
the reaction was stopped by heating at 9SoC for 2 min in a PCR machine. After addition 
of 1 III of 60llM T7-(dTb, the mix was first heated at 70°C for S min and then at 42°C 
for 10 min in a PCR machine. The following were added: 90 III RNase-free water, 30 III 
SX second strand buffer, 3 III (10 mM) dNTP, 4 III DNA polymerase I, and 1 III RNAse 
H and incubated at 16°C for 2 hr. 2 III T4 DNA polymerase were added and incubated 10 
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min at 16°C. The reaction was stopped with 10 I.tI of 0.5 M depc-treated EDT A. DNA 
was then extracted with 150 ).11 Phenol: Chloroform: Isoamylacetate (25:24:1) using PLG 
light columns (Fisher). The DNA was washed 3 times with a final volume of 500 ).11 and 
concentrated using the same Microcon-100 columns (Spun at 3000 rpm for 12 min in the 
microcentrifuge). The DNA was collected in 9 ).11. 
T7-polymerase RNA amplification (second round): 9 ).11 of ds cDNA were used 
for RNA amplification. They were mixed with the following from the Ampliscribe T7 
transcription kit (Epicentre Technologies AS2607): 2 ).11 of lOX transcription buffer, 1.3 
).11 each of 100 mM ofNTP, 2 ).11 DTT, 2 ).11 T7 polymerase. Incubation was carried out at 
37°C for 14 hr. 180 ).11 of water was added and RNA was extracted with Phenol: 
Chloroform: Isoamylacetate (25:24:1). RNA was washed 3 times and concentrated with 
Microcon-l00 columns as described above and collected in 9 ).11 of water. 
cDNA synthesis (third round): This was carried out exactly as in the second 
round. After extraction, DNA was washed and collected into 22 ).11 water. 
Biotinylation (third round of RNA synthesis): The following from the ENZO 
RNA transcript labeling kit (cat 42655) were mixed: 4 ).11 viall (HY reaction buffer), 4 ).11 
vial 2 (biotin NTPs), 4 ).11 vial 3 (DTT), 4 ).11 vial 4 (RNAse inhibitor), and 2 ).11 vial 5 (T7 
polymerase). Incubation was at 37°C for 4-5 hr. (mixing contents every 30-45 min) 
RNA clean-up: The Qiagen Rneasy total RNA isolation kit was used (cat. 
74104). First, 1.5 ).11 of RNA was saved for running a gel. 62 ).11 of RNAse-free water and 
350 ).11 of RL T buffer were added and mixed. 250 ).11 ethanol were added and the solution 
was applied to the affinity column. The elution was applied to the same affinity column 
again, followed by two washes with RPE buffer. RNA was eluted twice in 50 ).11 of 
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RNAse-free water each, (so that the final volume was 100Jll). For RNA precipitation, 50 
Jll of 7.5 M NH4Ac, 250 Jll cold EtOH and 1 Jll glycogen were added, incubated at -20°C 
1 hr, spun 30 min at 4°C, and washed twice with 500 Jll of 80% cold Ethanol. Clean 
biotinylated RNA was resuspended in 15 Jll RNAse-free water. Absorbance at 260/ 280 
nm was checked with 0.5 Jll. An electrophoretic gel was also run with 0.5 Jll RNA to 
check that a good smear of RNA synthesis was obtained. (RNA was stored at -80°C at 
this point.) 
RNA Fragmentation: (For this, the initial concentration should be > 0.6 Jlg/Jll 
and the final concentration in the fragmentation reaction should be > 0.5 Jlg/Jll.) 3.5 Jll 
5X fragmentation buffer (200 mM Tris-acetate, pH 8.1, 500 mM KOAc, 150 mM 
MgOAc) were added and incubated at 94°C for 35 min. 
Finally, 0.5 Jll were run on a gel to confirm that fragmentation of RNA occurred. 
(Fragmented RNA was stored at -20°C). 
2.3.3 Data analysis 
Custom Software: Data were first normalized by the Affymetrix software, so that 
the average intensity of each array was equal to an arbitrary target intensity. In this case, 
the target intensity was 2,500, a value typically set by the HHMI facility at Stanford, 
where these arrays have been scanned. (The average intensity of an array is calculated by 
averaging all the average difference values of every probe set on the array, excluding the 
highest 2% and lowest 2% of the values.) Normalized average difference values were 
exported and analyzed with custom software, written in Matlab (The MathWorks, Natick, 
MA), which is available at http://www.its.caltech.edul~mariela/gene_screen.html. The 
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software was based on the one described in Chapter 1, except that it also contemplated 
the existence of biotinylated cRNA probe triplicates for each subnucleus, called Cl, C2, 
C3 (for central nucleus replicates 1, 2, and 3); Ll, L2, and L3 (for lateral nucleus); MI, 
M2, and M3 (for medial nucleus). 
Three criteria were applied to identify genes enriched in each replicate of the 
-
three amygdala subnuclei: (1) the average difference (Ll) value for the gene in that 
subregion; (2) Significance of labeled cRNA hybridization to the probe cells on the 
microarrays; and (3) the ratio (fold-difference) of its Ll value in the reference subregion 
to that in each of the other six subregions (three replicates for each of the other two 
subnuclei being compared to). A given gene gi, with an average difference value in 
central nucleus-replicate 1 Ll ~,l , was considered to be enriched in this replicate relative to 
the other subnuclei examined if it satisfied the following constraints for these three 
criteria: 
Cl 
i) Ll > minimum g, 
ii) pos - neg> 6 if pairs used> 10 or 
pos - neg> 3 ifpairs used<lO 
iii) ~Cl/~other > 2.5 
gj gl 
~Cl/~other < 0 or g, g, for all six other samples (LI, L2, 
L3, MI, M2 and M3). 
In this case, the minimum value was set = 200 (for reference, the arrays were 
normalized to a target intensity of 2500 and the noise levels were between 20 and 30). 
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Constraint ii) is a good indication of whether the hybridization of the synthesized 
cRNA probe to the arrays is significant or rather due to nonspecific binding, and is 
analogous to the Present call in the Affymetrix software2• 
Visual Inspection: The hybridization parameters to the microarrays of each 
enriched gene identified with the custom software were visually inspected to further 
narrow down the list of candidate genes for in situ hybridization follow-up experiments. 
Genes that had average difference values that varied considerably across replicates from 
the same subnucleus were not considered good candidates. Similarly, I did not expect to 
observe reliable differences in gene expression by in situ hybridization for genes with 
relatively high average difference values in all replicates whose difference (pos-neg) was 
about the same for all subnuclei. 
2.3.4 In situ hybridization 
The protocol for the In Situ hybridization was described in Chapter 1. 
2.4 Results 
2.4.1 Analytical characterization of differentially expressed genes 
Before analyzing the data in detail, I wanted to assess whether the quality of 
cRNA probe preparation was good in spite of the extra manipulation (i.e., LCM 
2 When the intensity of the perfect match probe cell is significantly greater than that of the corresponding 
mismatch probe cell, the probe pair is termed positive (pos). When the intensity of the mismatch probe cell 
is significantly greater than that of the corresponding perfect match probe cell, the probe pair is termed 
negative (neg). For a more detailed definition of the pos and neg parameters, see the Affymetrix user 
manual. These two parameters are evaluated by the Affymetrix software for Present or Absent calls. In this 
software, 3 conditions are required for a Present call: a large (pos/ neg) ratio, a high proportion of (pos/ 
pairs used) and a high ratio of hybridization between perfect match probe cells / mismatch probe cells. 
Since the first 2 conditions are not independent, I decided to express the constraint regarding the pos and 
neg parameters in a single clause in ii). Condition i) in my software deals with hybridization intensity. 
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extraction, RNA amplification) compared to the prevIOUS screen, where tissue was 
dissected intact and amplification was not required. I first calculated the distribution of 
the average difference values for all genes from each replicate (Fig. 1). The histograms 
resembled those obtained with probe prepared from intact tissue, like the ones plotted in 
Fig. lA, Chapter 1. In addition, I checked whether the genes that had been identified as 
amygdala-enriched in the previous screen had consistent average difference values in the 
current study. Of the 33 genes previously identified, about 20 were represented on the 
current micro arrays 3. Of these, 10 that had high average difference values also had high 
average difference values in the current screen. Notably, the differential expression 
within the amygdala of some genes previously characterized by in situ hybridization was 
apparent in the new dataset. To name a few, Lhx-7 had mean average difference values of 
1261,63, and 174 in the central, lateral, and medial amygdala, respectively, and was only 
detected in the central nucleus by in situ hybridization (not shown). Similarly, Arp-1 had 
average difference values of 1164 in the central, 2700 in the lateral and 3094 in the 
medial subnuclei and was expressed in the lateral and medial nuclei (Chapter 1, Fig. 2D). 
These preliminary analyses indicated that cRNA probe preparation was not 
awfully biased and that at least part of the data reproduced the findings of the previous 
screen. I then analytically estimated the extent of differentially expressed genes within 
the amygdala subnuclei revealed by this screen. 
The number of differentially enriched genes that fulfilled the selection criteria 
described in the Data Analysis section is presented in Table 1. There were 358 genes 
3 The previous screen was done with older micro array sets (Mu 11K and Mu 19K) no longer available from 
Affymetrix. For the screen described in this chapter, the new generation of arrays, also from Afrymetrix 
(U74v2), was used. The latest set includes a more comprehensive coverage of the mouse genome. 
However, there are several probe sets (from the Mu19K sub arrays, corresponding to TIGR clusters 
sequences), that are not represented in the U74v2 arrays. 
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differentially enriched. This constitutes about 1 % of the ~36,000 genes and ESTs 
examined by the microarrays. On the other hand, I was curious to know the percentage of 
genes that were expressed in all subnuclei. The number and percentage of genes that were 
deemed Present by the Affymetrix software and had average difference values larger than 
200 in all triplicates of all subnuclei is shown in Table 2, for the U74v2A sub array. For 
comparison, the numbers of Present genes with average difference >200 in each 
subnucleus are also shown. Roughly, 32% of interrogated genes were expressed in each 
subnucleus, and 25% of genes were detected in all of them. 
To narrow down the list of candidate genes with the highest relative differences of 
expression within the amygdala, a visual inspection of various parameters was carried out 
(see Data Analysis section). For example, 104 different genes of the U74v2A array were 
differentially expressed (Table 1, the genes appearing in more than one replicate were 
counted only once). However, only 15 genes remained in consideration after visual 
inspection. Of those, 5 were further discarded because they were expressed in many other 
tissues or brain regions based on other microarray experiments4. The remaining top 7 
candidates were then selected for in situ hybridization. 5 of these gave in situ 
hybridization patterns consistent with the microarray readings. I was unable to synthesize 
in situ probe for the other 2 candidates. 
4 Three other datasets were utilized for this purpose: the one described in Chapter I (Zirlinger et aI., 2001) 
of 5 brain regions, the one described in (Sandberg et aI., 2000) of 6 brain regions, and another dataset 
(available at http://expression.gnf.org) including expression data of several brain regions and other organs. 
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2.4.2 Validation of Genechip results by in situ hybridization 
Selected candidates were chosen for in situ hybridization analysis (see Data 
Analysis section for selection criteria). Probes for 18 different genes or ESTs (from all 
three sub arrays) were synthesized. Of these, 4 (22%) gave no signal. Of the remaining 14 
probes, 11 hybridized in complete agreement with the microarray readings (11114= 79%). 
3 probes gave a hybridization signal with moderate agreement with microarray readings 
(3/14= 21 %). Similarly to the previous study, the rate of false positives may be actually 
lower, since in most cases the probe for in situ was not optimized, or simply, the 
abundance level of the transcripts may be too low for the detection limit of the 
nonisotopic method used. The overall rate of agreement between micro array readings and 
in situ hybridization is remarkably close to the one obtained in the previous screen, which 
was about 60% in both cases. 
Figure 1 shows examples of genes enriched in the central subnucleus. Probe 873, 
neuromedin NI neurotensin (Fig. 2A) is primarily expressed in the central nucleus 
(arrow), and in scattered cells in the medial nucleus (arrowhead). The lateral nucleus 
(white arrow) is devoid of signal. Probe Bh1, neuromedin B precursor (Fig. 2B) is also 
highly enriched in the central nucleus (arrow), while the lateral (white arrow) and the 
medial (arrowhead) nuclei show undetectable expression levels. Neuromedin B was also 
highly expressed in the olfactory bulb. Both neuropeptides neuromedin B precursor and 
neuromedin N were in addition expressed in the hypothalamus. One EST, probe 153/138, 
was also enriched in the central nucleus (Fig. 2C, arrow). Examples of genes enriched in 
the lateral nucleus are shown in Fig. 3. Probe 117, kinesin-like protein is more 
abundantly expressed in the lateral nucleus (arrow), than in the central or medial nuclei 
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(Fig. 3A). A similar pattern of expression was observed with probe 126, an EST (Fig. 
3B). Note cortical expression of probes 117 and 126 (black arrowheads). Gastrin 
releasing peptide, probe 440 (Fig. 3C), was also highly enriched in the lateral nucleus 
(arrow) and in the basomedial nucleus (black arrowhead). Figure 4 depicts genes 
enriched in the medial subnucleus (arrows), such as prolactin receptor (Fig.4A) and 
thyrotropin releasing hormone receptor (Fig. 4B). Gastrin releasing peptide, thyrotropin 
releasing hormone receptor, and prolactin· receptor were also expressed in the 
hypothalamus (not shown). Counterstaining was performed on the same sections with 
Neurotrace, a fluorescent nuclear staining in order to delineate subnuclei (Panels D, E 
and F, dashed lines). In addition, Nissl staining was performed on contiguous sections 
(example shown in Fig. 4C). 
2.5 Discussion 
2.5.1 Methodological considerations 
Doing replicate cRNA biotinylated probes for each sample proved crucial. The 
overall rate of agreement between in situ hybridization and micro array results was 60% 
(11 genes out of 18 tested), and would have been lower had we omitted replicate analysis. 
This rate of agreement was the same as the one obtained in the screen described in the 
earlier chapter where a single sample for each region was used. This suggests that 
replicate analysis from LCM-extracted material coupled to RNA amplification ensures 
results comparable to micro array analysis from hand dissected brain regions, at least as 
validated by in situ hybridization. It should be noted once again that the rate of false 
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negatives might indeed be lower than observed if more sensitive methods of detection, 
such as radioactive in situ hybridization or other biochemical assays, were used. 
Inspection of Table I illustrates another advantage of analyzing replicate samples. Medial 
region replicate 2 (M2) showed an unusually large number of enriched genes when 
compared to the other replicates. The reason for this is unclear, but may be due to partial 
degradation of the cRNA biotinylated probe5. However, most genes did not appear to be 
enriched in the other two medial amygdala replicates, and were thus not seriously 
considered as good candidates for in situ hybridization follow-up experiments. Moreover, 
the majority (73% or 8/11) of differentially enriched genes validated by in situ 
hybridization were enriched in at least two replicates. The remaining genes were also 
relatively enriched in all corresponding triplicates of a particular subnucleus but fulfilled 
the enrichment criteria set in the algorithm in just one6• 
It is interesting to comment on the abundance levels of the enriched genes 
identified. Among the 115 enriched genes from sub array U74v2A (Table 1), their mean 
average difference value was 13,471. Excluding the 36 enriched genes from M2, which 
showed unusually high values, the mean average difference value was 2,431 (n=79). For 
comparison, the array mean intensity was normalized to 2,500. Thus, enriched genes 
identified by this screen seemed to be expressed at relatively high levels. This is 
surprising, since higher complexities in RNA populations are found in low abundance 
5 It is also apparent from Fig. 1 that average difference values in M2 were higher. Note the larger mean 
average difference value for this sample (dashed line). I suspect of RNA degradation because the Medial 
region was the last one to be dissected by LCM and because the proportion of Present genes was lower in 
this sample (~37%) compared to the others (~45%). If this is true, the implication is then that shorter cRNA 
molecules bind with higher affinity to the microarrays. 
6 In the remaining 2 replicates, the fold-difference was not larger than 2.5, the ratio-threshold set in my 
custom program to identify enriched genes, and were thus not selected by the algorithm in such two cases. 
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transcripts (Lewin, 2000). Together, this has several implications. First, RNA 
amplification of LCM-extracted tissue may be only efficient for highly expressed genes, 
and thus genes expressed at lower levels, which are more likely to be differentially 
expressed, are lost in the process of LCM extraction or amplification. Alternatively, 
lower abundance genes may have been successfully isolated by LCM and amplified, but 
might have shown variable hybridization to the microarrays, and thus non-reproducible 
readings in different replicates of the same region. Finally, as already stated in the 
Introduction, many yet unidentified highly specific genes may not be represented on the 
mlcroarrays. 
It is then valid to ask, is it worth the effort to start with LCM-dissected tissue? I 
think the answer is yes, because it partially overcomes the dilution problem referred to in 
the Introduction. I shall exemplifY this claim with the behavior of genes characterized by 
in situ hybridization in the LCM-screen, which also showed higher levels of expression in 
the amygdala compared to the other four brain regions previously studied (not shown). 
Among those 11 enriched genes, 7 were represented on the older generation of arrays 
used for the previous screen. In all cases, their fold difference in amygdala expression 
relative to the other four brain regions was too low. (The mean ratio of average difference 
values in the amygdala relative to the other four regions was about 1.6 in these 7 cases.) 
Moreover, 4 of those 7 genes were considered to be Absent in the amygdala by the 
previous microarray readings. To summarize, most amygdaloid subnucleus-enriched 
genes currently identified were not recognized as amygdala-enriched in the previous 
screen because their levels of expression appeared too low, most likely due to expression 
averaging in the large piece of dissected amygdaloid tissue. 
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In agreement with our previous study (Zirlinger et aI., 2001), these results also 
suggest that in situ hybridization is essential to confirm microarray data. About 80% of 
genes that showed in situ hybridization signal were consistent with microarray readings; 
the rest showed moderate agreement. In addition, in situ hybridization also revealed other 
sites of expression, such as the hypothalamus or cortex, not included in the micro array 
samples. The high spatial resolution of in situ hybridization allowed for the direct 
observation of gene expression in specific subnuclei. The genes identified with this 
screen were expressed in contiguous cell populations and most showed boundaries of 
expression contained in defined amygdaloid subnuclei. This validates the hypothesis 
proposed in our earlier study (Zirlinger et aI., 2001) that most amygdala-enriched genes 
may respect subnuclear boundaries of expression. 
2.5.2 When is a differentially expressed gene a good candidate for in 
situ hybridization? 
Some conclusions can be drawn from inspection of the vanous parameters 
provided by the Affymetrix software. Again, I will illustrate this point exemplifying with 
the genes validated by in situ hybridization in both screens. The parameters most useful 
for this analysis are the number of positives and pairs used, the absolute call (Present / 
Absent) and the differential call (Increase / Decrease). Briefly, the first two parameters 
indicate the extent of significant hybridization of the cRNA labeled probe to the probe 
cells on the array and indirectly, whether significant hybridization was observed 
throughout the whole length of the gene. The differential call indicates whether there was 
a difference in hybridization across the different samples examined. It is scored based on 
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the comparison of cRNA hybridization to each probe cell (of the 16 or 20) representing a 
gene on the array across different samples 7 . 
Table 3 details the parameters observed for a set of 21 differentially enriched 
genes whose expression patterns were confirmed by in situ hybridization. Among the 13 
genes enriched in the amygdala relative to four other brain regions, the ratio of positive 
probe cells/ pairs used was 60%. This initially suggested that in order for a gene to be 
detected by in situ hybridization, the number of positive cells should be high. I have tried 
to incorporate this lesson from my first screen, in the criteria to search for differentially 
enriched genes in my latest screen (see condition ii) in custom algorithm.) Among the 8 
genes identified in this screen, such ratio was 66%. Similarly, in 92% of the cases of the 
first screen the Affymetrix software indicated an absolute call of Present, while all genes 
identified in the second screen were also deemed Present by that software. Again, 
condition ii) in my latest custom algorithm incorporated this idea. (See Data Analysis 
section for a discussion on this.) 
Finally, differential calls in principle provide an indication of whether genes are 
differentially expressed. However, I have found in my limited examples that these are not 
always necessarily true. In other words, I have identified genes (~ 40% of the ones 
analyzed) indeed differentially expressed as detected by in situ hybridization that, 
nevertheless, showed a call of No change in expression across different brain regions 
(Table 3). Conversely, I have observed no change in expression by in situ hybridization 
in genes that had a differential call of increase or decrease (not shown). Thus, if a 
candidate differentially expressed gene has different average difference values in distinct 
7 The reader is referred to the Affymetrix user guide for a detailed description of these parameters. 
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brain regions, I would not automatically consider it a bad candidate if a differential call of 
Na change is attributed by the Affymetrix software. 
I have also observed that for candidate genes with relatively high average 
difference values in all regions, it is useful to examine the pas and neg values closely. In 
these cases, good candidates are the genes that have higher pas (and lower neg) values in 
the region of interest compared to the other regions. Otherwise, if a gene shows high 
average difference values and similar pas and neg values in all regions, it is unlikely that 
relative differences in expression levels can be appreciated by in situ hybridization. 
I have considered these notions when visually inspecting the genes identified with 
the custom program to further narrow down the number of candidate genes for in situ 
hybridization validation experiments. 
2.5.3 Identity of selected genes differentially expressed in the 
amygdala 
An exhaustive review of all identified genes enriched in the amygdala would 
constitute a list of disconnected information, so I shall concentrate on few genes that may 
directly participate in the modulation of amygdaloid function. Of course this is a 
subjective list, and a structural gene product may be as crucial to amygdala function as a 
signaling molecule. However, it is simpler today to conceptualize that differential 
expression of signaling molecules, such as neuropeptides, better explain underlying 
differences in brain function. I will also attempt to summarize reported sites of expression 
of these genes both in the brain and the body. For this, I relied on classical literature 
searches and on expression data based on microarray studies performed on different brain 
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regions8 and organs9. There are some difficulties in the interpretation of these several 
reports. First, in classical publications, there is not always a general consensus on sites of 
expression of particular genes. The discrepancies may be due to different detection 
methods employed, or may be simply due to partial reports of sites of expression in 
published literature. In the case of micro array databases, it is hard to extrapolate average 
difference values to "real" expression, for the numerous reasons discussed before 10. 
Nevertheless, I summarize below the expression data and relevant information of some 
genes identified by this screen. 
Since the centromedial aspect of the amygdala is the second neuropeptide-rich 
region in the brain (following the hypothalamus) (Roberts et ai., 1982), I will focus on 
what is known about some neuropeptides and their receptors. 
Neuromedin N and its receptors: Neuromedin N and its analog Neurotensin are 
synthesized from a common precursor. They were first purified from bovine 
hypothalamus and intestines (Vincent et ai., 1999). Central administration of neurotensin 
8 A database containing several brain regions, including neocortex, olfactory bulb, hypothalamus, 
hippocampus, amygdala, cerebellum, midbrain and striatum, developed by Carro lee Barlow and colleagues 
at the Salk Institute. 
9 A body map including most organs and brain regions available at http://expression.gnf.org 
10 Ideally, one would like to predict expression patterns based on Affymetrix parameters from micro array 
readings. It is hard, however to do so, and the number of examples I have analyzed thus far is probably not 
high enough to draw general conclusions. However, in order to predict "real" expression, I would 
implement the same principles that I have described in the previous section to choose candidate genes for in 
situ hybridization validation. In a few words, expression may be only detected if the number of positive 
cells is high, particularly if a gene has low average difference values. In addition, differences in expression 
for a gene with relatively high average difference values everywhere may be only detected if the difference 
of[pos-neg] is significantly different across different samples. Finally, if a gene has a considerably lower 
average difference value in one tissue compared to other tissues, its expression may not be detected in the 
former by in situ hybridization, even ifit is deemed Present, particularly if the number of positive cells is 
lower than in other tissues. Specifically, I have found that if a gene has the "potential" to have several 
positive cells in some tissues, its expression may be below the detection limit of in situ hybridization (or 
may not be really present) in a sample having considerably fewer number of positive cells. 
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induces hypothermia, analgesia and increased dopamine release and turnover (Mazella et 
aI., 1996). In the periphery it produces contraction and relaxation in distal colon and 
proximal ileum, respectively, and can act as a growth factor in many cell types. The 
central effects can be induced by both intracerebral administration or by direct peptide 
injection into the central amygdaloid nucleus (Roberts, 1992). It is expressed by at least 
two different cell types in the central nucleus (Roberts, 1992) suggesting that there may 
be further differences among neurotensin-containing cells. There are 3 different types of 
neurotensin receptors reported to date: two are G-protein coupled receptors (GPCRs), 
whereas the third one is a single-pass membrane receptor identical to gp95/sorti1ing 
(Vincent et ai., 1999). The function of this latter receptor is not entirely clear yet, but may 
be involved in intracellular sorting, or in peptide clearance. The GPCRs have different 
tissue distribution. NTS 1, the high affinity receptor is localized in intestine and in many 
brain regions, such as the diagonal band of Broca, septum, hypothalamus, substantia 
nigra, and ventral tegmental area (Vincent et ai., 1999). Others also report expression of 
NTS 1 in hippocampus, amygdala and cortex, and more moderately in the thalamus 
(Pettibone et ai., 2002). The low affinity receptor, nts2, is expressed at high levels in 
cerebellum, hippocampus, piriform cortex and neocortex (Mazella et ai., 1996). 
Interestingly, the two receptors appear to be differentially regulated developmentally as 
well: NTS1 expression is present from birth, peaks around 7-10 days postnatally, and 
decreases to adult levels between 30-40 days. Conversely, nts2 expression starts after 2 
weeks and reaches maximum levels around 30 days postnatally (Mazella et ai., 1996; 
Vincent et ai., 1999). 
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Neurotensin expression in brain is well reported, however, some micro array 
experiments (Barlow database) fail to detect neurotensin expression in brain. However, 
this may be due to improper probe cell design in the microarrays, since expression of this 
neuropeptide is obvious in the brain (Fig. 2A). Microarrays do detect neurotensin 
receptor (nts2) expression in basically all brain regions examined, as well as in most body 
organs, with highest expression in kidney, thyroid and spleen. 
Neuromedin B (NMB) and NMB receptor: NMB belongs to the bombesin-like 
peptides family, originally isolated from amphibian skin. There are two bombesin-like 
peptides in mammals: NMB, related to amphibian ranatensin, and gastrin-releasing 
peptide (Merali et aI., 1999) (see below). NMB is expressed in lung and gastrointestinal 
tract, where it is released in response to food ingestion, to inhibit further food intake 
(Merali et aI., 1999). The olfactory bulb has high expression levels based on microarray 
data (my own), which was validated by in situ hybridization. Central effects of NMB 
action include hypothermia. Published manuscripts report expression of the NMB 
receptor in olfactory nucleus, cortex, hippocampus, amygdala, hypothalamus and brain 
stem (Ohki-Hamazaki et aI., 1999), whereas microarray data indicate that it is present in 
neocortex, amygdala, spinal cord and hippocampus and in other organs, most notably in 
prostate. In contrast to deletion of other bombesin-like peptide receptors (see below), 
NMB receptor knock-out mice have no obvious behavioral phenotype (Yamada et aI., 
2002). 
78 
Gastrin-releasing peptide (GRP) and GRP receptor: As mentioned above, 
GRP belongs to the bombesin-like family of peptides and is related to bombesin. It 
regulates food intake by inducing satiety and mediates gastric smooth muscle contraction 
(Ohki-Hamazaki et at, 1999). It is heavily expressed in the lung and gastrointestinal tract 
as well as in the brain. Central infusion of GRP produces hypothermia (Ohki-Hamazaki 
et at, 1999). It is expressed in the hypothalamus as well as in the lateral amygdaloid 
complex (Fig. 3C). It is interesting that microdialysis studies suggest that GRP is released 
at the central nucleus of the amygdala by both food intake and stressor exposure (Merali 
et at, 1998). This constitutes an example of the information flow in the amygdala: from 
lateral to medial structures, alluded to before. GRP receptor expression is mostly detected 
in large intestine and to a lesser degree, in kidney, by micro array measurements. Other 
micro array studies indicate that it is also expressed in cortex, hippocampus, amygdala, 
hypothalamus and brain stem. The receptor has been knocked-out and transgenic mice 
show increased social and locomotor activity (Yamada et at, 2002). Interestingly, there is 
a third type of bombesin-like peptide receptor, BRS-3, whose endogenous ligand has not 
yet been identified. BRS-3 deficient mice exhibit hyperphagia, obesity and decreased 
social behavior (Ohki-Hamazaki et at, 1997; Yamada et at, 2002). 
Prolactin and prolactin receptors: Prolactin has been implicated in a variety of 
cellular functions, rangmg from osmoregulation, lactation, reproduction and 
immunomodulation (Horseman et at, 1997). It is secreted mainly by the pituitary and 
placenta and can also modulate maternal behavior (Grattan, 2001). The prolactin receptor 
is a type-l cytokine receptor encoded by a single multi-exon gene that produces many 
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isofonns from multiple promoter usages and alternative splicing (Onnandy et aI., 1998). 
This generates products with identical extracellular domains, but different cytoplasmic 
domains, which affects signal transduction (Schuler et aI., 2001). The receptor is 
expressed in multiple tissues, such as mammary gland, testis, lung, blood cells, liver, 
ovary and prostate (Horseman et aI., 1997), which is also reported by microarray data. It 
is not clear, however, which isofonn(s) are expressed in each case. In brain, cerebellum 
and hypothalamus are both rich in prolactin receptor based on microarray data, although 
no cerebellum expression was detected by in situ hybridization in my experiments (not 
shown). RNase protection assays indicate that the short and long isofonn are expressed in 
striatum and substantia nigra, but expression of the short fonn was not detected by RT-
peR (Pi et aI., 2002) by the same authors, maybe because of the lower sensitivity of the 
latter method. In any case, this illustrates how seemingly contradicting results can be 
obtained with the use of different detection techniques. 
Despite expression in multiple organs, gene deletion by homologous 
recombination in transgenic mice indicated that prolactin receptor is necessary for 
mammopoiesis, but not for hematopoiesis, and also caused infertility in females 
(Horseman et aI., 1997). 
Retinoic-acid metabolizing cytochrome p450: I would like to also mention the 
identification of this gene, which has very localized expression patterns in the lateral and 
central amygdala (Fig. SA). It was originally identified in my first screen, when 
comparing gene expression among amygdala and four other brain regions. The original 
transcript represented on the microarrays was an EST (TIGR cluster identifier 
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TC156ll). To establish its identity I perfonned rapid amplification of cDNA ends 
(RACE) and computational "extensions" of this gene based on database infonnation. This 
suggested that the gene was a cytochrome p450, but the conclusion was not finn since I 
could not extend the product (either by RACE or computationally) to the coding region 
and the alignments were not perfect. BLAST of the EST sequence to the genomic 
sequence database rendered alignment to a non-coding region, about ~2 kb downstream 
of a predicted cytochrome p450. I then synthesized a probe for in situ hybridization with 
the coding sequence of this latter gene and found that the expression pattern (Fig. 5B) 
was like that of the EST. This supported the idea that the EST indeed corresponded to a 
p450 cytochrome. Since then, cloning and expression of a novel retinoic-acid 
metabolizing cytochrome p450 (MacLean et aI., 2001) supported that such was the 
identity of this gene. Interestingly, differential expression of related retinoic-acid 
metabolizing enzymes during mouse development was appreciated (Abu-Abed et aI., 
2002). 
The p450 cytochrome genes constitute a superfamily composed of at least 74 gene 
families (Nelson et aI., 1996), but the number is growing continually (Nelson, 1999). At 
least14 families exist in all mammals (Nelson et aI., 1996), which comprise 26 
subfamilies. Each subfamily usually represents a cluster of tightly linked genes widely 
scattered throughout the genome. In addition, many genes undergo alternative splicing 
and are driven from alternate promoters, which produces considerable transcript 
variability. Moreover, tissue and temporal expressions of cytochrome p450 family 
members are tightly regulated (Omura, 1999), which adds to their complex pattern of 
expression and suggests crucial physiological roles for these genes. Altogether, this raises 
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the intriguing possibility that specific brain regions possess different combinatorials of 
p450 cytochrome family members expression. 
2.5.4 On the use of LCM and DNA microarray technologies to identify 
specifically expressed transcripts useful for gene targeting in 
transgenic mice 
The results presented in these two chapters demonstrate that the combination of 
micro array analysis and in situ hybridization provide a useful means to identifying 
enriched genes in distinct brain regions. These genes could be used to target heterologous 
gene expression in transgenic mice. The ideal gene for targeting purposes should be very 
specifically expressed in the brain region of interest and nowhere else in the brain (or 
body). In addition, it should be expressed in such specific manner throughout 
development of the nervous system, or only after if it is formed ll . However, it should be 
noted that the majority, if not all, of enriched genes identified so far by these screens have 
restricted domains of expression in more than just one brain region. Nevertheless, they 
could still be useful for designing transgenic mice if a combination of strategies is used. 
Binary systems could provide higher specificity. For instance, the promoter of a "semi-
specific" gene (i.e., one that has more than one restricted site of expression) could drive 
expression of a heterologous gene of interest preceded by a transcriptional STOP cassette 
II Unless, of course, one uses an inducible system. 
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(flanked by loxP sites). Then, a viral injection ofCre recombinase 12 in the brain region of 
study would locally activate the transgene (Wang et aI., 1996). In addition, a similar 
strategy could be used if the promoter of a second "semi-specific" gene drives Cre 
expression instead. In this case, both semi-specific genes should have overlapping 
expression domains only in the region of interest. Other sites of expression for either 
gene would not matter, as the coexistence of both parts of the system is required for 
trans gene expression. Examples of pairs of genes that could be used in these binary 
systems are shown in Table 4, provided they are expressed in the same cells. 
12 For a description of the Cre/\oxP recombination system, see next Chapter. 
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Table 2-1: Number of genes differentially expressed. 
S b U74 2A u array v 
Region! 1 2 3 Overlap in 2 Overlap in 3 
replicate replicates replicates 
C 9 18 6 2 5 
L 8 8 10 0 0 
M 12 36 8 2 2 
S b U74 2B u array v 
Region! 1 2 3 Overlap in 2 Overlap in 3 
replicate replicates replicates 
C 13 10 8 3 1 
L 9 11 2 0 0 
M 19 51 23 5 4 
S b U74 2C u array v 
Region! 1 2 3 Overlap in 2 Overlap in 3 
replicate replicates replicates 
C 14 8 11 5 0 
L 12 10 5 1 1 
M 29 32 13 5 1 
All U74 2 b v su arrays com b· d me 
Region! 1 2 3 Overlap in 2 Overlap in 3 
replicate replicates replicates 
C 36 36 25 10 6 
L 29 29 17 1 1 
M 60 119 44 12 7 
The number of genes enriched by at least 2.5-fold in each replicate with respect to 
the other six samples (3 replicates for each of the two remaining subnuclei) is indicated in 
the first three columns. The fourth (and fifth) columns show the number of enriched 
genes that were identified in 2 (or 3) replicates of the same subnucleus. The numbers are 
shown first separately for each of the U74v2 sub arrays and then I present the data after 
combining all sub arrays in the bottom table. 
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Table 2-2 Number of Present and Absent genes. 
Region Present and avg diff > 200 Absent or avg diff < 200 
3 subnuclei 3155(25%) 2060 (16 %) 
Central 4210 (34 %) 3057 (24 %) 
Lateral 4161 (33 %) 2938 (24 %) 
Medial 3578 (29 %) 2800 (22 %) 
The number of genes on subarray U74v2A Present based on the Affymetrix 
software and with average difference (avg diff) values larger than 200 are indicated in the 
first column. The number of genes that were either Absent or had average difference 
values lower than 200 are indicated in the second column. The genes with average 
difference values larger than 200, which were present in all three subnuclei, are indicated 
in the first row. Percentages of the total 12,488 genes and ESTs represented on the 
U74v2A sub array are indicated in parentheses. 
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Table 2-3 Affymetrix parameters of selected genes. 
Amygdala-enriched Amygdala-subnuclei -
genes relative to 4 other enriched genes 
brain regions 
number of genes analyzed 13 8 
positive / pairs used 60% 66% 
absolute call: Present 92% 100 % 
differential call: Decrease 62% 60% 
differential call: No Change 38% 40% 
Inspection of selected parameters provided by the Affymetrix software for 
selected genes whose expression patterns were confIrmed by in situ hybridization. 
Parameters for the screen described in Chapter 1 are presented in the fIrst column. The 
second column shows the results obtained in the screen described in this chapter. 
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Table 2-4 Combinations of "semi-specific" genes useful for gene targeting. 
Gene 1 Gene 2 Target region 
X76653, arp-I (chapter I, TIGR cluster TC30886, lateral and medial amygdala 
fig.2D) chaperonin £ subunit 
(chapter I, fig. 3F) 
X76653, arp-I (chapter I, AB041584, unconventional lateral (but not basolateral) 
fig.2D) type myosin (chapter 1 ,fig amygdala 
3A) 
D 1 0214, prolactin receptor U43298, laminin p3 medial amygdala 
(chapter 2, fig. 4A) (chapter I, fig. 2C ) 
TIGR cluster TC15611, BE135978, EST (Chapter 2, central amygdala 
retinoic acid metabolizing fig. 2C, probe 153/138.) 
p450 cytochrome (chapter 
2, fig. 5A and 5B) 
Examples of combinations of "semi-specific" genes useful for gene targeting in 
transgenic mice. Genbank accessions or TIGR identifiers of pairs of genes that show 
overlapping expression in the target regions are indicated. It remains to be tested, 
however, whether these genes are expressed in the same cells. 
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2.5.5 Figure legends 
Figure 2-1: Distribution of normalized average difference values. 
Distribution of nonnalized average difference (!J.) values in each of the nine 
samples (C 1, C2, C3= each of the central amygdala replicates; Ll, L2, L3= each of the 
lateral amygdala replicates; M1, M2, M3= each of the medial amygdala replicates). Only 
the U74v2a array is plotted here, but all other chips had similar distributions. For clarity, 
only values below 8,000 are shown. Dotted lines indicate the mean value. Bin size is 200. 
Figure 2-2: Genes enriched in the central nucleus. 
Genes enriched in the central nucleus. The central nucleus is indicated with a 
black arrow, the lateral with a white arrow and the medial with an arrowhead. A: Probe 
873: neuromedin N/ neurotensin. B: probe Bh1, neuromedin B precursor. C: Probe 153/ 
138, EST. D-F: Subnuclei are delineated with a dash line based on neurotrace 
counterstaining of sections A-C, respectively. 
Figure 2-3: Genes enriched in the lateral nucleus. 
Genes enriched in the lateral nucleus. The lateral nucleus is indicated with a black 
arrow, the central with a white arrow, and the medial with a white arrowhead. Black 
arrowhead indicates cortex in A and B, and basomedial amygdaloid nucleus in C. A: 
Probe 117, kinesin-like protein. B: probe 126, EST. C: Probe 440, gastrin releasing 
peptide. D-F: Subnuclei are delineated with a dash line based on neurotrace 
counterstaining of sections A-C, respectively. 
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Figure 2-4: Genes enriched in the medial nucleus. 
Genes enriched in the medial nucleus. The medial nucleus is indicated with a 
black arrow, the lateral with a white arrow and the central with an arrowhead. A: Probe 
133, prolactin receptor. B: probe c3, thyrotropin releasing hormone receptor. C: Nissl 
staining of a consecutive section. D-E: Subnuclei are delineated with a dash line based on 
neurotrace counterstaining of sections A and B, respectively. 
Figure 2-5: p450 cytochrome. 
(A) In situ hybridization signal in the lateral and central amygdala obtained with 
probe TC15611, derived from an EST. By 5' RACE, it was determined that it 
corresponded to retinoic acid metabolizing p450 cytochrome. (B) In situ hybridization 
with retinoic acid metabolizing p450 cytochrome probe shows the same signal as in (A). 
A-B: black arrows: lateral amygdala nucleus; white arrows: central nucleus. (C) Note 
extra-amygdaloid expression in subiculum (black arrow) and dentate gyrus (white arrow). 
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APPENDIX 1: ANALYSIS OF QUANTITATIVE GENE 
EXPRESSION DATA 
The availability of techniques to simultaneously interrogate levels of expression 
of thousands of genes in a quantitative way has generated unprecedented amounts of data 
in biology. However, it is not a simple task to find transcripts that reliably change 
expression levels under various conditions or in distinct samples among thousands of 
others that are invariant. 
Several new manuscripts describing algorithms, heuristics and procedures to 
analyze microarray experiments have appeared in the last two or three years (see 
references below). Furthermore, there is at least one commercial software targeted 
specifically to analyze gene expression data (GeneSpring, Redwood City, CA) and 
several other bioinformatics companies that offer both custom software and technical 
support to study DNA micro array data (for example, Informax Inc., Bethesda, MD). 
Other clustering algorithms are publicly available to academic researchers (e.g., Tamayo 
et aI., 1999). 
The hypothesis, methods and types of questions addressed with these different 
tools overlap but are not necessarily identical. Here I briefly review some of these 
methods. (For a short description of these, please refer to 
http://www.silicongenetics.com/cgi/SiG.cgilProducts/GeneSpring/tools.sm±). I 
also directly compare the results obtained with our program (see Chapters 1 and 2) and 
those obtained with another powerful software, Bullfrog, developed by David Lockhart 
and others, now working at the Salk Institute (San Diego, CA). 
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Description of other algorithms and heuristics 
One of the most common methods used to analyze gene expression data involves 
the use of clustering algorithms. The general idea behind these algorithms is to separate 
all the transcripts into clusters that share common expression patterns. The underlying 
hypothesis is that there are groups of genes with common properties, perhaps 
participating in a common biochemical pathway, that are co-expressed under certain 
experimental conditions. This has proven to be very useful in some cases (e.g., (Brown et 
aI., 2000; Eisen et aI., 1998; Tamayo et aI., 1999), reviewed in (Sherlock, 2000)). 
One of the most commonly employed clustering algorithms is based on the 
nearest neighbor (or k-nearest neighbors) algorithm and hierarchical clustering (Eisen et 
aI., 1998). Unfortunately, one of the drawbacks in the most typical applications of these 
clustering ideas is that the number of clusters is fixed beforehand. This seems to be a 
rather artificial situation. If one were to generate data from a single unimodal distribution, 
these algorithms would still produce several clusters as output. In other words, even in 
the absence of clusters of genes with common expression, these algorithms "find" plenty 
of genes belonging to separate clusters. It should be noted that the lack of clusters (or the 
presence of small clusters) is a perfectly valid biological scenario. It may happen that 
under particular experimental conditions only a small set of transcripts (out of several 
thousands) change their expression pattern. A more rigorous and systematic approach to 
clustering involves the use of Bayesian statistics based on latent variables (see, e.g., Long 
et aI., 2001). Using Expectation-Maximization or Support Vector Machines (Brown et aI., 
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2000) allows the direct comparison of distinct models based on different numbers of 
clusters. These techniques are perhaps less widely used now in the DNA micro array 
analysis community, perhaps due to their increased complexity and computational 
requirements. However, they permit to simultaneously estimate the cluster boundaries as 
well as the optimal number of clusters. 
Other approaches attempt to directly look for genes that are overexpressed in one 
sample with respect to all others. It would be interesting to estimate the probability that a 
given gene shows apparent enrichment by chance. The quantitative way of doing this 
would require establishing the variability of repeated measurements of a given gene in 
one sample and comparing this to the difference in expression levels for the same gene in 
other samples. Unfortunately, the high cost of DNA microarrays still precludes from 
obtaining a large number of replicates. Even in the best scenario, it is hard to prepare 
more than two or three replicates. (The importance of replicates has already been 
discussed in Chapter 2.) 
Most of the methods to analyze gene expression datasets are based on studying 
the changes in the value called "average difference" 13 , already described in Chapter 1. 
This variable is fundamental in estimating changes in levels of gene expression. 
However, as noted in the previous chapters, very important information can also be 
obtained by paying attention to the number of positive and negative probe cells for each 
transcript (recall that there are about 20 different match and mismatch probe cells to 
interrogate the expression of each transcript and the average difference value is just one 
parameter derived from microarray scannings). In our case, ignoring these other 
13 Or relative fluorescent hybridization signals in cDNA arrays. 
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parameters would lead to an mcrease in the number of reported enriched transcripts, 
incrementing the number of false positives. 
In general, two types of errors can be made in the analysis of DNA microarray 
data: misses and false positives. The former refers to the probability that an interesting 
candidate gene is overlooked. The latter refers to the probability that the reported genes 
do not show a biologically relevant change in expression. Unfortunately, for most of the 
papers described above, no independent validation of the results by other methods is 
reported and is therefore difficult to assess the accuracy of the methods. It is not 
uncommon to see papers reporting only a few candidate genes or describing hundreds or 
thousands of potentially interesting genes divided into tens of clusters. The biological 
significance of these results without further validation remains unclear. 
I have already discussed the validation by in situ hybridization of the results 
obtained with our algorithmic methods (Chapters 1 and 2). I turn now to the comparison 
of our results to those obtained by other micro array data analysis methods. 
Comparison of our results to those obtained with other 
algorithms 
Genecluster 
It was already mentioned in Chapter 1 that our custom algorithml4 proved more 
efficient than Genecluster, which implements Self Organizing Maps, in the identification 
of genes enriched in single brain regions. In our first screen, the number of genes in 
14 Our custom programs are available at http://www.its.caltech.edul~mariela!gene_screen.html 
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clusters derived from single region-overexpressed transcripts was 6-10 fold larger than 
the number of enriched genes identified with our algorithm, depending on the parameters 
used for clustering. The extra genes belonging to these clusters were mainly expressed at 
very low levels or did not show a fold change in expression high enough with respect to 
all the other regions to be considered good candidates for follow-up experiments. Since 
we were also interested in identifying genes that were enriched in single regions, we did 
not perform this clustering analysis in our later screen. 
Bullfrog 
Contrary to clustering algorithms, Bullfrog was specifically developed to analyze 
micro array data obtained with Affymetrix chips. This provides the opportunity to filter 
data not only based on average difference values, but also on other parameters calculated 
by the Affymetrix software, such as Present Absent calls, or DecreaselNo change 
differential calls l5 . The advantage of this is that the significance of the differential 
hybridization to the arrays of biotinylated cRNA probes from different samples can be 
also taken into account. Let's take a hypothetical case: a high average difference value 
that is mainly due to unusually high hybridization of the labeled cRNA probe to a single 
perfect match cell among the ~20 representing a particular gene. However, other perfect 
match probe cells do not show intense hybridization, indicating that the gene may not be 
really present and that hybridization to a single perfect match probe cell is an artifact. 
Bullfrog is designed so that this hypothetical gene's high average difference value is not 
misleading. In other words, the Present/Absent calls are considered together with average 
15 Please see Chapter 2 for definition of these various parameters. 
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difference values to decide if a gene is differentially expressed. In contrast, clustering 
algorithms would treat this gene as a real, high-abundance transcript. 
Bullfrog is user friendly because it allows the experimenter to set different criteria 
for the identification of enriched genes. In addition, it allows the consideration of 
replicate experiments so that multiple comparisons can be made between different 
replicates of distinct samples. Let me illustrate this with the comparison of gene 
expression between three samples: sample A (with replicates Al and A2), sample B (with 
replicates BI and B2), and sample C (with replicates CI and C2). 
Before feeding the data into Bullfrog, it is required that all possible pair-wise 
comparison files are generated by the Affymetrix software. For example, to identify 
genes enriched in A, Al and A2 are designed as "baseline" files and BI, B2, CI, C2 are 
the 'experimental' files that must be generated in comparison to the baseline files. In this 
case, one would need to generate eight Affymetrix comparison files as follows: 









The developers of Bullfrog recommend the following set of criteria to identify 
genes enriched in A with respect to both Band C: 
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i) Gene must be Present in the Baseline file in at least Q out of the 8 comparisons 
ii) Gene must have an average difference value >625 16 in at least 6 of the 8 
baseline files 
iii) Gene must have a Decrease call in at least Q out of the 8 experimental files 
iv) The ratio of [average difference in baseline / average difference ill 
experimental file] must be > L8. in at least Q out of the 8 comparisons. 
The versatility of the program can be appreciated, as all underlined values can be 
independently modified by the user. (It should be noted that 16 analogous comparison 
files must be generated using Band C as baselines if genes enriched in these samples are 
also sought.) 
To analyze my data from the U74v2A sub array, I changed some parameters so 
that the criteria implemented resembled the criteria imposed in my custom program (cf. 
Chapter 2, Data Analysis section). Thus, I modified constraints ii) and iv) as follows: 
ii) Gene must have an average difference value >200 in at least 6 of the 8 baseline 
files 
iv) The ratio of average difference in baseline / average difference in experimental 
file must be> 2.5 in at least 6 out of the 8 comparisons. 
Constraints i) and iii) were not modified. 
16 For an array that has been normalized to a target intensity of2,500. 
101 
I first determined the pairs of replicates within each amygdala subnucleus that 
were the most similar. The pairs that had the least variability were C2 and C3, L2 and L3, 
and M 1 and M2, which differed in between 15-100 genes each. I then used these pairs to 
generate 24 (8 x 3 samples) comparison files as described above. 
The numbers of genes identified with these conditions are listed in Table 1 (in 
Bullfrog-l column). The table also shows the number of enriched genes identified with 
the custom program (cf. Table 1, Chapter 2). I noticed that according to Bullfrog, the 
medial amygdala had an unusually large number of enriched genes. The reason for this is 
not clear, but may be due to partial degradation of cRNA biotinylated probe. (Please refer 
to footnote 5 in Chapter 2 for discussion.) 
Further inspection of all M triplicates suggested that M3 was the most different 
from the 3, but it is probably the best, since it contains the largest number of Present 
genes (47% vs. 37% and 38% in MI and M2, respectively) 17. Thus, I reanalyzed the 
dataset but considering M3 only for the medial nucleus. The analytical criteria and 
replicates from the central and lateral nuclei were otherwise the same. The results are 
presented in the column Bullfrog-2 in Table I. In this case, the number of enriched genes 
in the medial region resembles that of the other nuclei, whose numbers of enriched genes 
also vary slightly. The genes identified by Bullfrog-I and Bullfrog-2 are not all the same. 
The number of total genes differentially enriched identified by the combination of both is 
listed in the last column. It can be appreciated already how sensitive the results are with 
respect to variations in replicate samples. Replicate M2 was particularly "noisy" and thus 
changed the identification of enriched genes not only in the medial region, but also in the 
17 C2, C3, L2 and L3 had ~45% of Present genes each. 
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samples from the other regions. Results obtained with our custom program also indicated 
that the M2 sample was different from the rest. Once more, the value of performing 
replicate analysis when synthesizing cRNA probes with sensitive steps such as LCM-
extraction and RNA amplification is underscored. 
Even though the order of magnitude of the number of genes differentially 
enriched was the same for Bullfrog or our custom analysis, their identities were not 
necessarily the same. 25%, 42%, and 33% of enriched genes were identified by both 
programs in the central, lateral, and medial amygdala, respectively. More significant 
perhaps is the efficiency with which Bullfrog identified the genes that were confirmed to 
be differentially enriched by in situ hybridization. Of these, 60% were identified by 
Bullfrog. 
It is important to keep in mind that both programs have their pros and cons. 
Bullfrog has the potential to be more stringent, since many more parameters can be 
independently modified. At the same time, it may be more sensitive to duplicate 
variation. However, in some cases, allowing for some variation between replicates may 
facilitate the identification of extra enriched genes. In addition, the need to generate all 
Affymetrix pairwise comparison files is not very practical. Nevertheless, I believe both 
programs may prove even more helpful if some modifications to the Affymetrix software 
are done when reading signal hybridization from probes derived from LCM extraction 
and RNA amplification steps. These may consist, for example, on re-specifying the 
criteria for determining positive and negative probe cells, which in tum, affect the 
Present/Absent and Decrease/No change calls. Several iterations of re-specification of 
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such criteria followed by independent experimental confirmation may be required to fine-
tune the Affymetrix output for better data analysis in such cases. 
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Table Ap-O-l: Comparison with Bullfrog. 
region custom Bullfrog-1 Bullfrog-2 Bullfrog-1 + -2 
Central 26 5 20 20 
Lateral 26 10 4 12 
Medial 52 82 36 111 
total 104 97 60 143 
Numbers of differentially enriched genes identified with our custom software and 
with Bullfrog among the 12,488 genes represented on the U74v2A sub array. Replicates 
M1 and M2 were used in Bullfrog-I, whereas M3 was used in Bullfrog-2.The last column 
shows the number of total genes that were identified in both cases. 
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3 NEURON SUBTYPE SPECIFICATION PRECEDES 
NEURON-GLIAL FATE DETERMINATION 
3.1 Introduction 
Prominent cellular diversity is a key attribute of the nervous system. Neural 
progenitor cells are responsible for generating such diversity. They give rise to various 
neurons and glia in different locations, thus playing a role in the complex intercellular 
relationships characteristic of the nervous system. In addition to the generation of cellular 
diversity, the normal development of the nervous system requires that different types of 
cell develop at specific times and in appropriate ratios. To understand how neural 
progenitor cells develop, it is important to characterize these cells and determine the cell 
types that they give rise to. I have analyzed some aspects of neural cell lineage 
diversification in a cellular subpopulation of the developing peripheral nervous system, 
which is amenable to such studies. Neural crest cells are a transient cellular population, 
induced at the dorsolateral edge of the neural plate, from where they delaminate and 
migrate along specific routes to many destinations in the vertebrate embryo. These cells 
differentiate into a wide variety of cell types, including neurons and glial cells of the 
peripheral nervous system, pigment cells, smooth muscle and cartilage and bone in the 
head (Le Douarin and Kalcheim, 1999). What is the strategy used by these cells to 
generate such diversity? 
The following are two extreme alternative hypotheses: i) Do neural crest cells 
represent a homogeneous, multipotent population of precursor cells which generate 
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different derivatives influenced by environmental factors; or rather, ii) are there pre-
specified progenitors with predetermined limited developmental capacities? 
Numerous experiments suggested that at least some neural crest cells are 
pleuripotent (Bronner-Fraser and Fraser, 1988; Bronner-Fraser and Fraser, 1989; 
Serbedzija et aI., 1994), generating sensory and sympathetic neurons and their associated 
glia. However in these experiments, other NCCs generated only a subset of these 
derivatives. Others (Henion and Weston, 1997) also implied the occurrence of early fate 
restriction. Does the existence of restricted fates truly reflect precursor specification? Or 
is it simply due to stochastic variations in the behavior of a homogeneous, multipotent 
population? 
Reexamination of these issues was required. I have used a genetic system to 
permanently label a subpopulation of neural crest cells marked by the expression of the 
proneural gene Neurogenin-2. The strategy involved inducible Cre recombinase-
dependent expression of a reporter gene in Neurogenin-2 expressing cells and their 
progeny. Neurogenin-2 is a bHLH DNA-binding factor necessary for the development of 
some sensory neurons (Ma et aI., 1999) but dispensable for the generation of autonomic 
neurons (Fode et aI., 1998) and is expressed early in the ontogeny of some neural crest 
cells. 
By comparing the fate of these cellular derivates to the bulk crest population 
marked by expression of Wntl, I concluded that at least some neural crest progenitor cells 
are strongly biased for a sensory rather than an autonomic sublineage. Specifically, 
Ngn2+ progenitors were four times more likely than Wntl+ neural crest cells to contribute 
to sensory rather than sympathetic ganglia. Within dorsal root ganglia, however, both 
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Ngn2- and Wntl-expressing cells were equally likely to generate neurons or glia. These 
data suggest that Ngn2 marks a neural crest subpopulation with a predictable fate bias, 
early in migration. Moreover, such neuronal subtype specification is acquired before 
commitment to a particular neuronal or glial fate. These data, together with other work 
(Lu et aI., 2002; White et aI., 2001; Zhou and Anderson, 2002) challenge the hitherto 
textbook view of neural cell lineage segregation, which stated that neuronal and glial 
precursors were segregated first, before neuronal subtype specification occurred 
(Anderson, 2001; Gage, 2000; Temple and Qian, 1996). 
Parts of this chapter have been reported elsewhere (Zirlinger, M., Lo, L., 
McMahon, J., McMahon, A. P., and Anderson, D. J. (2002). Transient expression of the 
bHLH factor Neurogenin-2 marks a sUbpopulation of neural crest cells biased for a 
sensory but not a neuronal fate. Proc. NatI. Acad. Sci. USA, In press.) 
At the end of this chapter I briefly discuss our attempts to obtain Cre-dependent 
reporter expression in the adult brain. 
We thank C. Schuurmans and F. Guillemot for providing the Ngn2 genomIc 
construct and Ngn2-lacZ mice, P. Soriano for Rosa26-loxp reporter mice, B. Kennedy, S. 
Pease and the staff of T AFCIT for expert help in the generation and maintenance of 
genetically modified mice, L. Reichardt and F. Rice for anti-Trk antibodies, and C. 
Birchmeier for the anti-BFABP antibody. We thank G. Kreiman for help with 
mathematical simulations, J. Yamada for genotyping, S. Pintchovski and G. Mosconi for 
help with experiments. 
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3.2Transient expression of the bHLH factor Neurogenin-2 marks a 
subpopulation of neural crest cells biased for a sensory but not a 
neuronal fate 
The neural crest presents a model system for studying neural cell lineage 
segregation. Neural crest cells (NCCs) generate the sensory and autonomic neurons of the 
peripheral nervous system, and their associated glia, after migrating from the dorso-
lateral neural tube (Le Douarin and Kalcheim, 1999). Single-cell lineage marking 
experiments in vivo have indicated that some pre-migratory trunk NCCs are pleuripotent, 
generating neurons and glia in both sensory and autonomic (sympathetic) ganglia 
(Bronner-Fraser and Fraser, 1988; Bronner-Fraser and Fraser, 1989; Serbedzija et ai., 
1994). However in these experiments, other NCCs generated only a subset of these 
derivatives, e.g., in sensory but not autonomic ganglia. Because the marked cells were 
selected at random, it could not be distinguished whether NCCs are homogeneous and 
pleuripotent, but exhibit heterogeneity in their fates due to stochastic variation, or rather 
are heterogeneous and comprise subpopulations with deterministic fate restrictions that 
could not be prospectively identified. Lineage-marking studies performed on migrating 
neural crest cells in vitro have revealed evidence of rapid restriction to neuronal or glial 
fates (Henion and Weston, 1997), but the neuronal subtype(s) involved were not 
examined. 
Evidence of molecular heterogeneity among early NCCs has been suggested by 
the often transient expression of various antigenic markers and genes (e.g., Barbu et ai., 
1986; reviewed in Le Douarin and Kalcheim, 1999). However, without some way to 
convert the expression of such markers into a permanent lineage tracer, it remained 
109 
unclear whether this heterogeneity reflected early fate-specification. Here we have 
achieved such a conversion by using a conditional form of Cre recombinase to 
permanently mark a subset of NCCs that transiently express the proneural bHLH 
transcription factor Neurogenin2 (Ngn2) (Gradwohl et aI., 1996; Sommer et aI., 1996). 
Ngn2 is required for the differentiation of a subset of sensory neurons (Ma et aI., 1999), 
but is dispensable for autonomic neurons and for Schwann (glial) cells in peripheral 
nerves (Fode et aI., 1998). The genetic requirement for Ngn2 in sensory neurons, 
however, leaves open the question of whether it is expressed by progenitors restricted to a 
sensory neuron fate (Fig. 1, A4), or rather by cells with a broader developmental potential 
(Fig. 1, A1-A3). 
To address this question, we have employed a conditional, binary system for fate-
mapping of Ngn2-expressing progenitor cells in vivo based on Cre-Iox-mediated DNA 
recombination (Danielian et aI., 1998; Zinyk et aI., 1998). We have expressed a 4-
hydroxy tamoxifen (4-0H Txf)-inducible form ofCre recombinase, CreER™ (Brocard et 
aI., 1997; Danielian et aI., 1998; Metzger et aI., 1995), from Ngn2 genomic regulatory 
elements in mice (Fig. 1B). Such Ngn2-CreER™ mice are then crossed to mice carrying 
a ubiquitously expressed, Cre-dependent lacZ reporter gene (Soriano, 1999). In embryos 
from this intercross, lacZ expression can be activated only in Ngn2-expressing 
progenitors. Because activation of the reporter gene involves a cell-heritable DNA 
rearrangement event, lacZ expression will persist in the progeny of transiently Ngn2-
expressing cells (Fig. 1C). Since 4-0H Txf has a half-life of only 0.5-2 hrs in vivo 
(Danielian et aI., 1998), activation of CreER ™ can be further restricted to a relatively 
narrow developmental time window when the ligand is injected. Thus the final 
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expression pattern of the lacZ reporter will exclusively identify the progeny of cells 
expressing Ngn2-CreER™ during this time window, and will not include cells that 
express Ngn2 at later times (Fig. lC, large lower oval). 
3.2.1 Material and methods 
Mouse manipulations: Homologous recombination in ES cells was employed to 
replace the Ngn2 coding sequence with CreER™ (Danielian et aI., 1998), via the same 
strategy used to generate Ngn2 knockouts (Fode et aI., 1998). Ngn2-CreERTM mice bred 
into a CS7B16/J background were crossed to Rosa26-loxp reporter mice (Soriano, 1999) 
to generate embryos for analysis. In other experiments, mice harboring a Wntl-CreER™ 
transgene (Danielian et aI., 1998) were bred to the same line of reporter mice. 4-0H Txf 
was injected intraperitoneally (1 mg/mouse) to activate Cre-ER™. Injections to activate 
CreER™ at E8.7S-E9.0 were performed between S PM and midnight (counting the 
morning the vaginal plug was identified as EO.S), and to activate it at E9.S were 
performed between 8 AM and noon the following day. Embryos were analyzed at E12.S, 
or in some experiments at EI0.5. 
Histology: Embryos were fixed in 4% PFA for 1-2 hr at RT, embedded, frozen 
and sectioned at IS j.lm. For double-labeling (Durbec and Rougon, 2001), sections were 
first X-gal-stained (Beddington et aI., 1989) overnight at room temperature, post-fixed in 
4% PFA, pre-blocked, and then incubated for I.S hr at RT with the appropriate primary 
antibodies: mouse monoclonal anti-Isl-l (IgG 1, Developmental Studies Hybridoma 
Bank,1: 1 dilution); rabbit anti-TH (Sigma, 1: 1000 dilution); rabbit anti- BF ABP (C. 
Birchmeier, 1: 1000 dilution); rabbit anti-trk-A (L. Reichardt, I :2000 dilution); rabbit 
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anti-trk-B (L. Reichardt, 1: 1000 dilution); goat anti-trk-C (L. Reichardt, 1 :500 dilution). 
Antibody staining was developed with DAB using the Vecstatin ABC kit (Vector labs, 
Inc.). Fluorescent secondary antibodies were Alexa red anti-rabbit (Molecular Probes) or 
FITC-conjugated anti-mouse IgG 1 (Southern Biotech), (1 :250 dilution). 
3.2.2 Overview of the genetic strategy employed 
Current molecular techniques allow precise genetic modifications in the mouse. 
Not only can specific nucleotide sequences be targeted in the genome but also genetic 
switches can be designed to tum genes on (or off) at desired times. A powerful tool for 
the creation of modified animals is the Cre-site specific DNA recombinase of 
bacteriophage PI (reviewed in (Sauer, 1998)). Cre is a 38-kDa product that recognizes a 
34-bp site called 10xP and efficiently catalyzes reciprocal conservative DNA 
recombination between pairs of 10xP sites, which results in excision of the DNA between 
them. The 10xP site consists of two 13-bp inverted repeats flanking an 8-bp 
nonpalindromic core region. Importantly, no accessory host factor or DNA topological 
requirements are needed for efficient Cre-mediated DNA recombination. A useful way of 
controlling expression of a trans gene is to design it as a "dormant" transgene so that it 
can be only activated under specific circumstances. One way of doing this is by inserting 
a STOP signal flanked by 10xP sites, between the transgene and its promoter. The STOP 
signal can be removed by Cre-mediated excision, for example, by intercrossing with a 
second mouse expressing Cre in specific tissues. The STOP sequence consists of a spacer 
DNA (from the yeast HIS3 gene), the small intron and polyadenylation signal from 
SV 40, followed by a gratuitous ATG translation start and 5' splice donor signal to 
112 
suppress correct expression from any residual transcription of the desired downstream 
gene (Lakso et aI., 1992). Thus, this cassette prevents expression of the downstream gene 
until the STOP signal is removed. The tissue specificity of expression for the 
recombinationally activated dormant trans gene is a function both of the promoter 
specificity of the target dormant trans gene and of the promoter specificity of the ere 
trans gene, so that the resulting expression pattern of the dormant trans gene is confined to 
the intersection of the two expression patterns. For instance, intercross of a transgenic 
mouse that expresses the dormant transgene ubiquitously and one that expresses ere 
recombinase in a spatially or developmentally limited fashion will provide activation of 
the dormant trans gene that is dictated solely by the promoter driving ere. In this case, the 
dormant trans gene was simply a lacZ reporter gene, which allowed for lineage analysis in 
the mouse. ere expression and ensuing recombination removed the STOP sequence to 
allow reporter gene expression not only in the cells in which recombination took place, 
but also in their progeny (Soriano, 1999). Furthermore, another degree of specificity was 
achieved by introducing a temporal control of ere recombinase functional expression. A 
fusion protein was created between ere and the ligand-binding domain of the estrogen 
receptor (Brocard et aI., 1997; Danielian et aI., 1998; Schwenk et aI., 1998), which could 
only be activated upon addition of ligand. Moreover, the estrogen-binding domain had a 
point mutation that provided higher affinity for tamoxifen (a synthetic ligand) than to 
endogenous estrogen. The use of both steroid agonists that do not appreciably target 
endogenous steroid receptors and of ligand-binding domains responsive only to 
exogenously added ligand allowed for the precise temporal control of reporter gene 
expression in transgenic mice. 
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3.2.3 Results 
In E9.5 embryos, NGN2 is expressed in both the dorsal neural tube (Fig. 2A, C; 
white arrowheads), and in a subset of migrating NCCs marked by SoxlO (Britsch et aI., 
2001; Kuhlbrodt et aI., 1998) (Fig. 2A, C; white arrows). NGN2+SoxlO+ NCCs were 
exclusively found in the dorsal part of the neural crest migration stream (Fig. 2B, 
arrows), and never detected near the sympathetic ganglia (SG) (Fig. 2B, C; open 
arrowheads). Similarly, examination of embryos from a conventional Ngn21acZ knock-in 
line (Fode et aI., 2000; Scardigli et aI., 2001) at ElO.5 revealed numerous lacZ+ cells in 
the DRG (Fig. 2D, black arrowheads) but none in the vicinity of the SG (Fig. 2D, white 
arrowheads). These data could indicate that Ngn2-expressing cells never give rise to 
sympathetic neurons, or that Ngn2 is very transiently expressed in precursors of such 
autonomic neurons. To resolve this issue, we permanently marked the progeny of Ngn2-
expressing cells by injecting pregnant mothers carrying embryos from an Ngn2-CreERTM 
x Rosa-loxPSTOPloxP-lacZ intercross with 4-0H Txf, at E9.0 (n=6 embryos) and E9.5 
(n=15 embryos). In such embryos, a very small proportion «5%) of lacZ+ neural crest-
derived cells were observed in the SG, identified by counter-staining with antibody to 
tyrosine hydroxylase (TH; Fig. 3C, D; arrows). Thus some Ngn2-expressing cells do 
appear to generate sympathetic neurons. 
To determine whether the relative contribution of Ngn2-expressing cells to DRG 
vs. SG was quantitatively different from the NCC popUlation as a whole, we performed a 
similar analysis on embryos containing a Wntl-CreER™ trans gene (Danielian et aI., 
1998). Wntl is expressed in the dorsal neural tube and roof-plate from the onset of neural 
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crest migration (Serbedzija and McMahon, 1997), and Wntl-expressing NCCs populate 
all of the tissues derived from the neural crest (Jiang et aI., 2000). Injections of embryos 
from Wntl-CreER™ x Rosa-!oxPSTOP!oxP- !acZ intercrosses with 4-0H Txf were 
performed at similar times to that in the Ngn2-CreERTM experiments (E8.75-E9.0, and 
E9.5), and the embryos were analyzed at E12.5 (Fig. 3B). 
To quantify the results, we counted the total number of lacZ+ cells in the DRG 
plus SG in every fourth section through the trunk region. There were many more (~18-
fold) lacZ+ neural crest-derived cells in Wntl-CreER™-expressing embryos, presumably 
reflecting both the expression of Wntl in more cells than Ngn2, and at higher levels from 
the multicopy trans gene. Therefore, we first normalized the data by calculating the 
percentage of labeled ganglionic cells in either the DRG or SG for each embryo, and then 
taking the mean of these values across all embryos of a given genotype (n=21 Ngn2-
CreER™ embryos; n=4 Wntl-CreER™ embryos). As expected, in Wntl-CreER™ 
embryos the average percent of cells in the DRG was ~5-fold higher than that in the SG 
(Table 1), reflecting the larger size of the sensory ganglia. Furthermore, this percentage 
was higher when 4-0H Txf injection was carried out at E9.5 (6.7-fold) than at E8.75-
E9.0 (3.7-fold; Table 1), consistent with the fact that NCCs continue to populate the 
DRGs after they have stopped colonizing the SGs (Serbedzija et aI., 1990; Weston and 
Butler, 1966). 
Despite this overall DRG-bias of the bulk NCC population, however, in Ngn2-
CreER™ embryos the percentage of labeled cells in the DRG was ~20-fold higher than in 
the SG (Table 1). Thus, cells derived from Ngn2-expressing progenitors contributed to 
sensory ganglia rather than sympathetic ganglia at a frequency 3- to 4-fold higher than 
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that of Wntl-expressing progenitors, at both early and late injection times (Table 1). To 
ensure that this difference was not an artifact of the smaller number of labeled cells in 
Ngn2-CreERTM embryos (~67 cells per embryo in DRG+SG, vs. 1,258 cells per embryo 
in DRG+SG of Wntl-CreER™ embryos), we performed a Monte Carlo simulation to 
randomize the data, using the actual number of cells counted in each of the 21 embryos 
examined but assuming that the distribution of cells between the DRG and SG was 
actually the same as that measured in Wntl-CreER™ embryos (83% in DRG, 17% in SG, 
a ratio of 4.8 (Table1)). After 10,000 iterations of this simulation, the probability that the 
ratio [%cells in DRG]/[%in SG] of ~20 that we actually measured in Ngn2-CreER™ 
embryos (Table1) was due to chance was < 0.001. Consistent with this, the percentage of 
Wntl-derived cells in SG was ~3.5-fold higher than the percentage of Ngn2-derived cells 
in these autonomic ganglia. Thus, by several measures NCCs expressing Ngn2 are more 
likely to colonize sensory ganglia than are those expressing Wntl. This difference is 
likely to be an underestimate, since the Wntl-expressing NCC population itself 
presumably contains Ngn2-expressing cells. 
At the time of 4-0H-Txfinjection, NGN2+ cells are located in both the dorsal and 
ventral neural tube, as well as in the neural crest (Fig. 2A-C). Strikingly, in embryos 
analyzed at E12.5 there were no labeled neurons in the dorsal neural tube; rather, they 
were found in neural crest derivatives and in the ventral neural tube (Fig. 2G, H). That 
reporter activation did occur in some dorsal neural tube cells at E9.5 is supported by the 
fact that lacZ+ cells could still be detected in this location in embryos analyzed at EIO.5 
(Fig. 2F), and by the persistence at E12.5 of a few labeled progenitor-like cells with an 
elongated morphology and endfoot in the dorsal ventricular zone (Fig. 2H, I, white 
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arrow). These data suggest that most NGN2+ cells in the dorsal neural tube at E9.5 may 
be premigratory neural crest or dual crest-CNS progenitor cells (Bronner-Fraser and 
Fraser, 1988; Bronner-Fraser and Fraser, 1989). However we cannot formally exclude 
that some of these cells die, or migrate ventrally. 
We next asked whether there was any bias in the differentiation of Ngn2-
expressing cells to neuronal vs. glial fates in the sensory ganglia. To do this, we 
performed double-labeling for lacZ expression and the pan-neuronal markers Is11 (Fig. 
3E, F) or NeuN (Fig. 3G) to identify neurons, or anti-brain fatty acid binding protein 
(BF ABP) antibody staining to identify peripheral glia (Britsch et aI., 2001) (Fig. 3H, I). 
Double-labeled lacZ+Is11 + (or lacZ+NeuN+) neurons were clearly distinguishable from 
lacZ+Is11- non-neuronal cells (Fig. 3E-G; arrows vs. arrowheads, respectively). 
Expression of lacZ in these latter, non-neuronal cells was co-localized with that of 
BF ABP; this was particularly clear in the dorsal roots and peripheral nerve (Fig. 3H, I; 
arrows) where there are no neuronal cell bodies. Quantification indicated that the 
percentage of lacZ+ neurons and non-neuronal DRG cells was statistically 
indistinguishable in embryos injected with 4-0H Txf at either E9.0 or E9.5 (Table 2). A 
similar result was obtained in Wntl-CreER™ embryos (52±3% LacZ+Isl+ and 48±3% 
LacZ+lsr cells; n = 2 embryos). Therefore, Ngn2+ expressing cells give rise to both 
neurons and non neuronal cells in similar proportions, as does the bulk NCC population. 
These data indicate that while Ngn2-expressing NCCs are strongly biased towards 
generating sensory derivatives, they are not biased towards generating neuronal vs. glial 
derivatives. 
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Finally, we examined the distribution of Ngn2-derived cells among different 
sensory neuron subtypes by double-labeling using antibodies to the NGF receptor trkA, 
the BDNF receptor trkB, or the NT-3 receptor, trkC. These receptors are predominantly, 
although not exclusively, expressed by nociceptive, mechanoceptive, and proprioceptive 
sensory neurons, respectively, (reviewed in ref. Snider, 1994). We estimated that ~68% 
of lacZ+ neurons in the DRG are trkA+ (Fig. 4A-F, arrows; n=lO embryos), a number 
remarkably close to the percentage of all neurons that express the receptor at this stage 
(~70%) (Mu et aI., 1993). A much smaller proportion oflacZ+ cells appeared to be trkB+ 
or trkC+ (Fig. 4C-F, arrows), consistent with the fact that these receptors are expressed by 
a smaller proportion of all sensory neurons at this stage (Mu et aI., 1993). Thus, these 
data suggest that Ngn2-expressing NCCs contribute to mUltiple classes of sensory 
neurons in DRG, without any apparent bias towards a particular subtype. 
3.2.4 Discussion 
Classical lineage tracing studies have left open the question of whether the 
premigratory and early migrating neural crest IS a homogeneous population of 
pleuripotent cells, or whether it is heterogeneous and contains both pleuripotent and 
intrinsically fate-restricted cells. The results presented here identify at least one 
subpopulation of NCCs, namely that marked by expression of Ngn2, which exhibits a 
predictable bias in its differentiated fate from an early stage in migration. Ngn2-
expressmg cells are ~20 times more likely to generate sensory than autonomic 
(sympathetic) derivatives, and this bias is 3 to 4-fold greater than that of bulk NCCs 
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marked by expreSSlOn of Wntl. This conclusion is supported even when taking into 
account the fact that there are more labeled NCCs in Wntl-CreER™ embryos. 
The fact that even a few Ngn2-expressing NCCs give rise to autonomic 
derivatives indicates that Ngn2 does not mark inevitable commitment to a sensory fate, 
but rather a strong bias to such a fate. This bias may reflect an inherently probabilistic 
influence of Ngn2 on sensory fate specification, or the influence of additional unknown 
but deterministic factors. For example, forced expression of Ngns promotes sensory 
differentiation both in vivo (Perez et al., 1999) and in cultured PNS progenitor cells, but 
in vitro this effect can be overridden by environmental signals that promote autonomic 
neurogenesis (Lo et al., 2002). These data suggest that there are other determinants of 
sensory identity required in addition to Ngns to commit cells to a sensory fate. Perhaps 
the small fraction of Ngn2CreER™-expressing NCCs that generated autonomic 
derivatives represents those cells in which such putative sensory identity co-determinants 
had not yet been expressed at the time of 4-0H Txf injection. Alternatively, commitment 
to a sensory fate may require prolonged or enhanced Ngn2 expression, analogous to the 
commitment to a neural precursor fate of Drosophila epithelial cells expressing high 
levels of prone ural genes (Cub as et al., 1991). 
The identification of Ngn2-expressing cells as strongly biased to a sensory fate 
suggests that those marked NCCs that generated only sensory derivatives in the chick 
lineage tracing experiments (Bronner-Fraser and Fraser, 1988; Bronner-Fraser and 
Fraser, 1989; Serbedzija et al., 1994) may have been intrinsically restricted to this fate, 
and could be equivalent to or overlapping with the Ngn2-expressing population. The fact, 
moreover, that Ngn2 is expressed in pre-migratory as well as in migrating neural crest 
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cells (Fig. 2A and refs. Ma et aI., 1999; Sommer et aI., 1996) further suggests that such a 
developmental bias may be acquired by NCCs at a relatively early stage in their 
ontogeny, perhaps even before they exit the neural tube (Fig. 5A). However, we cannot 
exclude that such premigratory NGN2+ cells contribute most of the sympathetic progeny 
derived from the Ngn2-expressing population. Thus, the exact time and place at which 
restriction to a sensory fate is imposed remain to be determined. Whatever the case, our 
results suggest that from the earliest stages of migration, the neural crest is not a 
homogeneous population of pleuripotent cells, but rather contains deterministically 
distinct sUbpopulations with predictable fate biases. 
Why should there be a subpopulation of Ngn2-expressing NCCs pre-specified for 
a sensory fate? In previous studies, we have shown that Ngn2 is required in a 
subpopulation of early differentiating sensory precursors that preferentially generate 
large-diameter sensory neurons (Frank and Sanes, 1991), including the trkC+ and trkB+ 
subclasses (Ma et aI., 1999). In contrast, Ngnl is required by a different, later-
differentiating sUbpopulation of sensory precursors that generates predominantly smaller-
diameter, trkA + neurons (Frank and Sanes, 1991; Ma et aI., 1999). The early sensory 
fate-specification of Ngn2-expressing NCCs may reflect a need to ensure rapid 
differentiation of these cells at the earliest stages of sensory ganglion formation. At 
apparent odds with this view is our observation that the majority of sensory neurons 
derived from Ngn2-expressing cells are trkA+. However, this may simply reflect the fact 
that Ngn2 is also expressed by the later-differentiating, Ngnl-dependent subpopulation, 
even though these precursors do not require Ngn2 function (Ma et aI., 1999). Consistent 
with this idea, there is evidence for cross-activation of Ngn2 expression by Ngnl in the 
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PNS (Ma et aI., 1998). Because the Ngnl-dependent precursors constitute the majority of 
the DRG precursor population, and because these precursors can compensate for the 
defective differentiation of Ngn2-dependent precursors in Ngn2-1- mutants (Ma et aI., 
1999), it is highly unlikely that any differences in the fate of Ngn2-CreERTM-expressing 
cells would be detectable in an Ngn2-1- background. 
Our results further suggest that Ngn2-expressing NCCs are not committed to a 
neuronal fate, despite their bias for a sensory identity. Consistent with this conclusion, 
CNS precursors isolated on the basis of Ngn2 expression can generate glia as well as 
neurons in vitro (Nieto, 2001), although it was not determined whether these cells are 
restricted to generating specific neuronal subtypes. Previously, we showed that post-
migratory neural crest stem cells in the sciatic nerve are restricted to autonomic fates but 
can still generate both neurons and glia (White et aI., 2001). Those studies, however, left 
open the converse question of whether all sensory progenitors also generate autonomic 
derivatives, or whether there exists a complementary popUlation of sensory-restricted 
multipotent neuro-glial progenitors. In vitro studies have provided evidence of sensory-
restricted progenitors, but whether these cells also generated glia could not be determined 
(Greenwood et aI., 1999). The present results indicate that sensory-restricted precursors 
generate neurons and glia with equal probabilities, in a similar fashion as the bulk neural 
crest population marked by Wntl expression. Taken together, these data imply that, at 
least in the PNS, multipotential neural progenitors become specified for certain aspects of 
neuronal subtype identity (Fig. 5B, Ps and P A) before they have become committed to 
neuronal or glial fates. 
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This conclusion challenges current models of neural cell lineage diversification, 
in which progenitors are typically depicted as first committing to neuronal or glial fates 
(Fig. 5C, PN and Po), before acquiring particular neuronal subtype identities (reviewed in 
refs. Anderson, 2001; Gage, 1998). Evidence for such restricted neuronal and glial 
precursors has been provided by in vitro studies of embryonic spinal cord-derived 
progenitor cells (Kalyani et aI., 1998; Mayer-Proschel et aI., 1997; Rao and Mayer-
Proschel, 1997; Rao et aI., 1998). However, recent studies suggest that in vivo, spinal 
cord progenitors are specified for particular neuronal and glial subtype identities before 
choosing between neuronal and glial fates (Lu et aI., 2002; Zhou and Anderson, 2002). 
Thus, while some finer aspects of neuronal subtype identity may not be acquired until 
after precursors commit to a neuronal fate, at least certain broad subclasses (e.g., sensory 
vs. autonomic; motoneuron vs. interneuron) are specified while progenitors still possess 
both neuronal and glial capacities. Such a decision logic could reflect the dual role of 
bHLH proneural genes in controlling the neuron vs. glial fate decision (reviewed in ref. 
Vetter, 2001), and in neuronal identity determination (e.g., ref. Gowan et aI., 2001). The 
need to coordinate the latter role with other transcriptional programs that specify neuronal 
identity (Jessell, 2000; Scardigli et aI., 2001) may necessitate that such programs are 
established at the time proneural genes are first expressed, when neural progenitors are 
competent for, but not committed to, a neuronal fate (Lo et aI., 1997). 
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Table 3-1 Relative contributions of Ngn2- and WntI-derived neural crest cells to sensory and 
sympathetic ganglia. 
Injxn stage ReI. DRG col.: ReI. DRG col.: DRG Ratio 
Ngn2-CreERa Wntl-CreERa [N gn21W ntI] b 
E8.75-E9.0 11.2 3.7 3.0 
E9.5 27.6 6.7 4.1 
Combined 19.5 4.8 4.0 
The percentage of cells in the DRG or SG was first calculated for each embryo as 
[(# cells in DRG)/(# cells in DRG + # cells in SG)] x 100%, or [(# cells in SG)/(# cells in 
DRG + # cells in SG)] x 100%, respectively. The mean of this percentage was then 
calculated for all embryos of a given genotype. The mean percentage of cells in the 
DRG, or in the SG, in Ngn2-CreER embryos (n=21) was statistically significantly 
different from that in WntJ-CreER embryos (n=4) at all stages (p<0.01). aThe relative 
colonization of the DRG compared to the SG was then calculated as the [mean % of cells 
in DRG/ mean % of cells in the SG]. bThe relative preference of Ngn2-derived cells to 
colonize the DRG compared to Wntl-derived cells is calculated as the ratio of the 
numbers in the first two columns. 
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Table 3-2 Relative contribution of Ngn2-derived neural crest cells to neuronal vs. non-neuronal 
derivatives in sensory ganglia. 
Stage of injxn Neurons Non-neuronal cells 
(no. of embryos) 
E9 (n=5) 56±6%a 44±6%a 
E9.5 (n=l1) 52±5% 48±5% 
combined 53±4% 47±4% 
The percentage of lacZ-labe1ed cells that were neurons (lsl1 +) or non-neuronal 
cells (lsll-) was measured in the DRG of Ngn2-CreERTM embryos injected at the 
indicated stages; the numbers represent the mean±SEM. aThere was no statistically 
significant difference in the percentage of neurons vs. non-neuronal cells at either stage. 
Similar results were obtained in Wntl-CreER™ embryos (see text). 
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3.2.5 Figure legends 
Figure 3-1 Mapping the fate of Ngn2-expressing cells. 
(A) Ngn2 is required for the development of a subset of sensory neurons (Ns) 
(Fode et aI., 1998; Ma et aI., 1999), but may be transiently expressed by progenitors with 
a broader developmental potential (examples illustrated in 1-4). Na=autonomic neuron; 
G=glia. (B) Strategy for inducible activation of the Rosa26-1acZ reporter gene by 4-0H 
Txf-inducible Cre expressed from the Ngn2 locus. (C) Because 4-0H Txf has a half-life 
in vivo of only 0.5-2 hrs (Danielian et aI., 1998), CreER™ will be active in Ngn2-
expressing cells only at the time of injection of the steroid ligand. The progeny of these 
cells can be detected by expression of lacZ at later times (EI2.5; blue ovals). Other cells 
expressing Ngn2 at these later times will not express lacZ due to the absence of 4-0H Txf 
(E12.5, white oval). 
Figure 3-2 Fate of transiently Ngn2-expressing cells in the neural tube. 
(A-C) Double-label immunofluorescence staining of a section through the caudal 
trunk region of an E9.5 mouse embryo with antibodies to NGN2 (A, green) and the pan-
neural crest marker Soxl0 (B, red). White arrowheads indicate NGN2+SoxlO- cells in the 
dorsal neural tube, open arrow indicates NGN2+SoxlO- motoneuron precursors in the 
ventral neural tube; white arrows indicate NGN2+Soxl0+ neural crest cells in the dorsal 
migration pathway, open arrowheads indicate NGNTSoxlO+ cells migrating ventrally 
towards the dorsal aorta (da). (D, E) Analysis of conventional Ngn21acZ knock-in 
embryos (Fode et aI., 2000; Scardigli et aI., 2001). (D) At EIO.5 numerous lacZ+ cells 
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are visible in the DRG (black arrowheads) and ventral nerve roots (arrows) but not in the 
region of the SG (white arrowheads). (E) By EI2.5, expression in the DRG is no longer 
detectable (arrowheads) and there is extensive expression in the dorso-Iateral neural tube 
(arrows). (F-J) Analysis of Ngn2CreER™ x RosaSTOPlacZ embryos injected with 4-0H 
Txf at E9.5 and analyzed at ElO.5 (F) or E12.5 (G-J). (F) Some Ngn2-CreERTM-
expressing cells were in the dorsal neural tube at the time ofCre activation (arrows). (G, 
H) By E12.5 there are very few lacZ+ cells in the dorsal neural tube and numerous 
labeled cells in DRG (white arrowhead) and dorsal roots (black arrowhead); contrast this 
with the pattern seen using the conventional Ngn2lacZ reporter (E). Arrow in (G) 
indicates motorneurons. (H-J) occasional elongated, lacZ+ cells with an endfoot in the 
ventricular zone are seen at E12.5 in the dorsal (H, I white arrow) and ventral (H, J black 
arrow) regions of the spinal cord; I, J are higher-magnification views of the dorsal and 
ventral regions of the section shown in (H). Such cells are not seen in conventional 
Ngn2-lacZ knock-in mice at the same age (cf. E vs. H). 
Figure 3-3 Distribution of progeny derived from Ngn2CreER™-expressing NCCs in the PNS. 
All panels are from Ngn2-CreER™ xRosaSTOPlacZ embryos injected at E9.5 and 
analyzed at EI2.5, except for (B) which is from a control Wntl-CreER™ x 
RosaSTOPlacZ embryo similarly injected and analyzed. Arrows in (A-B) indicate DRG, 
arrowheads SG. (C, D) Example of a rare section from Ngn2-CreER™ embryos with a 
lacZ+ cell in the SG (arrow), visualized by counter-staining for TH (brown); (D) shows a 
higher-magnification view of the SG. Arrowhead indicates DRG. See Table I for 
quantification. (E-G) Double-labeling reveals that lacZ+ cells in the DRG include both 
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neuronal (ls11 + or NeuN+, arrows) and non-neuronal (ls11- or NeuN-, arrowheads) cells. 
NT indicates neural tube. The magnification in (G) is slightly higher than in (F). (H, I) 
Ngn2-expressing NCCs generate BF ABP+ glial cells in dorsal root (large arrow) and 
peripheral nerve (H, small arrows) as well as in the DRG. Neurons and non-neuronal 
cells are generated in statistically indistinguishable proportions (see Table 2). 
Figure 3-4 Ngn2-expressing NCCs generate multiple sensory neuron subtypes in the DRG. 
Sections through DRG of E12.5 Ngn2-CreERTM embryos injected with 4-0H 
Tamoxifen at E9.5. (A, B) Sections double-labeled to reveal lacZ+ (blue) and trkA+ 
(brown) cells at low (A) and high (B) magnification. Arrows indicate double-positive 
cells, arrowheads a lacZ+, trkA- cell. (C, D) Double-labeling for lacZ+ and trkB+ cells. (E, 
F) Double-labeling for lacZ+ and trkC+ cells. In each case, analysis in multiple focal 
planes confirmed the co-localization ofXgal staining and anti-trk antibody staining. 
Figure 3-5 Summary diagram. 
(A) Illustration of experimental results. Transient activation of Cre recombinase 
in Ngn2-expressing cells in the dorsal neural tube and/or migrating neural crest at E9.0-
9.5 leads to progeny that by E12.5 have predominantly populated the DRG and 
surrounding nerve roots; both neurons (blue circles) and glia (blue diamonds) are found 
in this location. (B-D) Possible modes of neural crest lineage segregation. (B) Neural 
crest cells (NCC) first generate autonomic- and sensory-restricted progenitors (P A and Ps, 
respectively). These progenitors then each generate neurons (NA' Ns) and glia (GA and 
Gs). (C) NCCs first generate neuronal- and glial-restricted progenitors (PN and Po, 
127 
respectively), which then differentiate into autonomic and sensory neurons or glia. (D) 
NCCs directly generate autonomic and sensory neurons and glia without restricted 
intermediates. (E) Wntl expression marks NCCs, while NGN2 is predominantly 
expressed by sensory-restricted progenitors, favoring the model in (B). Dotted arrow 
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3.2.6 Experiments with Ngn2-CreER™ adult mice 
We designed these transgenic mice for two purposes originally. On the one hand, 
for embryonic studies like those described above, and on the other, for manipulations in 
adult mice with the hope to conditionally inhibit adult neurogenesis. This latter 
application failed because we were not able to induce lacZ expression in reporter mice 
when 4-0H Txf was injected in the adult. Since I had previously observed that some 
Ngn2-expressing cells in the subgranular zone of the adult dentate gyrus were dividing 
(not shown), the goal was to ablate these cells by crossing Ngn2-CreER TM animals to 
transgenic mice expressing Cre-dependent thymidine kinase (analogous to reporter mice 
expressing Cre-dependent lacZ). For cell ablation, a drug, ganciclovir, must be provided, 
so that only dividing thymidine kinase-expressing cells undergo cell death because 
ganciclovir is turned into a toxic product by this enzyme (Heyman et aI., 1989). Thus, in 
principle, we should have been able to temporally control (first by means of 4-0H Txf-
Cre activation and then by ganciclovir treatment) the ablation of dividing, Ngn2-
expressing cells. This could serve to study the role, if any, of adult neurogenesis 
(reviewed in Gould et aI., 1999; Kempermann and Gage, 2000). 
There are multiple reasons that could explain why reporter activation was not 
observed in the adult, even after multiple high doses of 4-0H Txf injections 18. It is 
possible that the level of Ngn2 produced in the adult (and thus, of CreER TM) is simply not 
high enough to elicit Cre-mediated DNA recombination. Previous successful Cre-
dependent DNA recombination in the adult was observed when multicopy transgenic 
promoters were driving Cre expression (for example, Brocard et aI., 1997), but in general 
18 I administered ~ 5-10 times the dose reported in (Brocard et aI., 1997) that obtained ere activation in 
adult skin (see next). 
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these studies do not show recombination in brain (but see below). On the other hand, 
knocking-in of Cre recombinase induced DNA recombination in one case (Hebert and 
McConnell, 2000), but the enzyme was not fused to any regulatory domain, like the 
estrogen-responsive one utilized in our studies. Thus the strength of an unmodified 
recombinase may be higher than the fusion we used. In this regard, a recent report 
quantitated that tamoxifen-induced excision had a 5-10% efficiency rate compared to a 
general unmodified Cre deletor line (Guo et aI., 2002). They also observed different 
extents of recombination in various tissues, of which muscle and pancreas had the most 
extensive, even though a general strong promoter (consisting of the CMV early enhancer 
and chicken p-actin promoter) was employed (Guo et aI., 2002). 
Alternatively, the degree of Cre activation by 4-0H Txf may have been 
insufficient. A number of different mutated estrogen responsive domains have been used 
in transgenic mice (Indra et aI., 1999), with varying recombination efficiencies. The 
fusion used for the present study was of the "first generation" of CreER TM fusions 
synthesized, before improved versions were produced by specific mutations in other 
positions of the ER domain. 
There is at least one recent study reporting the successful application of the 
CreER ™/loxP recombination technology in the brain (Weber et aI., 2001), where a 
strong neuronal promoter (prion protein promoter) was employed. It is noted by the 
authors that strong positional effects were obtained in mice generated by pronuclear 
injection, since Cre expression varied extensively in different transgenic lines. In general, 
a complicating factor in the use of these technologies is the positional effect (Lacy et aI., 
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1983), which produces mosaicism III the target tissue or inappropriate transgene 
expression, depending on the site of trans gene insertion in the genome. 
Other attempts of inducible recombination in adult brain took advantage of Cre 
and progesterone receptor fusions. The principle is the same as in CreER ™ fusions, but 
activation of the recombinase is produced by the synthetic steroid RU486 instead. One 
study (Kellendonk et aI., 1999) compared activation efficiencies of Cre fused with either 
estrogen or progesterone ligand binding domains in vitro, and concluded that the latter 
were more promising for use in brain. It is thus possible that Cre fusions with other 
ligand-activated domains, such as progesterone, are more effective for targeting trans gene 
expression in brain. As examples, specific neuronal populations, such as cerebellar 
Purkinje (Kitayama et aI., 2001) or granule (Tsujita et aI., 1999) cells have been already 
targeted by RU486 administration in transgenic mice. 
To summarize, either because of low transgene copy numbers driven by the 
NGN2 promoter, or because of low effective concentrations of active Cre (i.e. only 
partially activated by 4-0H Txf), or a combination of both, we could not observe lacZ 
induction in adult brains of Ngn2-CreER TM, Rosa-loxPSTOPloxP-lacZ double 
transgenic mice. 
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4 CONCLUDING REMARKS 
I have chosen to study neural diversity to uncover the molecular details of the 
nervous system. I have attacked the problem from many angles by applying a 
combination of techniques. Several conclusions can be drawn from this work, some of 
which can be better appreciated if we place it under perspective. 
4.1 A technological revolution: microarrays and 
biological research 
In principle, micro array technology has a tremendous potential to accelerate basic 
science research. It provides the opportunity to simultaneously scrutinize expression of 
thousands of genes under different behavioral or pathological conditions or in mutant 
backgrounds (Lockhart and Barlow, 2001). This has revolutionized biological research 
recently, as illustrated by the existence of > 1600 citations of "micro array" in Pubmed 
since late 1995, when the first papers were published (e.g., Schena et aI., 1995). 
Some of the results presented here represent in a way "proof of principle" 
experiments. I foresee a near future in which these types of studies will be carried out 
systematically, with the help of automated systems. It is probably a good analogy to 
compare the leap accomplished in the field of genetics when automated sequencers were 
introduced to the revolution caused by the development of micro array technology. 
Obtaining sequence or expression data for a single gene used to involve plenty of time 
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and intensive work, whereas nowadays, collecting such data for thousands of genes at 
once is becoming customary in many (wealthy) labs and can be generated in a matter of 
days. 
4.2 Application of microarray technology to the study of 
the brain 
Despite the benefits of this recently developed technology, it was not a priori 
clear that it could be applied to the study of the nervous system, given the brain cellular 
complexity (Serafini, 1999). In addition, oligonucleotide microarray technology is 
confined to the interrogation of known genes or ESTs of reported sequences. Again, it 
was not clear either that the representation of genes on these types of arrays would 
comprise a comprehensive cohort of brain genes (Cao and Dulac, 2001). The results 
presented here show that microarray technology can indeed be applied to the study of 
brain regions. They highlight, though that a thorough validation of results is required by 
an independent method. In situ hybridization proved to be an adequate method of 
confirmation and also provided detailed anatomical information of gene expression at a 
high level of resolution, fundamental for the analysis of the brain. 
The dilution of potentially enriched transcripts of low abundance among genes 
more broadly expressed is a serious concern. As discussed in chapter 2, starting the 
analysis with more homogeneous tissue (obtained by LCM), circumvented part of this 
problem. Several new genes were identified in my second screen that appeared not to be 
particularly enriched in the amygdala in the first screen, and were thus missed in the 
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original study. Perhaps the next level of refinement will require starting with single cells 
to further enrich for rare transcripts and solve the dilution problem. 
It is also possible that the use of cDNA microarrays (which are not restricted to 
the interrogation of known genes or ESTs) augments the set of transcripts analyzed in 
brain profiling studies. However, as sequence databases are expanding continually, the 
representation of genes (and predicted genes) on updated oligonucleotide arrays may be 
appropriate enough for conclusive molecular analyses of brain regions. 
4.3 Molecular signature of brain regions 
In general, there were few genes (~ 0.3- 1.0 %) differentially expressed across 
different brain regions or within the amygdala. As already pointed out in the discussion in 
chapter 2, this is somewhat contrary to the intuitive idea that the complexity of the brain 
is due in part to the actions of genes differentially expressed. However, apart from the 
genes that are most likely missed due to the dilution problem or because they are not yet 
represented on the arrays, it is also possible that the molecular differences across brain 
regions are mainly based on different combinatorial collections of genes. Moreover, 
many genes could be differentially processed in each brain region (Cao and Dulac, 2001), 
which would be largely undetected by current oligonucleotide microarrays. Recent 
genome-wide analyses of alternative splicing indicate that 40-60% of human genes have 
alternative splice forms (Lander et aI., 2001), resulting in an amazing potential functional 
diversity. 
It will be very interesting to design splicing-specific micro arrays (like the ones 
made for yeast (Clark et aI., 2002)) for gene profiling in the brain. Another intriguing 
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possibility, so far largely unexplored, is that differentially transcribed non-coding RNA 
sequences (Eddy, 2002; Eddy, 1999) playa role in generating neural functional diversity. 
4.4 Data analysis 
As previously discussed, independent validation of mlcroarray data was 
indispensable. In addition, the results obtained also underscore the need for careful data 
analysis for the selection of candidate genes with potential differential expression. The 
custom programs that we developed for this purpose are only examples of such tools. 
There are a number of other programs useful for microarray data analysis, such as 
clustering algorithms like Genecluster and Genespring, or other software, such as 
Bullfrog, (all described in Appendix 1). It is important to note that clustering algorithms 
only consider values of average differences and disregard all the other parameters 
calculated by the Affymetrix software. These programs can be useful when large 
collections of genes are analyzed and a global picture of expression data is sought. 
However, to find genes that are highly enriched in one region with respect to all others it 
is important to set specific criteria for enrichment, which cannot be done with clustering 
algorithms. Our program permits the explicit specification of multiple criteria for 
enrichment and also, in contrast to clustering algorithms, allows for specifying 
constraints about the ratio of expression in one brain region relative to all others. It is 
interesting that the principles behind our program are very similar to the ones 
implemented by the Bullfrog program, independently developed by David Lockhart 
(founding president of Affymetrix Inc.) and others. 
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4.5 From molecular boundaries to functional 
specialization 
Although for the wrong reasons, Franz Gall suggested already in the eighteenth 
century that different regions of the brain are specialized to fulfill distinct and specific 
functions (Finger, 2000). For example, the amygdala is known to playa fundamental role 
in the processing of emotional stimuli (Davis, 1992; LeDoux, 1995). The seminal work of 
Brodmann at the beginning of the last century described different regions of the human 
brain based on cellular morphology and network anatomy (Kandel et at., 2000). 
Remarkably, it has become evident that many of these boundaries described by 
cytoarchitectonic criteria also mark rather clear functional boundaries as observed by 
electrophysiological, lesion and functional imaging studies. The so-called Brodmann map 
is commonly used nowadays, particularly in functional imaging studies, to refer to 
specific regions of the brain. 
Strikingly, the studies presented in Chapters 1 and 2 showed that most boundaries 
of gene expression in the amygdala were concordant with subregional limits defined by 
cytoarchitectonic criteria. By extension, most brain regions may harbor genes whose 
expression domains are contained within subregion boundaries. 
I propose that a further refinement in the delineation of brain structures can be 
obtained based on molecular signatures, as illustrated in Chapter 1. In other words, gene 
expression domains may uncover sub-boundaries not obviously marked by classical 
histological staining techniques, which may lead to the revelation of functional roles 
previously unnoticed. 
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In general, the use of molecular markers to delimit specific brain regions opens 
the possibility for studying the functional architecture of the brain at an unprecedented 
level of resolution. Specifically, region-enriched genes obtained using these techniques 
could potentially provide direct tools to experimentally manipulate and dissect specific 
brain functions, as discussed below, through the use of transgenic technologies. 
4.6 Immediate applications of these studies 
4.6.1 Identification of markers for transgenic studies: 
The genes identified in these screens may prove to be useful for gene targeting 
experiments in transgenic mice. For instance, they could be used to drive expression of a 
reporter gene or axonal tracer. This could define the sites of expression of their gene 
products and also map axonal projections. Alternatively, a desired gene could be used to 
alter the physiology of specific cells or to simply ablate them, such as a 'silencing' gene 
that decreases neuronal excitability (Johns et aI., 1999; Nadeau et aI., 2000), or a toxic 
chemical or toxin (Hara et aI., 2001; Nirenberg and Cepko, 1993; Nirenberg and Meister, 
1997), respectively. This manipulation could be used to define the role that specific 
neurons play under different behaviors. As already discussed in chapter 2, combinations 
of "semi-specific" genes (having more than one restricted site of expression) could be 
employed to achieve selective targeting. For example, there are a number of binary 
systems that require the presence of two components to activate transcription of a 
heterologous gene. These include the Cre-IoxP recombination system (reviewed in 
Chapter 3), the tetracycline (Gossen and Bujard, 1992; Gossen et aI., 1995) and the 
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ecdysone (Christopherson et aI., 1992; No et aI., 1996) inducible systems (reviewed in 
Saez et aI., 1997). In principle one could build a Venn diagram of gene expression in the 
brain and take advantage of transcripts that have overlapping expression domains in the 
region of interest to design transgenic mice. I have identified a number of pairs of 
amygdala-enriched genes that could be used for this purpose (see Table 4 Chapter 2). 
Along these lines it is important to mention the recent development of techniques for 
efficiently designing bacterial artificial chromosomes (BACs) for use in BAC transgenic 
mice (reviewed in Heintz, 2001). With this method, transgenic mice can be created faster 
than with conventional transgenic techniques. It will most likely prove useful for the 
genetic manipulation of genes or neurons under different behaviors once specific genes 
(or combination of semi-specific genes) are further identified. 
4.6.2 Analysis of regulatory regions 
Another interesting application of these studies is in the analysis of gene 
regulatory regions. Transcripts that are coexpressed in one brain region are likely to share 
regulatory sequences in their enhancer regions. Microarray data can be invaluable for this 
analysis since it can potentially inform of all the transcripts expressed in each brain area. 
By careful examination of sequences flanking the transcriptional initiation (or, if not 
available, translational start) of these genes, it may be possible to find conserved motifs 
in genes similarly expressed. This principle has been successfully applied in yeast (Pilpel 
et aI., 2001; Tavazoie et aI., 1999) and plants (Harmer et ai., 2000). Regulatory sequences 
responsible for gene expression control during progression of the cell cycle or light-dark 
phases were identified in each case, respectively. Since the yeast and plant genomes are 
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more compact than the mouse's, it is easier to perform regulatory region analysis in these 
organisms, in which only ~ lkb of upstream sequences are considered. In mouse it is 
necessary to analyze larger flanking regions, since enhancer sequences can be located 
several tens of kilobases upstream (or downstream) of the site of transcriptional initiation 
(Lewin, 2000). The task of identifying common motifs is thus computationally more 
intensive in higher organisms. Very few comparisons have been done to date. However, 
the job will be soon tremendously simplified with the public availability of the sequenced 
genome and micro array gene expression data. Identifying brain nucleus-specific 
regulatory regions would predict the identification of further genes bearing the same 
regulatory regions that may be expressed in the same area. In addition, these 
computational studies may help design promoter constructs for transgenic mice. 
4.7 Mechanisms of generation of diverse neurons and 
glia 
My thesis work also deals with the study of neural crest lineage diversification. 
Methodologically and intellectually, this work was rather different from the screens 
carried out to molecularly characterize the amygdala. In this case, a specific question was 
asked: is the neural crest a homogeneous cell population or rather, is it formed partly by 
cells with predictable fate biases? It was concluded in Chapter 3 that some neural crest 
cells are biased towards the generation of sensory rather than autonomic neurons in spite 
of producing neurons and glia indistinguishably. The demonstration of such 
diversification is important because it guides the way in which the problem of neural cell 
lineage segregation is further studied. Also, as mentioned in that chapter, together with 
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other recent work (Lu et aI., 2002; White et aI., 2001; Zhou and Anderson, 2002), this 
challenged the hitherto view that neurons and glia arise from separate neuronal or glial 
precursors. Thus it seems that general aspects of neuronal subtype identity (i.e. sensory 
vs. autonomic) can be acquired when progenitor cells are still capable of generating both 
neurons and glia. 
4.8 Long-term Applications 
The combination of hypotheses and techniques employed in this thesis will 
probably prove a very robust method for the study of nervous system development and 
function. For example, microarrays could uncover the molecular signature of not only 
every brain region, but also of every neural cell population during development, provided 
fine dissecting techniques, such as LCM, permit the isolation of specific cell types. One 
could thus effectively obtain a molecular brain atlas of the developing and adult brain, 
such that the information generated could serve to study problems at the level of detail 
similar to the work described in Chapter 3. There is evidence that the analysis of 
transcripts differentially expressed by specific neuronal populations during neurogenesis 
can shed light on their development (Kuhar et aI., 1993). Specifically, this work nicely 
shows how the identification of molecular markers uncovered phases in cerebellar 
histogenesis that were previously unrecognized. 
Last, the examples presented here pave the way for conducting hypothesis-driven 
approaches to global profiling of gene expression that will complement the findings 
obtained by more general screens undertaken with no preconceptions. Hence, broad, 
systems neuroscience questions will be finally addressed at molecular resolution. 
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